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One of the most significant changes in the management of tuber­
culosis over the past decade has been the trend to treat patients in 
general hospitals and outpatient clinics rather than within the con­
fines of a sanatorium. This decentralization could result in more and 
more laboratories receiving fewer and fewer specimens, a change 
which could’cause laboratory personnel to become less proficient in 
bacteriology at a time when the need for skill in identifying the many 
mycobacteria now recovered in the clinical laboratory is increasing.
The successful clinical management of tuberculosis has not been 
paralleled by a commensurate simplification of laboratory pro­
cedures or an ease of test performance. To the contrary, many new 
potentially pathogenic mycobacteria are now recognized, and 
refined digestion-decontamination procedures are needed to isolate 
these bacilli from clinical material; requests are made for suscep­
tibility tests against routine and less commonly used drugs and a 
multiplicity of complex in vitro tests are needed to insure that these 
new species are precisely identified. Strain-to-strain variation in test 
response and occasional inherent, erratic test results are some of the 
often unrecognized problems the clinical mycobacteriologist faces. 
Unless laboratory personnel perform these in vitro tests frequently, 
one must question whether they have enough day-to-day experience 
to maintain equipment, active test reagents, and the expertise needed 
to properly perform and interpret the many complex procedures re­
quired. As a general “rule-of-thumb” it is suggested that proficiency 
may be maintained by microscopic examination of 10- 15 smears per 
week, or by routine digestion and culture of 20 clinical specimens 
per week.
To counter this growing concern about the adequacy of diag­
nostic laboratory services, the American Thoracic Society issued a 
policy statement (1) recommending three different levels of laborato­
ry service, the components of which were detailed in a later publica­
tion (2). The functions to be performed at each level of service are 
indicated in Table 1.
L
L
The “Levels of Service” program is one of self-evaluation. All 
laboratory directors take pride in the capabilities of their personnel 
to perform various procedures and differential tests. Unfortunately, 
the time may come when a laboratory director finds that certain tests 
are performed so infrequently that the results are not creditable. The 
director must then decide either to (1) refer the test or procedure to 
another institution or (2) upgrade laboratory performance through 
appropriate programs of training and proficiency testing. This deci-
L.
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Table 1. Levels of laboratory service for mycobacterial diseases.
Level Type of Facility Type of Service —
I Physician's Office 
Outpatient Clinic 
Small Hospitals
Collect good specimens. Ship to 
Level II or III for culture. 
Microscopic examination. —
Treatment Center 
Selected Laboratories 
(City, County, State, 
or Private)
Collect specimens.
Microscopic examination. 
Cultural isolation of organism. 
Identification of M. tuberculosis. 
Susceptibility tests”.
Refer “other” mycobacterial 
isolates to Level Ill for 
identification.
—
III Reference Laboratory 
(State, Federal, Private)
All procedures of Level II. 
Identification of all 
mycobacteria. Susceptibility 
tests’ *
—
* Examples of Type of Facility are suggestive, not directive.
‘ Laboratory personnel should not perform susceptibility tests unless they (1) can iden­
tify the organism they are testing, and (2) perform a sufficient number of such tests to 
be cognizant of the many problems associated with the procedure.
sion is made after a careful review of laboratory procedures and cri­
tical self-evaluation. Here are some of the questions that should be 
answered before the decision is made. What is the frequency of re­
quested service for mycobacteriology in the laboratory? Does the 
work volume justify the time and effort currently allocated to 
mycobacteriology? Are you as a laboratory director confident of the 
results you provide the clinician (are they specific or vague)? Do you 
have the facilities required for the safe handling of specimens?
No guilt feelings should be associated with a negative response 
to any of these questions. If bacteriologists would remember that the 
clinician relies on the laboratory results to establish the diagnosis of 
mycobacterial disease and perhaps to prescribe curative therapy for 
his (her) patient, then the importance of accurate, dependable test 
results, and the need for honest self appraisal of laboratory perfor­
mance become obvious.
This manual was prepared as a guide for Level II laboratories 
only. Detailed procedures are presented for the isolation and precise 
identification of Mycobucterium tuberculosis. Methods for rough 
grouping all other mycobacteria on the basis of pigment production 
and speed of growth may help the reference laboratories to which
2
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these cultures are referred for more definitive testing. Details for 
drug susceptibility testing by the submerged disc method are given. A 
special section on safety emphasizes the importance of individual 
responsibility in a laboratory, the recognition of potentially 
dangerous laboratory procedures, and the need for preventive main­
tenance to insure proper functioning of laboratory equipment.
Detailed step-by-step procedures for all methods are presented, 
so other publications will only rarely need to be referred to. Selected 
references are provided at the end of each section. The authors 
welcome your critical evaluation of this training manual.
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A. INTRODUCTION
Laboratory-associated infections are an occupational hazard for all 
personnel working in institutions where infectious disease agents are 
handled (7), and M. tuberculosis is one of the most important causes 
of such infections. Studies have shown (3,8) that the risk of tuber­
culous infection is three to five times greater among workers in the 
mycobacteriology laboratory than among other workers (secretaries, 
maintenance personnel, etc.) in the same institution. Most such in­
fections are attributed to the unrecognized production of potentially 
infectious aerosols containing tubercle bacilli (or other mycobac­
teria). It is important, therefore, to recognize those procedures which 
may produce aerosols and to take measures to prevent, reduce, or 
control them. In the case of M. tuberculosis, the most dangerous aero­
sols are those that produce droplet nuclei (particles 5/u, m in size). 
Such particles remain suspended indefinitely in air, and unless some 
effort is made to remove them, by controlled airflow or ventilation, 
these droplet nuclei may move freely about the laboratory and may 
infect people remote from the site where the aerosol originated.
Some laboratory manipulations that have been shown (4,9) to yield 
aerosols comprised mainly of droplet nuclei 5/u.m or less are:
Pouring of cultures, supernatent fluids, etc.
Using fixed volume automatic pipettors 
Mixing a fluid culture with a pipette 
Using high speed blenders 
Using paint shaking machines 
Dropping tubes or flasks of cultures 
Spilling suspensions from pipettes 
Breaking tubes during centrifugation
To minimize the possibility of laboratory-associated infections, we 
strongly recommend that specially designed suites be used for tuber­
culosis bacteriology (see Fig. 1). Such sites are of value only if they 
are properly constructed, maintained, and used. Administrators 
should insure that essential safety equipment is available, and 
laboratory supervisors should provide necessary training in the han­
dling and use of such equipment. The laboratory worker should be 
taught how to handle potentially infectious materials in a safe man­
ner, and further instructed that, when handling such materials, he (or 
she) is responsible not only for his own safety but for that of his co­
workers.
k.
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Figure 1. Laboratory suite.
The safety measures recommended in this section were accumulated 
by personnel during years of infection-free diagnostic and/or 
research work. Many of the subjects discussed here are detailed in 
sections on Biosafety Level III in a new CDC publication (12).
B. PERSONNEL
Personnel should be selected with care. They should be physically 
and mentally capable. Before beginning work in the laboratory, all 
personnel should have (1) a tuberculin skin test, (2) a chest X-ray, 
and (3) training in safety techniques and procedures. Other steps in a 
uniform program of surveillance testing of tuberculosis laboratory 
personnel are difficult to cite because of many unknown factors. A 
consideration of two laboratories, the “safe” and the “unknown”, 
may offer guidelines.
6
c1. The Safe Laboratory
A laboratory may be considered safe if all personnel have 
been trained in correct laboratory procedures, if all equip­
ment (especially the biological safety cabinet) is functioning 
properly, and if a routine skin testing program has revealed 
no tuberculin converters among the staff. In such a well- 
documented situation, tuberculin-negative personnel need 
not be skin tested more often than annually, and X-rays 
would be required only if an individual exhibited symptoms. 
If there is a frequent turnover of personnel (e.g., rotation 
through the different laboratory services of the institution) 
skin tests should be done every 3 to 6 months rather than an­
nually.
2. The “Unknown” Laboratory
In this situation little or nothing is known about the tuber­
culin conversion rate in the staff, i.e., there is no evidence 
that safety procedures are adequate or that equipment is func­
tioning properly. The following protocol is recommended.
a. Retest tuberculin negative staff at 4- to 6-month intervals, 
until it is evident that all equipment is functioning properly 
and that staff members are adhering to safety procedures (i.e., 
no conversions are noted). Arbitrarily, 2 to 3 person-years of 
tuberculin negativity among laboratory workers should be 
evidence that good safety procedures are being practiced.
b. Require semiannual X-rays only for tuberculin-positive 
persons until evidence suggests that this is not necessary (i.e., 
no converters are seen among the tuberculin negative staff).
c. Monitor safety equipment and laboratory airflow to in­
sure optimal performance.
d. Discuss laboratory safety precautions with all laboratory 
personnel periodically.
If an employee converts from skin test negative to positive, do the 
following:
Refer the employee to a physician for care or appropriate treatment. 
Have the employee check his (or her) laboratory habits.
Reevaluate laboratory safety equipment and procedures.
Remember that even the best safety equipment is no substitute for 
meticulous technique on the part of a careful, safety-conscious bac­
teriologist.
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C. ROOM ARRANGEMENT AND CARE
Mycobacterial examinations should be permitted only in a laborato­
ry having a biological safety cabinet (BSC) that is tested and certified 
annually. A safe mycobacteriology laboratory should also have the 
following features:
1. A self-contained suite housing all equipment needed for pro­
cessing specimens from receipt to final report (Fig. 1).
2. A well-engineered one-pass ventilation system to maintain
airflow in one direction only, from ^ clean to a less clean 
area (indicated by bold arrows in Fig. 1). Short strips of 
tissue paper should be placed on air duct grills in doors and 
walls and in other appropriate locations as constant indica­
tors of the direction of airflow.
3. An exhaust system discharging air to the outside of the build­
ing at the roof or side into an area where the possibility of 
return to the building is minimal.
4. A separate room, within the suite, designated as the Isolation 
Room or Contaminated Area (see Figs. 1 and 2) and con­
taining a BSC to be used for all procedures which may gener­
ate potentially infectious aerosols (e.g., opening and process­
ing of clinical specimens, preparing slides, inoculating 
cultures, and performing in vitro tests). The exhaust air leav­
ing the BSC must pass through high efficiency particulate air 
(HEPA) filters before being discharged to the outside.
Airborne transmission is not the only route of tuberculous infection 
in the laboratory. The numerous manipulative procedures required 
to diagnose mycobacterial disease or to identify isolated bacilli, 
afford many opportunities for accidental infection. Uncovered cuts 
and abrasions provide a direct route for entrance of surface-con­
taminating organisms. A microbiologist may accidentally inoculate 
himself (or herself) with a needle and syringe or he (or she) may 
puncture the skin with contaminated, broken glassware. Because of 
these other routes of infection-uncommon though they are-all sur­
faces and all equipment within the isolation room should be regarded 
as potentially infectious. These should be regularly cleaned by 
whatever means is appropriate: disinfectant-swabbing, autoclaving, 
ultraviolet light. Good housekeeping is a cardinal rule in the Safe 
Laboratory.
General Maintenance in the Mycobacteriology Suite should be per­
formed only under careful supervision. Isolation room equipment 
should not be serviced, cleaned, or checked unless a trained tech­
nical or professional person is present to insure that adequate safety
8
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Figure 2. Isolation room.
precautions are observed. Before any major servicing the entire 
room, including the BSC, should be decontaminated (See VIII. Ap­
pendix. C. In Case of Accident, page 140). Later, the room, coun­
ters, and equipment should be swabbed with a 3% solution of amphyl 
(Lehn & Fink Industrial Products Div. of Sterling Drug Inc., 
Montvale, N. J. 07645) or an equally effective disinfectant. Use rub­
ber gloves.
Unauthorized persons should not be permitted in the Isolation 
Room. In the event of gross contamination (as by breakage of culture 
tubes), the entire room must be decontaminated (for details, see VIII. 
Appendix. C. In Case of Accident, page 140).
D. RECOMMENDED SAFETY EQUIPMENT AND SUP­
PLIES
Manuals describing the construction, use, maintenance, and decon­
tamination of Biological Safety Cabinets are available (1, 6, 10, 11). 
These manuals, as well as the descriptive literature from the 
manufacturer of the safety cabinet(s), should be available to 
laboratory staff and maintenance personnel.
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l. Biological Safety Cabinet (BSC)
The piece of equipment most needed to minimize the 
possibility of laboratory-associated mycobacterial infection 
is a well-maintained, properly functioning BSC. This may be 
either a negative pressure cabinet (Class I) or a vertical 
laminar flow model (Class II). No laboratory doing diag­
nostic mycobacteriology should be without a BSC. Use of a 
BSC does not mean that all chances for laboratory-associated 
infection are eliminated. Unfortunately, no BSC offers ab­
solute protection from infection. There is still no substitute 
for care and aseptic technique when performing all laborato­
ry procedures. Detailed instructions for use and maintenance 
of the Class II laminar flow bio-safety cabinet are presented 
elsewhere (6, 10, 11). Some basic instructions for properly 
functioning negative pressure (Class I) BSC follow:
a. Exhaust fan
(1) Make sure the fan draws a minimum of 75 linear 
feet of air per minute across the front opening. (The 
vertical laminar flow, or Class II, safety cabinet is 
preset at the factory to recirculate 70% to 90% of its 
air; the 10% to 30% room air drawn through the 
front opening provides an air barrier to minimize 
passage of airborne particles into or out from the 
cabinet work area. Trained or qualified personnel 
should periodically check the airflow in such 
cabinets.)
(2) Operate the fan during all manipulations with speci­
mens, cultures, or animals.
(3) Check the airflow every 3 months using an 
anemometer. Magnehelic gauges may be mounted 
on the cabinet to continuously monitor the pressure 
drop through the filters (airflow). When the air 
velocity at the front of a Class I cabinet drops below 
75 linear feet per minute, check to see that the 
exhaust blower fan is operating and that the pulley 
belts have not been broken. If the fan and pulley 
belts are functioning properly, it may be necessary 
to change the air filters in the BSC. Decontaminate 
the  ca b i ne t  wi th  an a p p r op r i a t e  gaseous  
formaldehyde (1) and install new filters.
b. Ultraviolet (UV) lights
(1) If the cabinet is equipped with UV lights for use in 
decontaminating the work surface, they will be
10
cmounted within the working area of the cabinet; use 
bulbs that emit rays primarily of wavelength 253.7 
nm.
(2) Do not operate the UV lights while the cabinet is in 
use because direct or reflected UV rays may burn 
the skin or eyes and may kill the mycobacteria.
(3) Turn the UV lights on immediately after finishing 
work in the cabinet and let them stay on for a 
minimum of 1 to 2 hours. (Continuous operation 
when the cabinet is not in use costs very little and 
may be more convenient.) UV light has very little 
penetrating power and only supplements proper 
airflow, chemical disinfection, and careful tech­
nique.
(4) Clean bulbs at least every 2 weeks (more often in ex­
cessively dusty areas) with a soft cloth soaked with 
ethyl alcohol to remove residue and dust.
(5) Check UV bulbs at least every 3 months for efficien­
cy of output. Use a portable UV intensity meter cap­
able of measuring UV radiation at a wavelength of 
253.7 nm. Visible blue light is NOT a reliable in­
dicator of germicidal UV output (253.7 nm). When 
output drops below 70% of initial reading for the 
bulb, replace the bulb.
c. Place a gauze pad (4-6 thicknesses) or towel (plastic- 
backed absorbent pads, such as disposable diapers, are 
acceptable) soaked in disinfectant (e.g., 3% amphyl) over 
the immediate work area in the BSC. This will minimize 
spatter or aerosols from spilled fluid. and disinfect viable 
organisms in such spills.
2. Protective Clothing
a. Wear a protective outer garment when handling infec­
tious material. The back fastening hospital surgical gown 
is good because the sleeves fit closely at the wrist and do 
not drag in the work area. The knitted cuff provides a 
good “seal” for surgical gloves and protects arms from 
infectious agents. An added safety factor is that the 
hospital gown is readily identified as belonging in the 
isolation room of the laboratory and not in the general 
work area. Front button laboratory coats are unsuitable 
( 12).
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b. Wear face masks (5) designed to filter >90% of particles 
in the size range 0.5 to 1.0 pm. Masks must fit the face
tightly (e.g., molded or cup-style masks). Remember, no 
BSC is 100% effective, failures sometimes occur, and the 
mask adds an additional measure of protection.
c. Wear rubber gloves; they guard against infection through 
cuts or abrasions on the skin.
d. Wear autoclavable or disposable shoe covers and caps;
they greatly minimize the chances of removing any in­
fectious agents from the isolation room.
e. Discard all protective clothing into covered containers or
laundry bags and autoclave before washing or disposing 
of the contents. Clothing, or even glassware, that is tightly 
packed in a container may have to be autoclaved for up to 
2 hours. Use spore strips to determine time required for 
representative loads.
3. Centrifuges
To minimize chances of infection from aerosols that result 
when tubes crack or shatter, centrifuge all digested clinical
specimens or suspensions of pure cultures in domed O-ring 
sealed aerosol-free safety carriers. Remove tubes from the 
safety carriers only inside the BSC (to minimize widespread 
distribution of aerosol in the event a tube does break in the 
aerosol-free carrier). An alternative to using safety carriers is 
to construct a separate air filtration system for centrifuges to 
control potentially infectious aerosols from shattered tubes 
(2) .  ‘
4. Safety pipetting devices
NEVER mouth pipette in the mycobacteriology laboratory. 
This is not based entirely on fear that infected material may 
be aspirated, but rather on the fact that a dangerous aerosol 
results from alternately sucking and expelling fluid through 
the pipette; in mouth pipetting, the nose is directly over the 
tube or flask in which the bacterial suspension is being mix­
ed. Several safety pipetting devices are available and should 
be used. See I.F.2, p. 18.
5. A utoclave
Place the autoclave in a convenient location (preferably with­
in the mycobacteriology suite) so that contaminated material 
and reusable items can be sterilized before being disposed of 
or washed. Monitor the autoclave with some sterilization 
check system.
12
e6. Splash proof container
To minimize the chance of contaminated fluids (e.g., super­
natant fluids from digested sputa) splashing back onto sur­
faces of the BSC, discard them in a special container. Two 
examples of such containers are shown in Figure 3.
1” below 
side arm
- 5 %  phenol
glass flask
Figure 3. Splash proof containers.
('
7. Alcohol-sand flask
Use an alcohol-sand flask to remove large clumps of bacilli 
or organic debris from wire loops or spades before flaming. 
The abrasive action of the sand cleans most of the debris 
from the wires and when the loop or spade is placed in the 
flame of a Bunsen burner, the alcohol causes rapid incinera­
tion of residual debris. See Figure 4 below.
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8. Culture transfer spade
Use a culture transfer spade to transfer solid culture growth 
from one medium to another. It is especially useful in making 
the heavy suspensions recommended for some in vitro tests. 
The spade, made of heavy (18-gauge) nichrome wire flat­
tened on one end by hammering to make an area 5 - 1 0  mm 
long by 0.3 to 0.5 mm thick, may be inserted into the handle 
normally used to hold an inoculting loop or needle. W ire of 
lighter gauge will bend in the sand. Use the spade with the 
alcohol-sand flask. See Figure 5 below.
9. O ther safety equipment and instructions
a. BE PREPARED. Have a container of 3% amphyl in ev­
ery room where specimens and cultures are handled or 
stored. In case of an accident, cover broken culture or 
specimen containers with cloth or paper towels, flood 
with amphyl, and let stand at least 1 hour before mopping 
up. If a culture or specimen container breaks in an open 
room, consider entire area contaminated with aerosol. 
Consult VIII. Appendix.C. In Case of Accident, page 
140.
b. Disinfectants
The killing action of disinfectants or germicides is not 
instantaneous, but varies from 15 to 30 seconds to 30 
minutes or longer, depending upon the concentration, 
presence of organic debris, and other factors. Some dis­
infectants, e.g., the quaternary ammonium compounds,
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cwill not kill tubercle bacilli. For general cleanup, use 
phenolics; use 3% amphyl, 2% cresol, and 3% lysol for 
tough clean-up jobs in the presence of organic debris, but 
handle these solutions only with rubber gloves to avoid 
skin irritation or bums. If contaminated materials are in- 
adverently handled with the bare hands, rinse hands with 
70% ethyl alcohol or a saponated phenolic disinfectant,
then wash thoroughly with soap and water.
c. Aerosol-free safety blenders
Although aerosol-free safety blenders permit infected 
tissues to be homogenized safely, the dangerous aerosol 
created persists inside the chamber for over an hour, so 
open only in a BSC. NEVER use ordinary kitchen-type 
blenders to homogenize infected or possibly infected 
tissues.
Fit specimen containers and test tubes with screwcaps 
lined with rubber, teflon, or other plastic.
Have covered discard pans available for all contaminated 
glassware or material. Be certain disinfectant or water is 
in the discard pan before the pan (with its contaminated 
contents) is placed in the autoclave. I f  the containers 
must be taken out of the mycobacteriology suite for 
autoclaving, tape the containers to minimize splatters or 
aerosols in the corriders. To permit free circulation of 
steam, remove the tape at the time the container is placed 
in the autoclave.
d
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f. If possible, use heat-adjustable slide warming tables set at 
65°C to 75°C for heat-fixing smears.
g. Carry tubes and plates containing cultures to and from
the incubators, BSC, and other locations in racks and 
baskets because they accidentally slip out of bare hands 
too easily.
h. If  possible, have foot operated controls for soap and 
water at the lavatories.
E. PRECAUTIONS IN THE ISOLATION ROOM
1. Before entering—
a. Assemble all materials and equipment. Label specimens, 
tubes for processing, media to be inoculated, slides, etc., 
and place them on a laboratory cart to be wheeled into 
the isolation room.
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b. Have extra supplies (media, dilution tubes, pipettes, and 
reagents) within easy reach of the isolation room.
c. Plan other work to do while in the laboratory, e.g.,
transfer cultures or make smears. There is often much 
“dead time” in the isolation room when the centrifuge is 
running; this time can be used productively if you plan 
ahead. Keep a check list, if necessary.
d. Put on protective clothing listed in D.2, p. 11.
2. ONCE IN THE ISOLATION ROOM, DO NOT LEAVE 
UNTIL YOUR TASK IS COMPLETED. If  you need addi­
tional equipment or supplies, ask someone to get them for 
you.
3. Consider everything in the isolation room potentially infec­
tious. Let no one enter without full protective clothing.
4. Perform ALL manipulations of specimens and cultures (ex­
cept centrifugation) inside the BSC (Fig. 6). Work over a 
gauze pad or towel soaked in 3% amphyl. Rewet the pad if it 
dries out.
5. Before opening any specimen container, disinfect the outside 
by wiping it with gauze soaked in 3% amphyl. The container 
may have been contaminated while the specimen was being 
collected or by leakage in transit.
6. Autoclave inner metal mailing container before reuse 
because it may be contaminated.
7. Place laboratory request slips, which accompany specimens, 
in a paper bag and autoclave before allowing the record clerk 
to handle them.
8. Perform all operations involving agitation of specimens only 
in aerosol-free containers or within the BSC.
9. Centrifuge specimens only in aerosol-free safety carriers or 
in a centrifuge equipped with an air exhaust system (see D.3
p. 12.
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£10. Heat fix all smears either on a slide warmer at 65°C for at 
least 2 hours (overnight is acceptable) or by passing 3 times 
slowly through the blue cone of the flame from a Bunsen 
burner. If  slides are left in the BSC for any length of time, 
shield them from UV rays which may render some mycobac­
teria nonacid-fast.
11. BEFORE flaming, clean inoculating loops or spades in an 
alcohol sand flask (see Fig. 4 and 5).
12. Always use safety pipetting devices (see Fig. 7). 
mouth pipette.
DO NOT
L
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13. Place all materials to be discarded into covered pans con­
taining 3% amphyl. Autoclave before sending to washroom. 
Certain materials may be damaged by autoclaving in 
phenolics (e.g., reuseable plastic centrifuge tubes may dis­
solve or craze); in such cases, use water in place of 3% 
amphyl.
14. Discard contaminated or potentially contaminated fluids 
into splash-proof containers (see Fig. 3) containing disinfec­
tant. Autoclave container before disposing of contents.
15. When work is completed and BEFORE leaving the isolation
room:
a. Cover all discard pans. Contaminated material must be
in covered containers when brought out of the isolation 
room.
b. Wipe the outsides of discard containers and culture tubes 
with disinfectant soaked gauze before bringing them out 
of the isolation room. Dip racks of culture tubes into a 
disinfectant bath (up to the screwcap) instead of swab­
bing individual tubes.
c. Swab the work area of the BSC, counters, and cart with 
3% amphyl or some other disinfectant. Scrub the area 
periodically with detergent solution to remove the oily 
residue of some disinfectants.
d. Place the gauze pad which covered the work area in a
covered container containing 3% amphyl.
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e. Turn on UV lights in the work area of the BSC (before 
doing so, remember to cover any microscope slide smears
that are left in the BSC).
f. Remove protective clothing (the MASK LAST) and
place in a covered container or laundry bag, which is left 
inside the isolation room. When the container or bag is 
full, autoclave it before laundering or disposing of con­
tents.
16. Upon leaving the room, scrub hands and arms well with soap 
and water. Do not wear watches or bracelets in the BSC room 
because they interfere with thorough cleansing of hands and 
arms.
F. HANDLING EQUIPMENT AND TOOLS PROPERLY
BEFORE beginning any work with potentially infectious material, 
be certain you know how to operate all the safety equipment you have 
and how to use those laboratory tools which can greatly minimize 
chances for laboratory-associated infection. Familiarize yourself 
with these tools. Try them first with a beaker of water or a heat-killed 
culture.
Work in an uncluttered area. This alone will reduce greatly the 
possibility of accidents.
1. Arrangement of equipment in the Class I BSC
Figure 6 shows a suggested arrangement of the work area in 
the BSC. NOTE ESPECIALLY that the area immediately in 
front of the worker is clear, thereby facilitating the handling 
of specimens and cultures. Any drops or spatter from 
pipettes, loops, tubes, etc. will probably fall onto the disinfec­
tant-soaked gauze, rather than onto other tubes or racks in 
the work area.
2. Safety pipettors
Several kinds are available commercially. Two that have the 
advantage of handling pipettes of variable volume (if needed) 
are the Propipettor and the Caulfield pipettor; follow 
manufacturer’s directions for use. Rubber bulbs are some­
times used on pipettes of 1 -ml volumes or less.
An inexpensive pipettor for use with pipettes of 1 -ml volume 
or less may be made by cutting 2 l/2-to 3 -inch pieces of flex­
ible rubber tubing that will fit snuggly over the pipettes you 
will use and inserting a small cork or rubber stopper in one 
end of the tubing.
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eTo operate, simply place the rubber tubing on a pipette, and 
BEFORE inserting it into the bacterial suspension you wish 
to pipette, expel the air from the pipette by rolling the tubing 
over the thumb of your right hand (the hand holding the 
pipette). After inserting the pipette tip into the bacterial 
suspension, gradually release the “rolled” tubing back to its
1
A key to letters on Figure 6 follows:
a. Discard pan for reusable pipettes.
b. Discard pan for test tubes, flasks, etc.
c. Discard container for disposables, plastic, paper, etc.
d. Splash-proof waste container for contaminated liquids (Figure 3).
e. Bunsen burner. The rubber connecting hose should be long enough 
for the flame to be within easy reach. Avoid over-heating the room 
by keeping flame low.
f. High-speed mixer to left of worker. Move to rear after processing 
specimens, if space is needed for work area.
g. Slide warmer to extreme left.
h. Pipette cannisters at right.
i. Alcohol-sand flask for cleaning spade or loop (Figures 4 and 5).
j. Safety pipetting devices, interval timers, pencils, loops, forceps, and
other small equipment.
k. Racks for tubes during processing, etc.
NOTE: This arrangement leaves a clear area immediately in front of the 
worker for handling specimens. Thus, any drops or invisible spatter are 
more likely to fall on the gauze, not the work.
Figure 6. Equipment in a biological safety cabinet (modifications may be necessary for 
other types of safety cabinets).
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Figure 7. Several types of safety pipettors: (a) Pipette filler; (b) Caulfield; (c) Rubber 
tubing pipettor (home made); (d) Rubber bulb.
Figure 8. Using the rubber tubing pipettor.
A. Cradle pipette over index finger and between tips of second and third fingers.
B. Expel air by “rolling” rubber tube over thumb with index finger.
C. Insert pipette into fluid suspension.
D. Suck up inoculum by slowly “unrolling” rubber tubing.
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E3.
normal position, thereby aspirating the culture suspension 
into the pipette.
Figure 7 shows several of these pipettors, and Figure 8 shows 
how to use the “rubber tubing” pipettor.
Practice using one of these types of pipettors with a beaker of 
tap water until you can control both the aspiration and deliv­
ery of desired volumes of fluid.
Proper removal of screwcap cover from test tube
Because most mycobacteria have a long generation time 
(12-l 8 hours), media inoculated with these organisms must 
sometimes be incubated up to 6 to 8 weeks or longer before 
being discarded. To retard dehydration during prolonged in­
cubation, place inoculated media in screwcap tubes or bottles 
(exceptions are the oleic acid albumin agar media commonly 
placed in Petri dishes).
To minimize contamination of screwcap-covered media, use 
aseptic technique in removing caps and inoculating media, 
just as one would use care in removing a cotton plug from a 
tube of medium in the general bacteriology laboratory.
DO NOT remove caps from tubed media and place them on 
the work surface while the medium is being inoculated. This 
is an open invitation to more rapidly growing (12- 18 minutes 
generation time) contaminating organisms, which can ruin 
your tuberculosis (TB) isolation media.
Assuming you are right-handed, (left-handers will use the op­
posite hands) grasp the test tube in the left hand. Place the lit- 
tie finger of the right hand around the screwcap (see Fig. 9). 
Hold the right hand rigid, and with the left hand unscrew the 
tube from the cap (the reason for this is that you may also be 
holding a loopful or pipetteful of inoculum in the right hand 
and you do not want to be waving this around in the air).
The opened tube should be held at about a 45” angle, with the 
opening facing the inside of the BSC to minimize contamina­
tion.
Hold the cap in your little finger while you remove inoculum 
^  from or inoculate the medium in the tube.
NEVER set the cap down on the work surface.
To reclose the tube, again hold the right hand rigid, and with 
»■. the left hand move the test tube up to the cap which is still
held by the right little finger. Once the tube is inside the cap, 
screw it down tightly with the left hand (see Fig. 9).
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4. Inoculating tubes of media with loops, spades, or pipettes.
The procedure for inoculating tubes of media with loops, 
spades, or pipettes varies only slightly from that described in
F.3 above and Figure 9. Remove and replace the cap exactly 
as before, except hold the tool for inoculating the screwcap- 
ped tube of medium in the right hand.
By using only the little finger to remove the test-tube cap, you 
have the thumb and first three fingers of the right hand to 
hold a loop, spade, or pipette.
Loops or spades can be easily held with the thumb and first 
two fingers. Because the pipette with an attached rubber tub­
ing safety pipettor may be the most difficult to maneuver, we 
will outline the procedure.
Cradle the pipette over the index finger and between the tips 
of the second and third fingers, as shown in Figure 10.
Figure 9. Removal of a screw-cap cover from a test tube.
A. Place little finger of right hand around screw cap.
B. Hold right hand rigid and unscrew tube from cap by turning left hand.
C. Remove tube from cap, but always point open end inward at about 45” angle.
D. Recap tube by holding right hand (and cap) rigid, while using left hand to screw tube 
back into cap.
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£Figure 10. Inoculating a tube of medium with a pipette.
A. Pipette cradled in rigidly held right hand; screw cap removed from tube 
(see also Figures 8 and 9).
B. Roll tubing over thumb and insert pipette into microbial suspension.
C. “Unroll” tubing to suck up inoculum.
D. Hold pipette hand still; remove tube from pipette and flame tube opening.
E-F. Recap the tube and replace in rack.
G. Select from rack the tube of medium to be inoculated.
H . Remove'cap in usual way, slide tube over pipette tip, and deposit desired amount of 
inoculum.
Remove the cap from the test tube, using the little finger of 
the right hand, as detailed in F.3., p. 2 1.
Hold the pipette hand stationary and unscrew the tube with 
the left hand.
When the cap is off, expel the air from the pipettor by folding 
the rubber tube over the thumb with the index finger (see 
F.2., p. 18, and Figure 8); insert the pipette into the opened 
tube and suck up the desired inoculum.
Hold the pipette hand still, and REMOVE THE TUBE 
FROM THE PIPETTE instead of pulling the pipette out of 
the tube.
While holding the pipette hand rigid, flame* the mouth of the 
open test tube and move it back into position in its cap. 
Tighten the tube and replace it in its rack.
Holding the pipette hand still, use the left hand to pick up the 
tube to be inoculated, and move the cap into position in the 
little finger of the right hand.
Go through the tube-opening process again.
Tilt the pipette tip downward slightly, to meet the open 
mouth of the now uncapped test tube. Deposit the desired in­
oculum, remove the tube from the pipette, flame, and recap as 
before.
Use the same procedure when carrying the inoculum on a 
spade or loop.
REMEMBER, keep the hand which holds the inoculating 
tool as still as possible because any excess movement could 
release potentially infectious aerosols.
5. Preparing culture suspensions from solid medium
Using the technique described in 3. and 4., pp. 21-22, asep- 
tically add 0.5 ml of sterile water or saline to a sterile screw- 
cap test tube. Take the wire spade in your right hand (see 
Figure 1 la) and sterilize it by heating it red hot in the blue 
cone of the Bunsen burner flame. Let the spade cool.
•Flaming the mouth of the test tube is an optional procedure. Flaming probably is 
not necessary in laminar flow safety cabinets (Class II). With negative pressure 
(Class I) cabinets, decide whether to llameafter determining theextent of contamin­
ation encountered without flaming.
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EPick up in your left hand the culture slant from which the 
bacterial suspension will be made and carefully remove the 
screwcap as described in 3. (p. 21) (see Figure 1 lb). Now 
flame the mouth of the tube.
Carefully insert the spade into the tube and position it so that 
the long flat plane of the spade is perpendicular to the surface 
of the slanted medium (Fig. 11 c). Scrape some growth off the 
surface of the culture slant with the spade. CAUTION: You 
only want bacterial growth, not medium, so’avoid scraping 
up pieces of the medium.
Carefully remove the spadeful of growth from the culture 
tube, flame the tube, and recap it as in 3., p. 2 1.
Pick up the tube containing the 0.5 ml sterile water, and 
carefully unscrew the cap. D ON ’T FORGET to hold the 
hand with the spadeful of growth stationary. The left hand 
does all the moving.
Flame the mouth of the tube and tip it so that the water flows 
up and wets the wall of the tube about 1 inch (25 mm) above 
the fluid surface (see Fig. 1 Id).
Bring the mouth of the tube up to the bacteria-ladened tip of 
the wire spade.
Insert the spade into the tube, being careful not to touch the 
sides of the tube because this might dislodge some of the 
growth.
Bring the tip of the spade (with bacteria on it) down to the 
portion of the tube with the wet wall.
k_ Turn the spade so the bacterial growth faces the wet glass wall
of the tube (Fig. 1 le).
Macerate the bacilli by moving the spade in a circle against 
the wet wall of the tube (Fig. 1 If)-
Always hold the tube at a 45” angle with the open end facing 
slightly inward to keep airborne contaminants from entering 
during this sometimes lengthy process.
When maceration is complete, use the tip of the spade to push 
the bacterial mass into the reservoir of fluid at the bottom of 
the tube (Fig. 1 lg).
Your inoculum is now ready for further standardization, if 
necessary, e.g., by turbidimetric methods or comparison with 
optical density standards.
See Figure 1 1 for details.
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Figure 11. Preparing culture suspension from solid medium.
A. Sterilize inoculating spade in Bunsen burner flame.
B. Remove screw cap from tube of culture. (See Figure 9.)
C. Insert blade of spade so long flat plane of spade is perpendicular to surface of medium; 
carefully scrape up bacterial growth. Recap culture tube and return to rack.
D. Tip test tube of water so that fluid wets wall 1 inch (25mm) above fluid surface.
E. Remove cap from tube of water and insert bacteria-laden spade and turn bacteria 
toward the wet wall of test tube.
F. Macerate bacillary mass by moving spade in circular motion against wall of test tube.
G. Push macerated bacilli down into fluid with tip of spade.
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6. Preparing serial tenfold dilutions
This requires a combination of the procedures described in
3. and 4. (pp. 21-22).
Serial tenfold dilutions of a heavy bacterial suspension are 
frequently needed in the mycobacteriology laboratory to (a) 
obtain isolated colonies on media later inoculated with a 
suitable dilution, (b) provide proper inoculum size for cer­
tain in vitro tests, or (c) prepare a bacterial suspension con­
taining appropriate numbers of bacterial cells to insure a
valid drug susceptibility test result.
To obtain these tenfold dilutions, make a series of successive
transfers of 1 part of bacterial suspension to 9 parts of sterile, 
bacteria-free diluent (water or saline). Do this by transferring 
1 ml of bacterial suspension to 9 ml of sterile water (or 0.5 
ml of bacterial suspension to 4.5 ml of diluent).
Aseptically pipette the dilution blanks (4.5-or 9.0-ml 
amounts) into sterile tubes as described in 4. p. 22 above by 
using a Propipettor or other pipettor for larger volumes of 
fluid. Alternatively, add the desired fluid volumes to non­
sterile screwcap tubes, tighten the caps securely, and sterilize 
the tubes in the autoclave (12 1 °C/1 5 minutes).
Place the starting bacterial suspension, with the desired num­
ber of dilution blanks, in a test-tube rack. Leave the first hole 
of the rack empty; then, as each tube is opened and used for 
dilutions, move it one place to the left in the rack, thereby in­
dicating that inoculum has been removed from that tube and 
used (this avoids the confusion of not knowing which tubes 
have been used and which have not).
Prelabel all dilution tubes with the final bacterial dilutions 
they will contain. The starting suspension is undiluted (U or 
10°). The first tenfold dilution is 1: 10 (or 10 1), the second 
1: 100 (or 1 0'2) the third 1: 1000 (or 1 0 3), etc.
Premix the starting bacterial suspension on a test tube mixer 
to get a homogeneous mixture.
Using skills learned in 3. and 4., pp. 21-22, aseptically 
remove the screwcap from the starting suspension, flame the 
mouth of the tube, and remove exactly 1 .0  ml (or 0.5 ml) of 
bacterial suspension from the tube, using a pipette and safety 
pipettor.
Flame the original tube, replace the cap, and place the tube in 
the left-most hole in the rack (indicating you are finished 
with the tube). Quickly pick up the “ 1 0 1 tube” in your left
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hand, aseptically open, and add the contents of your pipette 
to this tube.
Flame the tube, replace the cap, and then discard the used 
pipette into a long, low pipette discard pan containing some 
phenolic disinfectant (see Fig. 6).
Place this newly inoculated “ 1 O' tube” onto a test-tube mixer 
to thoroughly mix the contents. The bacterial population in 
this diluted tube now contains 10 times fewer (one tenth as 
many) bacteria per unit of volume than does a similar volume 
from the undiluted tube.
Place the safety pipettor onto another sterile pipette, and 
using procedures in steps 3. and 4. (pp. 21-22), remove the 
cap from the “ 1CT1 tube,” flame the mouth, and remove ex­
actly 1.0 ml (or 0.5 ml) of the suspension from this tube.
Flame the opening of the “ 1 0 1 tube,” recap it, and place it in 
the rack immediately next to the undiluted tube.
Pick up the “ 10 2 tube” in your left hand, open and flame it, 
and add to it the contents from the pipette.
Flame the tube, replace the cap, and then discard the used 
pipette as described above.
After mixing this “ 10 2 tube” on a test-tube mixer you will 
have a suspension with 10 times fewer (one tenth as many) 
bacteria than in the 10-' tube or 100 times fewer organisms 
than in the starting, undiluted suspension (e.g., 1/10x1/10 = 
1 /100 dilution).
Continue making similar dilutions until you have the desired 
concentration (see Fig. 12).
1.0 ml 1.0 ml 1.0 ml 1.0 ml 1.0
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Figure 12. Diagram for tenfold dilutions.
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7. Inoculating biplates or quadrant plates of agar medium 
with a capillary pipette.
When Middlebrook 7H- 10 or 7H- 11 agar is used for prim­
ary isolation of mycobacteria, the medium is usually placed 
in two-section plastic Petri dishes (biplates). Drug suscep­
tibility tests of tubercle bacilli are usually done in 7H- 10 
agar contained in four-sectioned plastic dishes (quadrant 
plates).
The capillary pipette often is used to place several drops of 
appropriate inoculum onto the agar medium in these sec­
tioned dishes.
Again, using procedures described in 3. and 4., pp. 21-22, 
place an appropriate safety pipettor onto a sterile capillary 
pipette and select the tube of inoculum to be used for the sec­
tioned dish.
Carefully remove the screwcap from the culture tube and 
flame the tube.
Expel some air from the capillary pipette by squeezing the 
bulb or rubber-tubing pipettor (a little experience will teach 
you how much the tubing or bulb must be squeezed for the 
small-volume capillary pipette). Place the pipette tip into the 
bacterial suspension and suck up the fluid. After removing 
the pipette from the test tube, flame and recap the tube, and 
replace it in the culture rack.
Using the thumb and middle finger of the left hand, remove 
the cover from the sectioned dish. CAUTION: Tilt the cover 
back toward yourself; if the cover is not held too far from the 
dish, it will act as a barrier to prevent airborne contaminants 
from impinging on the medium in the dish (see Fig. 13a).
Place the pipette tip at about a 45” angle and directly over the 
portion of medium to be inoculated (Fig. 13b).'
Squeeze the bulb to release one free-falling drop of in­
oculum. To minimize aerosol, touch the drop of inoculum to 
the surface of the medium just before it drops free of the 
pipette tip (Fig. 13c).
Space out three such drops on the surface of the dish, as 
shown in Figure 13 d. Each drop contains about 0.05 ml, so 
each section receives about 0.15 ml of inoculum. The drops 
may be left discrete and need not be spread to cover the sur­
face.
Replace the cover of the dish and discard the used pipette 
into a pan containing disinfectant.
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Figure 13. Inoculating plates of media with a capillary pipette
A. Tilt the cover of the plastic dish back toward yourself:
B. Pipette-ful of inoculum is held at 45” angle directly over portion of dish to be 
inoculated.
C. Touch the drop of inoculum to the surface of the medium just before it drops free 
from the pipette.
D. Three such drops of inoculum are usually placed on each section of the dish.
8. Spreading the inoculum over the surface of the medium
As an alternative to the procedure described in 7. (p. 29) per­
sonnel in some laboratories prefer full plates instead of sec­
tioned dishes of medium, or they prefer to spread the in­
oculum over the entire surface of the medium.
In such cases, place the desired volume of inoculum on the 
surface to be inoculated.
A convenient “spreader” may be made (with a bit of practice) 
from a sterile capillary pipette (follow drawings in Fig. 14).
Remove a sterile capillary pipette from the pipette cannister 
and carefully insert only the very tip of the pipette into the 
blue cone of flame in the Bunsen burner so that the end of the 
pipette is sealed with a ball of melted glass (Fig. 14a).
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Next make a bent “spreading arm” in the sealed pipette. The 
length of the “arm” depends upon the size of the dish being 
“spread.” If a full 1 00-mm dish is to be spread, make the arm 
about 40 mm long. If  a biplate or quadrant dish is to be 
spread, make the arm only 20-25 mm long. These spreaders 
can be made easily and quickly, so an occasional “bad” 
spreader should be discarded and a new one made. Again, 
practice in preparing these spreaders is the key to a good pro­
duct.
C
Figure 14. Preparation of a glass inoculum spreader.
A. Heat seal the open end of a capillary pipette in the blue cone of a Bunsen burner flame.
B. Hold pipette parallel to table top and heat at the point where bend is desired.
C. When tubing starts to bend, remove from flame but continue to hold parallel to table 
top; if properly done, a bend of 90” is usually obtained.
k.
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Holding the pipette parallel to the counter top, place the 
capillary tubing in the tip of the blue cone of flame at the 
point where you want the tubing to bend (Fig. 14b).
The moment the tubing begins to bend, remove it from the 
fire, but continue to hold the pipette parallel to the counter 
top.
The weight of the hot, bending glass is usually enough to 
create an angle of almost 90” (see Fig. 14c).
Allow the hot tubing a few moments to cool, and then spread 
your inoculum over the surface of the medium.
Discard the bent spreader immediately after you have 
finished with it.
9. Inoculating the “spinner” plate
The “spinner” plate method is a fast way to spread an in­
oculum on the surface of a full (not sectioned) dish of 
medium, with the intention of obtaining isolated colonies for 
observation and/or selective picking. You will need a Spray- 
Fisher Petri dish turntable.
Place the dish of medium to be inoculated onto the dish 
turntable. Using aseptic procedure, as described in 3. and 4. 
(pp. 2 1-22), remove a loopful of inoculum from the bac­
terial suspension from which you would like to obtain a 
growth of isolated colonies. Hold the loop in the right hand.
Using the thumb and middle finger of the left hand, remove 
the lid from the dish, and with the ring finger of the same 
hand, give the turntable a sharp pull toward you to set it spin­
ning counterclockwise (Fig. 15a).
The next procedure depends upon whether you wish to see 
isolated colonies in the center or at the periphery of the dish.
For isolated colonies in the center, touch the full face of the 
inoculating loop to the surface of the rotating plate at the 
outer edge (near 8 or 10 o ’clock), and gradually move it 
toward the center of the dish (Fig. 15b). NOTE: the dish is 
rotating through all this procedure. The resulting inoculum is 
in the form of a gradually decreasing spiral.
When the loop reaches the center, lift it from the medium, 
stop the turntable, and replace the cover on the dish.
For isolated colonies at the periphery of the plate, touch the 
loop of inoculum to the middle of the rotating dish and push
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it toward either 8 or 10 o’clock, lifting the loop just before it 
touches the edge of the dish (Fig. 15c).
Some culture suspensions (e.g., rapid growers) are extremely 
heavy and might still show confluent growth when inoculated 
as described above.
For heavy suspensions, dip the inoculating loop into the 
suspension, touch the loop to the side of the test tube to break 
the film of culture suspension, and then inoculate the spin­
ning plate as described above, using this “empty” loop as in­
oculum.
For even heavier suspensions, touch the “empty” loop to the 
rotating plate with the edge of the loop rather than the full 
face.
Figure 15. Inoculating the “spinner” plate.
A. Remove lid from dish with thumb and middle finger of left hand; use “ring” finger to 
spin dish counterclockwise.
B. To obtain isolated colonies in center, touch loop of inoculum to surface of rotating 
plate at outer edge (near 8 -or 10 -o'clock) and gradually move toward center. Lift 
loop when it reaches center of dish.
C. To obtain isolated colonies near periphery, touch loop to center of rotating dish and 
push it toward 8- or IO- o’clock. Lift loop before it touches edge of dish.
D. For heavy suspensions touch loopful of inoculum to inside wall of test tube to break 
film of culture suspension and/or inoculate plate with loop held on edge.
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See Figure 15 for drawings of the methods described.
A properly “streaked” plate should have five to eight spiral 
turns on it. It takes some practice to have the dish rotating at 
the right speed and to move the loop across the medium at the 
right speed (not too rapidly) to get a good spiral. Once 
mastered, however, the technique is a great time saver.
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A. COLLECTION
The definitive diagnosis of tuberculosis (or other mycobacterioses) 
demands that tubercle bacilli (or other mycobacteria) be isolated 
from clinical specimens submitted to the laboratory for culture. The 
efficiency of any laboratory procedure used to culture mycobacteria 
from clinical specimens depends on the manner in which the speci­
men is obtained and handled afterwards. Therefore, specimens must 
be collected with the utmost care and promptly transported to the 
laboratory.
For optimal results, clinical specimens should be collected before 
chemotherapy is started, because even a few days of drug therapy may 
kill or inhibit sufficient numbers of bacilli to leave the bacteriologic 
confirmation of disease in doubt. Specimens must be collected in 
clean, sterile containers. To minimize the possibilities of saprophytic 
or nonviable mycobacteria being carried from one specimen to 
another, use one-use disposable plastic containers; if this is not possi­
ble, use glass containers which have been cleaned with dichromate 
sulfuric acid or other good cleaning solution.
Mycobacteria may localize in almost any organ of the body, so the 
laboratory may expect a variety of clinical materials to be submitted 
for examination. Because tuberculosis is primarily a pulmonary dis­
ease, most of these specimens will be secretions from the lungs.
The microbiologist should be prepared to process all intact speci­
mens received, but he, or she, also should call the attention of attend­
ing medical personnel to inadequate specimens or possible reasons 
for negative culture reports (e.g., insufficient specimen, leakage in 
transit, and excessive delay in transport). The successful isolation of 
the causative agent of disease depends upon an adequate volume of 
specimen, properly collected and transported, and carefully pro­
cessed.
The major kinds of specimens received in the laboratory will be dis­
cussed separately.
1. Sputum
A series of three to six single, early morning specimens (2,10) 
usually collected on successive days, are easy to handle in the 
laboratory and are less likely to be contaminated, especially 
if they are delivered by mail (7). In contrast, if the specimens 
are not mailed (i.e., if they are processed at the same institu­
tion in which they were collected), pooled sputum specimens
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have been shown (9) to yield significantly more positive 
cultures than single morning collections. The same study 
showed however, that the single specimens yielded growth 
much earlier than the pooled specimens, so each kind of 
specimen has its advantages under appropriate circum­
stances. The choice of how many specimens to submit for in­
itial diagnosis may be regulated by careful microscopic ex­
amination of smears prepared from digested, concentrated 
sputa. If smears are strongly positive, three specimens may be 
sufficient to confirm the diagnosis. The patient whose bacilli 
are difficult to detect on a smear should submit five or six, or 
even more, sputum specimens.
If  mail-in specimens cannot be immediately shipped, they 
should be refrigerated to minimize overgrowth by undesira­
ble contaminants. Specimens to be mailed must be carefully 
sealed and properly packaged to avoid leakage or breakage in 
transit (see II.B., p. 39).
Patients should be instructed in securing the most useful 
specimen, the naturally produced sputum. They should be 
told that nasopharyngeal discharge and saliva are not 
sputum. W hat is desired is the normally thick, yellowish 
(sometimes blood-tinged) exudative material brought up 
from the lungs after a deep, productive cough. The mouth 
should be rinsed free of food, residual mouthwash, and oral 
medications before sputum is collected. Specimens should 
only be collected into laboratory-approved containers clearly 
labelled with the patient’s name and/or hospital number.
For both efficiency and proficiency in recovering mycobac­
teria, sputa should be collected and processed in the same 
container, and a 50-ml plastic, disposable centrifuge tube is 
recommended. Sputum volume should NEVER exceed one- 
fifth (10 ml) the volume of the collection container. This will 
permit adequate mixture of sputum with the digesting agent. 
It will also permit the digested sputum to be diluted enough 
to (i) minimize continued action of the toxic decontaminat­
ing agent and (ii) reduce the specific gravity of the digested 
sputum so that it can be more efficiently concentrated by 
centrifugation.
When the patient cannot expectorate or finds it difficult to 
do so, other methods may be used to collect pulmonary secre­
tions:
a. Sputum induction may be effected with warm, aero­
solized hypertonic salt solution (1,4,5,1 1). Patients
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cgenerally prefer this to aspiration of gastric contents, and 
the microbiologist knows that sputum obtained by this 
method is “cleaner” than a specimen aspirated from the 
stomach. Induced specimens should be so identified on 
the laboratory request slip, because they resemble saliva.
b. Laryngeal swabs (12,14) may be useful in patients who
raise no sputum or swallow it, e.g., small children.
c. Bronchoscopy and bronchial brushings may also be 
useful, not only for specimens collected at examination, 
but because the procedure itself often causes the patient 
to produce sputum naturally for several days. These latter 
specimens should also be processed.
L
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2. Gastric lavage (4 ,5)
When sputum is difficult to obtain as described above, gastric 
lavage can perhaps be performed. It might be indicated for (i) 
patients with radiologic evidence of tuberculosis whose 
sputum is negative by other methods of examination; (ii) un­
cooperative patients who “raise no sputum” or who swallow 
it; (iii) patients who cannot expectorate because of other dis­
orders, e.g., coma, neurological disease, etc.; (iv) patients 
suspected of submitting sputum other than their own; and (v) 
young children from whom sputum normally is difficult to 
obtain. The specimen is collected early in the morning before 
the patient has eaten, and preferably, while the patient is still 
in bed. Optimal results are attained when these specimens are 
collected from hospitalized patients, rather than when speci­
men is collected elsewhere and mailed to the laboratory. 
Likewise, patients should not be expected to travel long dis­
tances to hospital or clinic for collection of gastric lavage.
a. Twenty to 50 ml of chilled, sterile distilled water passed 
into the stomach through a disposable plastic stomach 
tube should provide an adequate sample.
b. The sample is recovered by using a sterile 50 ml syringe. 
It is placed in a sterile bottle or plastic tube.
The specimen should be processed promptly because 
mycobacteria die rapidly in gastric washings. If process­
ing is to be delayed, the gastric lavage should be 
neutralized (13). For each 35 to 50 ml of gastric wash­
ings, use 1.5 ml of 40% anhydrous disodium phosphate 
(Na2H P04) or two pH7.4 pHydrion buffer capsules or 
tablets.
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Although both patients and microbiologists seem to 
prefer induced sputum to gastric lavage, a combination 
of aerosol induction of sputum followed in 30 minutes by 
gastric lavage has been shown (3) to yield more positive 
cultures than either method alone.
3. U rine
Before a urine specimen is collected, the external genitalia 
should be carefully washed. The specimen should be col­
lected either as a single, early morning, voided midstream 
specimen (6), or as the total first morning specimen (8). Like 
the gastric lavage, urines are best collected and immediately 
processed in the hospital. Multiple specimens may have to be 
processed to demonstrate the presence of mycobacteria in the 
genitourinary tract, but this is far superior to the more cum­
bersome methods involved in handling the large volumes of 
24-hour pooled samples.
4. O ther body fluids
The physician aseptically collects such specimens as pleural, 
pericardial, spinal, synovial, and ascitic fluids, blood, bone 
marrow, and pus by using aspiration techniques or surgical 
procedure. Acid-fast bacilli are generally difficult to find in 
such specimens because they are so diluted by the large reser­
voir volume of the “infected” fluid. To improve chances of 
isolating mycobacteria from these specimens, laboratory per­
sonnel and the clinician must cooperate closely. For exam­
ple, by prior arrangement with laboratory personnel, asep- 
tically collected fluids may be placed immediately (i.e., at the 
bedside) into liquid medium (e.g., Middlebrook 7H-9, 
Dubos Tween albumin broth, Proskauer-Beck) in a ratio of 1 
part fluid specimen to 5 (or 10) parts of liquid medium. In­
cubating such cultures at 35” to 37°C in 10% CO„ with daily 
shaking, usually encourages the small numbers of mycobac­
teria to multiply. When weekly microscopic examination of 
stained smears from such cultures indicates the presence of 
acid-fast organisms, the liquid medium may be subcultured 
to solid media (egg or agar base) for growth and identifica­
tion of the mycobacterial pathogen. I f  the aseptically col­
lected fluid cannot be immediately inoculated into liquid 
medium, then sterile ammonium oxalate or heparin should 
be added to those fluids which may clot, and the specimens 
should be transported to the laboratory as quickly as possible.
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If  the collected specimens are not known to be sterile or if 
they are suspected of being contaminated they should be tre­
ated as described for sputum. If  specimen volume permits, 
however, one portion should be inoculated to media without 
prior treatment and the other portion digested or decontami­
nated before it is inoculated onto media.
5. Tissues
Like body fluids, small pieces of tissue suspected of contain­
ing mycobacteria should be collected aseptically and placed 
in sterile containers without preservatives or fixatives. For 
shipment to distant laboratories by mail, the specimen should 
be protected from drying by adding sterile saline to cover the 
tissue; specimens should be maintained at 5” to 10°C or ship­
ped in dry ice. I f  strict asepsis is observed in collecting and 
handling such specimens, they may be homogenized (only in 
a BSC) in sterile tissue grinders with a small amount of sterile 
saline or 0.2% bovine albumin and inoculated directly to li­
quid and solid media as described for body fluids. I f  the 
tissue is not known to be sterile, it may be homogenized first, 
with half of the homogenate being inoculated directly to 
media, and the other half treated as for sputum before being 
planted on media.
B. TRANSPORTATION
1. The shipment of diagnostic specimens such as urine, sputum, 
and tissue, and of cultures of etiologic agents, which includes 
all Mycobacterium spp., is subject to the packaging and label­
ing requirements of the Interstate Quarantine regulations 
(Federal Register, Title 42, Chapter 1, Part 72, revised July 
30, 1972). Compliance with the requirements of the regula­
tion is the responsibility of the shipper. Failure to comply 
with the applicable requirements subjects violators to penalty 
provisions which include fines and/or imprisonment.
Diagnostic specimens must be packaged to withstand leakage 
of contents, shocks, pressure changes, and other conditions 
incident to ordinary handling in transportation. The 
“ETIO LO G IC A G EN T/BIO M ED ICA L M A TERIA L” 
label (described below) must not be affixed to shipments of 
diagnostic specimens.
2. Etiologic agents are subject to additional specific contain­
ment packaging and labeling requirements. Cultures of 
Mycobacterium should be shipped to reference laboratories
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on solid medium in screw-cap tubes. Petri dish cultures and 
cultures in liquid medium must not be shipped.
Requirements for packaging etiologic agents are found in 
Section 72.25, paragraph (c) subparagraph (1) of the Inter­
state Quarantine regulations, as follows: Volume less than 50 
ml. Material shall be placed in a securely closed, watertight 
container (primary container [test tube, vial, etc.]) which 
shall be enclosed in a second, durable watertight container 
(secondary container). Several primary containers may be 
enclosed in a single secondary container, if the total volume 
of all the primary containers so enclosed does not exceed 50 
ml. The space at the top, bottom, and sides between the pri­
mary and secondary containers shall contain sufficient non­
particulate material to absorb the entire contents of the pri­
mary container(s) in case of breakage or leakage. Each set of 
primary and secondary containers shall then be enclosed in 
an outer shipping container constructed of corrugated fiber- 
board, cardboard, wood, or other material o f equivalent 
strength. See Figure 16.
Subparagraph (2) describes packaging of volumes of 50 ml or 
greater. This description is similar to (1) except that the 
volume in a single primary container may not be over 500 ml 
and the total volume enclosed within the outer shipping con­
tainer may not exceed 4000 ml.
Subparagraph (3) states that if dry ice is used as a refrigerant, 
it must be placed between the secondary and outer container 
in such a way that, as the dry ice sublimates, the secondary 
container does not become loose inside the outer container.
Department of Transportation regulations prohibit the ship­
ment o f more than 50 ml o f an etiologic agent in a primary 
container on a passenger aircraft. A  volume greater than 50 
ml may be carried by air freight provided it is properly 
packaged and the total volume within a single outer con­
tainer does not exceed 4000 ml.
An “ETIOLOGIC AGENT/BIOMEDICAL MATERIAL” 
label must be affixed on the outer container. These labels are 
available commercially (See Figure 16); they should measure 
2 inches high by 4 inches long, and be printed in red on a 
white background. Shippers o f etiologic agents must be 
familiar with the above regulations that govern packaging, 
labeling, and shipment o f these products in interstate com­
merce.
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PACKAGING AND 
LABELING OF 
ETIOLOGIC AGENTS
C R O S S S E C T I O N  
OF PROPER PACKING
The Interstate Quarantine Regulations (Code of Federal Regula­
tions, Title 42, Part 72.25, Etiologic Agents) was revised July 30, 
1972, to provide for packaging and labeling requirements for etio­
logic agents and certain other materials shipped in interstate traffic.
The figure diagrams packaging and labeling of etiologic agents in 
volumes less than 50 ml in accordance with the provisions of sub- 
paragraph (C)(1) of the cited regulation.
The Etiologic Agents-Biomedical Material label (see subparagraph 
[Cl [4] of regulations) which must be placed on all shipments of 
etiologic agents is depicted below. The label must be 2 inches high 
by 4 inches long and printed in red ink on white stock. For further 
information on any provision of this regulation contact:
Centers for Disease Control 
Attn: Office of Biosafety 
1600 Clifton Road 
Atlanta, Georgia 30333
Telephone: (404) 329-3883
ETIOLOGIC AGENTS
BIOMEDICAL
MATERIAL
IN CASE OF DAMAGE 
OR LEAKAGE 
N O TIFY : D IRECTO R , CDC 
A TLA N TA , GEO RGIA
404/633-5313
Figure 16.
Questions regarding this regulation should be addressed to:
Office of Biosafety 
Centers for Disease Control 
Atlanta, Georgia 30333 
(Telephone 404/329-3883)
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A. INTRODUCTION
The presence of mycobacteria in clinical specimens may be 
demonstrated either by examining stained smears through a 
microscope or by culturing the organisms on a variety of isolation 
media. The simplest procedure is microscopy. By far the fastest 
microscopic method is that of the direct smear in which selected 
cheesy, necrotic particles in the specimen are smeared onto the 
microscope slide, heat fixed, and then stained by using one of the 
procedures described later in this Section.
Because acid-fast bacilli cannot be specifically identified by smear 
examination and because many different species of mycobacteria are 
known to be potentially pathogenic for man, personnel in laborato­
ries at Levels II and III must isolate the organism on some culture 
medium before they can identify it precisely. Except under unusual 
circumstances, personnel in most Level II laboratories will not make 
direct smears. Instead, they will make microscopic observations of 
concentrated sediments of clinical specimens that have been digested 
and decontaminated for culture inoculation. Therefore, methods for 
digesting and decontaminating specimens will be described first. The 
concentrated sediment obtained by using these procedures may be 
examined microscopically (III, D., p. 61) or inoculated onto isola­
tion media.
Examination of the sources from which most clinical specimens 
suspected of containing mycobacteria are derived reveals an abun­
dance of many contaminating microorganisms, most of them sur­
rounded by organic debris (body fluids, white blood cells, red blood 
cells, tissue, etc.) which both maintains their viability and protects 
them from the harmful effects of decontaminating agents. Since these 
contaminating microbes generally reproduce much faster than 
mycobacteria, they will overgrow acid-fast organisms on culture 
media unless some attempt is made to inhibit or kill them.
The organic debris surrounding the organisms in a clinical specimen 
must therefore be liquefied, so that the decontaminating agents can 
kill the undesirable bacteria or fungi and the surviving mycobacteria 
can gain access to the nutrients of the medium onto which they are 
inoculated. Because mycobacteria are usually more resistant to the 
toxic effects of most chemical disinfectants than other microorgan­
isms, chemical decontamination of diagnostic specimens is often suc­
cessful.
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An ideal digesting-decontaminating solution should:
(1) Liquefy the organic debris in the specimen.
(2) Kill contaminating microorganisms.
(3) Not harm mycobacteria.
No one agent satisfies all three criteria, and investigators have been 
forced to make concessions in one or more areas in order to obtain 
mycobacterial growth on culture media.
Many digesting-decontaminating methods have been described, 
nearly all of which will kill a certain proportion of the mycobacteria 
in the specimen. To minimize the death of mycobacteria, the step-by­
step procedure in all digestion/decontamination methods must be 
followed precisely. The mildest digestants which still effectively sup­
press contaminants should be used. Several of the more widely 
recommended digestion procedures are detailed here.
B. ISOLATION PROCEDURES
1. N-Acetyl-L-Cysteine-Sodium Hydroxide (NALC-NaOH) 
Method (8, 10).
This method is used at CDC. A mucolytic agent, N-acetyl-L- 
cysteine, is used for digestion and sodium hydroxide for 
decontamination. Sodium citrate is included in the digestant 
mixture because of its ability to bind, by chelation, heavy 
metal ions that may be present in the specimen and could 
inactivate the acetylcysteine (5).
a. Materials
N-acetyl-L-cysteine-NaOH (NALC-NaOH) solution, 
prepared as described below.
Tubes, 50 ml centrifuge, preferably plastic disposable 
Media:
(1) Agar base, e.g., Middlebrook 7H- 10 or 7H- 11
(2) Egg base, e.g., Lowenstein-Jensen (L-J) or 
American Trudeau Society (ATS)
Microscope slides, frosted end
Phosphate buffered saline (0.067M), pH 6.8
Pipettes: 1,5,10 ml and capillary
Water, sterile distilled: (1) 30 to 40 ml/specimen
(2) 4.5 ml dilution blanks 
Bovine albumin, 0.2% solution in saline.*
*Bovine albumin may be obtained from the Armour Co. or Pentax, Inc., 
Kankakee, Illinois. To prepare 2% solution, dissolve 0.85 g NaCl in 100 ml 
distilled water, add 2 g of bovine albumin fraction V and dissolve by swirl­
ing or gently stirring on magnetic stirrer. Adjust pH to 6.8 with 4% NaOH 
and sterilize by Seitz or membrane filtration. For 0.2% solution, dilute this 
2% stock solution 1: 10 with sterile saline.
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cb. Preparations
.(1) Prepare the volume of NALC-NaOH needed as in­
dicated below:
Table 2. Preparation of N-acetyl-L-cysteine-sodium 
hydroxide solution
Volume of Mix indicated amounts (ml) of
Digestant Gm of NALC
Needed (ml) 4% NaOH' 2.9% sodium citrate2 to Add
50 25 25 0.25
100 50 50 0.50
200 100 100 1.00
500 250 250 2.50
1000 500 500 5.00
L
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‘Add 4.0 g NaOH to 100 ml distilled water.
2Add 2.9 g sodium citrate to 100 ml distilled water.
The NaOH and sodium citrate may be prepared and 
sterilized (by autoclaving) in advance of mixing. 
Prepare only the volume of final digestant actually 
needed, because mucolytic activity of NALC is lost 
on standing (use within 18 to 24 hours).
(2) Phosphate buffer solutions, 0.067M.Buffer solu­
tions are prepared by mixing two stock solutions in 
proportions to give the required pH.
(a) Stock Solutions
(i) 0 .0 6 7 M  d iso d iu m  p h o sp h a te : In a 
v o lum etric  flask  d isso lve  9.47 g o f 
anhydrous Na2H P04 in distilled water to 
make 1 liter (1,000 ml).
(ii) 0.067M monopotassium phosphate: In a 
volumetric flask dissolve 9.07 g of KH2P 0 4 
in distilled water to make 1 liter (1,000 ml).
(b) pH 6.8 Buffer Solution
Mix 50.0 ml of (i) with 50 ml of (ii).
Check pH on meter or with pH test paper.
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(c) pH 7.0 Buffer Solution
Mix 6 1.1 ml of (i) with 38.9 ml of (ii).
Check pH on meter or with pH test paper.
(d) pH 6.6 Buffer Solution
Mix 37.5 ml of (i) with 62.5 ml of (ii).
Check pH on meter or with pH test paper.
(3 ) Label media, slides and tubes with appropriate data, 
e.g., patient’s name, or hospital number, or speci­
men accession number. Media to be inoculated 
should show date of inoculation.
(4 ) Assemble supplies and place on cart or table near 
door to isolation room.
(5 ) Don protective clothing, enter isolation room, and 
transfer supplies onto work area.
c. Procedures
Sputum (natural or induced): 90% to 95% of all speci­
mens submitted to the laboratory for diagnosis of tuber­
culosis are sputa.
(1) Combine the desired amounts of NaOH-Na citrate 
solution (see table on page 45), add the appropri­
ate amount of NALC powder and mix.
(2) Line up specimens in numerical order and transfer 
sputum to centrifuge tubes. Do not add more than 
10 ml sputum to a 50 ml centrifuge tube. Add to the 
specimen a volume of NALC-NaOH solution equal 
to the volume of the specimen.
(3) Tighten cap of tube and mix by swirling on a test 
tube mixer until liquefied (usually 5 to 20 seconds). 
Avoid extreme agitation or frothing because this 
will oxidize and inactivate the acetylcysteine; the 
centrifugal mixing afforded by the test tube mixer is 
ideal. The height which the swirling mixture of 
sputum and digestant reaches when placed on a test 
tube mixer can be controlled by proper placement 
of fingers on the tube to be mixed and by regulating 
tube pressure on the rotating head of the mixer. 
Figure 17 shows the proper way to hold the tube.
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EFigure 17. Proper use of test-tube mixer.
(4) Let stand for 15 minutes (not over 20 minutes) at 
room temperature to decontaminate. If more active 
decontamination is desired, increase the concentra­
tion of NaOH in the above table to 5% or 6% in­
stead of increasing the time the specimen is exposed 
to digestant.
(5) Fill centrifuge tubes to 50-ml level with sterile dis­
tilled water or phosphate buffer, pH 6.8 (0.067M). 
Tighten screwcap and swirl by hand to mix.
(6) Centrifuge at 2,000 to 3,000 x g for 15 minutes 
using aerosol-free, sealed centrifuge cups. *
The rpm required to produce 2,000 to 3,000 x g 
will vary with the centrifuge and the radius of the 
rotating head.
(7) Decant the supernatant fluid into a discard can con­
taining disinfectant, flame the lip of the tube (or 
swab with disposable gauze pledget soaked in disin­
fectant), and replace the cap.
*If aerosol free cups are not available. a centrifuge may be modified to 
minimize or eliminate aerosols from broken or leaking tubes by installing an 
absolute filter and air evacuating pump on the centrifuge bowl (3).
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(8) Add 1 to 2 ml of sterile 0.2% bovine albumin frac­
tion V (see p. 44) with a sterile pipette. Shake gently 
to resuspend the sediment; this final suspension 
does not need to be neutralized. If sediment will be 
inoculated immediately onto media, sterile water or 
saline may be used in place of 0.2% bovine 
albumin.
(9) Mix sediment with a sterile 1 ml pipette and make 
1:10 dilution (Fig. 18) by adding 0.5 ml of resus­
pended sediment to 4.5 ml sterile water (or 1 ml to 
9.0 ml). Mix with the pipette or on vortex mixer 
with caps tight. Diluting the resuspended sediment 
decreases the concentration of any toxic substances 
which may inhibit growth of mycobacteria.
(10) Place 0.1 ml (two or three drops) of the 1: 10 dilu­
tion onto the surface of half of a biplate of 7H- 10 
medium.
(11) Place two drops of the 1: 10 dilution onto the sur­
face of each of the two tubes of Lowenstein-Jensen 
medium and spread the inoculum over the surface 
of the medium.
(12) Place two drops of the undiluted sediment onto the 
other half of the 7H- 10 biplate.
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(13) Place two drops of the undiluted sediment onto 
each of two tubes of Lowenstein-Jensen (LJ) 
medium and spread the inoculum over the surface 
of the medium.
(14) With a bent glass rod (see I F .8.,p. 30), spread the 
inoculum over the surface of the 7H-10 plates (the 
1: 10 dilution first, then the undiluted inoculum).
(15) Make two smears of the undiluted sediment by 
spreading a drop over an area 1 x 2 cm on the 
microscope slide (See D., p. 61 for details).
(16) Place slides on the electric slide warmer at 65” to 
70°C for 2 hours (or overnight) to heat fix.
(17) Place each 7H-10 plate in an individual C 0 2-per- 
meable polyethylene bag and incubate under 10% 
CO, at 35° to 37°C.
(18) Incubate the LJ medium at 35” to 37°C with tubes 
in a horizontal position and caps loosened. Incuba­
tion in an atmosphere of CO, will encourage earlier 
growth.
(19) If direct drug tests are to be performed, refrigerate 
the remaining undiluted sediment until ready to use.
OTHER LESS COMMONLY ENCOUNTERED SPECIMENS 
THAT MAY BE CULTURED FOR MYCOBACTERIA.
GASTRIC LAVAGE*
Mucoid gastric lavage
(1) Add 50 to 100 mg (“pinch”) of NALC powder to 
20 to 50 ml of gastric lavage.
(2) Mix by hand or with test tube mixer as for sputum.
(3 ) Centrifuge at 2,000 to 3,000 x g for 30 minutes.
(4) Decant supernatant fluid and resuspend sediment in 
2 to 5 ml of sterile distilled water.
(5 ) Add an equal volume of NALC-NaOH and proceed 
as for sputum.
*These specimens should be processed within 4 hours of collection.
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■Fluid gastric lavage
(1) Centrifuge entire specimen for 30 minutes.
(2) Decant and resuspend in 2 to 5 ml of sterile dis­
tilled water. Pool sediments if more than one con­
tainer is used for centrifugation.
(3) Add an equal volume of NALC-NaOH and proceed 
as for sputum.
LARYNGEAL SWAB
(1) With sterile forceps, transfer the swab to a sterile 
centrifuge tube.
(2) Add 2 ml sterile distilled water or saline.
(3 ) Add 2 ml NALC-NaOH.
(4) Swirl on test tube mixer.
(5 ) Let stand 15 minutes to decontaminate.
(6) With sterile forceps, remove swab from centrifuge 
tube.
(7 ) Fill the tube with sterile buffer or water and proceed 
as for sputum.
TISSUE
(1) Grind with sterile tissue grinder in sterile 0.85% 
saline or 0.2% bovine albumin. When tissue (e.g., 
from the lung) contains mucus, add a pinch of N- 
acetyl-L-cysteine.
(2) If tissue is collected and processed aseptically, in­
oculate directly to both liquid and solid media.
(a) Smear liquid culture once a week until acid-fast 
bacilli are seen microscopically. Inoculate solid 
media with this liquid culture as soon as smear 
is positive.
(b) If smear still is not positive after 6 to 8 weeks, 
streak each of four egg slants and two 7H-10 
plates with 0.1 ml or more of the broth culture 
and incubate at 35” to 37°C for 4 to 8 weeks.
(3) When tissue is not collected aseptically, place 
homogenate from (1) above into a tube and process 
as sputum.
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cBLOOD
(1) Add 10 ml aseptically collected blood to 50 ml of a 
Tween liquid medium, such as Dubos or Mid- 
dlebrook 7H-9.
(2) Incubate at 35” to 37°C.
(3) Smear this liquid culture once a week. Stain, and
examine smears under the microscope for presence 
of acid-fast bacilli.
(4) Inoculate solid media with any smear-positive li­
quid cultures.
OTHER BODY FLUIDS 
Muco-purulent materials
(1) Handle as for sputum when volume is 10 ml or less.
(2) Handle as for mucoid gastric lavage when volume is 
more than 10 ml.
Fluid materials
(1) If collected aseptically, centrifuge and inoculate 
sediment directly onto culture media.
(2) If not aseptically collected:
(a) Handle as for sputum when volume is 10 ml or 
less.
(b) Handle as for fluid gastric lavage when volume 
is more than 10 ml.
L
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2. Sodium Hydroxide (NaOH) Method (7, 8)
Sodium hydroxide is extremely toxic for mycobacteria as 
well as contaminants; therefore, care must be exercised in the 
use of this procedure, and prescribed time limits should be 
strictly adhered to.
a. Materials
Sodium hydroxide, pellets 
2.0 N HC1
Hydrochloric acid-phenol red indicator
Tubes, 50 ml centrifuge, preferably plastic disposable.
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b. Preparation
2% NaOH: 2 g per 100 ml distilled water
4%  NaOH: 4 g per 100 ml distilled water
(1) Select the desired concentration of NaOH (the 
lowest concentration compatible with effective 
digestion and decontamination should be used), 
prepare in volume, and sterilize by autoclaving.
(2) Prepare the 2.0 N HC1 by carefully adding 33 ml 
concentrated HC1 to 200 ml distilled water and 
sterilize by autoclaving.
(3) Prepare the HCl-phenol red indicator by combin­
ing 20 ml of phenol red solution* with 85 ml con­
centrated HC1 and enough distilled water to make 
1,000 ml. The phenol red indicator may also be 
used separately.
c . Procedure
(1) Add an equal volume of the appropriate NaOH 
solution to the specimen contained in a 50 ml 
centrifuge tube and tighten cap.
(2) Shake vigorously on a test-tube mixer until effec­
tively digested. Let stand for 15 to 20 minutes. The 
paint conditioning machine is still used in some 
laboratories to shake NaOH-treated specimens. The 
main reason for discouraging its use is that the 
danger of tubes breaking and aerosol being dissemi­
nated is greater with it than with the the test-tube 
mixer.
(3) Centrifuge the specimen for 15 minutes at 2000 to 
3000x g.
(4) Decant the supernatant fluid into a splash-proof 
container and neutralize the sediment with HC1 by 
either:
(a) Adding the HC1 -phenol red indicator drop by 
drop until the sediment turns a persistent 
yellow, or
(b) Adding a drop of the phenol red indicator and 
then adding HC1 drop by drop until the sedi­
ment turns a persistent yellow.
*8 0 m g  pheno l red p ow d e r in 2 0 m l 4% N a O H
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(5) Resuspend the sediment with 1 to 2 ml of sterile 
water (sterile solutions of saline or 0.2% bovine 
albumin may be used) and inoculate desired media.
W,
3. Zephiran-Trisodium Phosphate (Z-TSP) Method (10, 11)
In this technique (Z-TSP), trisodium phosphate is used to 
homogenize the specimen, and zephiran (benzalkonium 
chloride) is used to control contaminants. Zephiran is bac­
teriostatic to mycobacteria unless it is neutralized. The 
phospholipid of egg medium effectively neutralizes most of 
this quaternary ammonium compound, but most clear agar 
media do not have such a “built-in” neutralizer. Therefore, 
to insure growth on agar medium (e.g., 7H-10 or 7H -11) of 
mycobacteria in Z-TSP-digested specimens, the digested, 
centrifuged sediment must be washed with buffer before the 
agar medium is inoculated (4).
a. Materials
Zephiran-trisodium phosphate (Z-TSP)
Neutralizing buffer, pH 6.6
b. Preparation
(1) Z-TSP. Dissolve 1 Kg of trisodium phosphate 
(Na3P 0 4 • 12H20 )  in 4 liters of hot distilled water. 
To this, add 7.5 ml concentrated Zephiran (17% 
benzalkonium chloride, Winthrop Laboratories), 
mix well, and store at room temperature.
(2) Neutralizing buffer, pH 6.6 (see (d), p. 46).
(a) Mix 37.5 ml of stock buffer (i) and 62.5 ml of 
stock buffer (ii). Check on pH meter. Autoclave 
and store at room temperature, or
(b) Use neutralizing buffer (Difco).
c . Procedure
(1) Add to the specimen a quantity of Z-TSP equal to 
the volume of the specimen.
(2) Tighten screwcap securely and agitate vigorously on 
a shaking machine for 30 minutes.
(3) Let the specimen stand 20 to 30 minutes without
further agitation.
53
(4) Transfer specimen to 50-ml screwcap centrifuge 
tube and centrifuge at 2,000 to 3,000 x g for 20 
minutes.
(5) Decant the supernatant fluid into a splash-proof 
container and resuspend the sediment in 20 ml 
neutralizing buffer, pH 6.6, and mix well.
(6) Centrifuge the specimen again for 20 minutes, and 
discard the supernatant fluid into a splash-proof 
container, retaining some fluid to resuspend the 
sediment.
(7 ) Use a sterile capillary pipette to mix the sediment 
and inoculate three drops onto:
(a) Each tube of egg medium.
(b) Each plate of agar medium.
(8) Spread inoculum over surface of medium and incu­
bate egg medium horizontally at 35°C and agar 
medium in 10% CO2 at 35°C.
4. Cetylpyridinium Chloride-Sodium Chloride (CPC-NaCI)
Method (9).
This method (CPC-NaCI) was proposed as a means of decon­
taminating sputa in transit, so that upon arrival in the 
laboratory, the specimens would need only to be concen­
trated before being inoculated onto media. Preliminary ob­
servations suggest that this method (i) provides a significant 
decrease in the laboratory time required for processing sputa, 
(ii) increases the number of positive cultures of mycobacteria 
(especially bacilli other than M tuberculosis), and (iii) results 
in less contamination than the NALC-NaOH method.
Because cetylpyridinium  chloride is bacteriostatic to 
mycobacteria on agar base medium and because questions as 
to the effectiveness of neutralizing buffer have not been 
resolved, only egg base medium is inoculated in this pro­
cedure. The NaCl liquefies and the CPC decontaminates the 
specimen.
a. Materials
Cetylpyridinium chloride, 1%
Sodium chloride, 2%
Centrifuge tubes, 50 ml, preferably plastic disposable. 
Sterile water, 20 to 30 ml per specimen.
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cSterile saline or 0.2% bovine albumin fraction V, 1 to 2 
ml per specimen.
b. Preparation
(1) CPC-NaCl. Dissolve 10 g cetylpyridinium chloride 
and 20 g of NaCl in 1 liter of distilled water. The 
solution is self- sterilizing and remains stable for ex­
tended periods at room temperature if caps are kept 
tight and the solution is protected from light and ex­
cessive heat. Crystals that may form in the working 
solution may be dissolved with gentle heat.
(2) 0.2% bovine albumin fraction V (see footnote, p.
44).
c. Procedure
(1) Collect sputa in 50-ml screwcap centrifuge tubes.
(2) Add an equal volume of the CPC-NaCl solution, 
securely tighten caps, and shake by hand (inside 
biological safety cabinet) until specimens become 
fluid.
(3 ) Package specimens in double mailing containers 
and send to the laboratory for processing. The 
specimen is digested and decontaminated in transit.
(4) After receiving the specimen in a laboratory, fill 
each sputum container to the 50-ml mark with 
sterile distilled water, replace the cap, and tighten 
securely.
(5) Centrifuge the specimen at 2,000 to 3,000 x g for 
20 minutes.
(6) Decant supernatant fluid into splash-proof con­
tainer and suspend the sediment in 1 to 2 ml sterile 
water, saline, or 0.2% bovine albumin fraction V.
(7 ) Inoculate resuspended sediment onto egg medium.
(8) Incubate medium at 35” to 37°C.
5. Oxalic Acid Method (2, 10).
w. , This method is used to process specimens from patients
w hose cultures are consisten tly  contam inated  w ith 
I Pseudomonas species.
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a. Materials
5% Oxalic acid
4% Sodium hydroxide
Physiological saline
Indicator solution, phenol red
b. Preparation
(1) Oxalic acid (C2H20 4 2H20): mix 5 g per 100 ml 
distilled water and autoclave.
(2) Sodium hydroxide: Mix 4 g per 100 ml distilled 
water and autoclave.
(3 ) Physiological saline: Mix 0.85 g per 100 ml dis­
tilled water and autoclave.
(4 ) Phenol red indicator: Dissolve 80 mg phenol red 
powder in 20 ml 4% NaOH. When solution is com­
plete, bring volume up to 1,000 ml.
c . Procedure
(1) Add an equal volume of 5% oxalic acid to each 
specimen.
(2) Mix on test-tube mixer. Let stand for 30 minutes 
with occasional shaking.
(3 ) Add sterile saline to lower the specific gravity and 
dilute the acid.
(4) Centrifuge the specimen at 2,000 to 3,000 x g for 
20 minutes.
(5) Decant the supernatent fluid into splash-proof con­
tainer.
(6) Add a few drops of the phenol red indicator to the 
sediment and neutralize with the 4%  NaOH until 
the first persistent pale pink color forms.
(7 ) Inoculate media and incubate at 35” to 37°C.
(8) Make a smear and stain for acid-fast bacilli.
6. Sulfuric Acid Method (10,12).
When urine specimens processed by other methods consis­
tently yield contaminated cultures, the sulfuric acid method 
may provide satisfactory culture results.
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ea. Materials
4% Sulfuric acid 
4% Sodium hydroxide 
Sterile distilled water 
Indicator, phenol red
b. Preparations
(1) Sulfuric acid (H 2S04): Add slowly, while stirring,
40 ml of concentrated sulfuric acid to 960 ml of 
distilled water. Store at 4°C.
(2) Sodium hydroxide: Dissolve 4 g in 100 ml distilled 
water and autoclave.
(3) Phenol red indicator: Dissolve 80 mg phenol red
powder in 20 ml 4% NaOH. When solution is com­
plete, bring volume to 1,000 ml.
c. Procedure
(1) Centrifuge entire specimen for 30 minutes at 2,000 
to 3,000 x g. This may require several tubes.
(2) Decant supernatant fluid and consolidate sedi­
ments. If volume is small, add 1 or 2 ml of sterile 
water.
(3) Add an equal volume of 4% H 2S04 to the sediment.
(4 ) Mix and allow to stand for 15 minutes.
(5) Fill the tube to the 50-ml mark with sterile water.
(6) Centrifuge at 2,000 to 3,000 x g for 15 minutes. 
Decant supernatant fluid into splash-proof con­
tainer.
(7)
(8 )
(9)
Add to the sediment a few drops of the phenol red 
indicator solution and neutralize with 4% NaOH 
until the first pale pink color forms.
Inoculate and incubate media at 35” to 37°C.
Make a smear and stain for acid-fast bacilli. 
Although earlier literature may discourage this, the 
observation of large numbers of AFB in stained 
smears is usually evidence of infection. The detec­
tion of only rare AFB is of doubtful or no signifi­
cance.
57
C. INCUBATION OF CULTURES
1. Plates of inoculated media may stay for a few hours at room 
temperature before they are placed in CO, permeable 
polyethylene plastic bags and sealed for incubation. Keep 
shielded from light (6).
2. Temperature: 35” ±2°C, not to exceed 37°C. All cultures 
from skin lesions must also be incubated at a temperature not 
to exceed 33°C, because such cultures may contain M, 
marinum or M, ulcerans which grow better at the lower tem­
perature.
3. Atmosphere: 5% to 10% carbon dioxide in air (1).
4. Medium in tubes:
Place in a slanted position with the screwcap loose for at least 
1 week to permit exposure to carbon dioxide and consequent 
stimulation of growth. If necessary, then tighten caps to pre­
vent dehydration, and stand tubes upright if space is a 
problem.
5. 7H- 10 medium in plates:
Place plates medium-side down in a plastic bag; polyethylene 
allows carbon dioxide to pass into the bag. Seal the bag with 
tape or a heat-sealing apparatus, or fold the top over two or 
three times and staple. Squeeze the air out of the bag before 
sealing.
6. If excess moisture accumulates during incubation, some of 
the following suggestions may be helpful:
a. Avoid inoculating a wet medium surface. Take plates out 
of the refrigerator on the day before they are to be inocul­
ated and leave them at room temperature in a clean, dark 
area.
b. After inoculating the media, shield the plates from con­
taminating air currents and direct or indirect daylight. 
Leave the plates for several hours before placing them in 
the incubator. This permits most of the inoculum fluid to 
evaporate or to be absorbed.
c . During incubation:
(1) Incubate plates in individual bags. This facili­
tates weekly reading of plates. Furthermore, 
moisture tends to accumulate in the plate on the 
bottom of the pile, and rotation helps prevent 
this.
c(2) If  several plates are incubated in a large bag, 
stack them no more than six high. Pressure of 
the upper plates may “seal” moisture in lower 
plates and also may interfere with the circula­
tion of CO,.
(3) Incubate plastic plates on an “insulating” sur­
face. Plastic plates in direct contact with metal 
shelves seem to collect more moisture than those 
“insulated” from the metal shelving. Styrofoam 
(1/2 inch) and corrugated cardboard are 
satisfactory insulators.
(4) Avoid incubating plates on shelves adjacent to 
the door. Alternating warm and cool air cur­
rents, created by opening and closing the door, 
cause moisture to collect within the plastic bags.
(5) Make sure that the air within the incubator is 
circulating properly.
d. When reading plates stacked in large plastic bags, open
the bags immediately after removing them from the in­
cubator. Plates incubated singly in transparent plastic 
bags may be read without opening the bag.
e. Condensate on the inside of plate lids interferes with
reading cultures. To avoid this, have a warming pad* ad­
jacent to the microscope and place plates on it lidside 
down.
7. For maximum growth on culture media:
a. Follow directions precisely during decontamination pro­
cedure. Overexposure to the chemicals may “damage” 
mycobacteria and retard their growth.
b. Make sure pH is balanced. An imbalance may be due to:
(1) Failure to centrifuge sufficiently to pack the 
sediment so that all the supernate can be de­
canted, or
(2) A too heavy inoculum, which interferes with the 
buffering action of the medium.
L
*An electric heating pad is satisfactory.
u
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c. Make sure the supply of CO, in the incubator is 
sufficient.
(1) The recommended concentration of CO, is 5% 
to 10%. Concentrations above 40% may be 
lethal to mycobacteria.
(2) Test the atmosphere of the incubator daily with 
a Fyrite CO, gas analyzer, or some other means 
of determining the concentration of CO,.
(3) Be certain the plastic bags in which the plates 
are incubated are of polyethylene, which per­
mits CO, to circulate; Mylar bags are not CO, 
permeable.
(4) Many strains of mycobacteria are dependent 
upon CO, and will not grow without it.
d. In preparing media:
(1) Use good quality ingredients and follow direc­
tions.
(2) Do not overheat medium during preparation. 
Monitor temperature of autoclaves and inspissa- 
tors.
(3) Do not expose the medium to direct daylight 
during or after preparation. This is especially 
important for 7 H -10 and 7 H -11 (6).
(4) Make sure plates of agar medium contain 20 ml; 
otherwise, the medium may be so thin that it 
dries out during storage or incubation.
e. Since some strains of mycobacteria grow more 
slowly than others and may need to be incubated a 
week or two longer than most to produce visible 
colonies, do not discard cultures as negative until 
after at least 6 to 8 weeks.
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D. ACID-FAST MICROSCOPY
The observation of acid-fast bacilli in stained smears examined 
under the microscope may be the first bacteriologic evidence that 
mycobacteria are present in a clinical specimen.
Although smear examination is the least sensitive method for detect­
ing mycobacteria and does not permit the observed organisms to be 
specifically identified, it is the easiest and most rapid procedure that 
can be performed in the laboratory, and it can be helpful in several 
ways: (1) it provides a presumptive diagnosis of mycobacterial dis­
ease; (2) it makes it possible to rapidly identify most infectious cases 
(i.e., those smear positive); (3) it can confirm that cultures growing 
on media are indeed acid-fast; (4) it may be used to follow the 
progress of tuberculosis patients on chemotherapy; and (5) it is useful 
in determining appropriate dilutions of sediments for direct drug 
susceptibility tests.
General comments and precautions.
Microscope slides used for acid-fast staining should be new, clean, 
and unscratched. Acid-fast material from previous smears may be 
retained (e.g., in scratches) on old, washed, and reused slides, and 
thus may lead to false positive reports.
L
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One end of the slide should be labeled with the patient’s name and/or 
hospital identification number, and date.
The specimen to be smeared should be spread over an area approx­
imately 2 cm square; the 1 -x 2-cm rectangle below illustrates the size.
Specimen material may be smeared over a larger area, but this would 
be self-defeating. If  a microscopist examines 100 to 300 fields on a 
stained smear 1 x 2  cm, he or she only views 1 /100 to 4/1 00 of the 
entire area of the smear (10,19). A larger smear, examined in the 
same manner, would further reduce examining efficiency. Keep the 
area of the smear fairly small; 1 x 2 cm is satisfactory.
Use a bacteriological loop, applicator stick, swab, or pipette to make 
the smear. The loop may be reused after it is dipped into an alcohol 
sand flask and sterilized in the flame of a Bunsen burner, but ap­
plicator sticks, swabs, and pipettes should be discarded after each 
smear is prepared.
Let the smear air dry, and then heat fix it. The smear may be heat fix­
ed on an electric slide warmer at 65” to 75°C for at least 2 hours 
(overnight is acceptable), or it may be passed 3 to 4 times through the 
blue cone of a burner flame as for other bacteriological smears.
Heat fixing does not always kill the mycobacteria, so be careful while 
handling smears. Always discard stained slides into covered pans 
containing disinfectant solution and autoclave before disposal, or 
discard into 3% amphyl solution overnight. Many acid-fast staining 
procedures have been described, including hot and cold staining 
methods, and those which employ fluorochrome dyes. Some work 
well and others are less satisfactory, but all are based on the property 
of mycobacteria to retain the primary stain, even after being exposed 
to strong mineral acids or acid-alcohol-thus the term “acid-fast 
bacilli.”
Care must be exercised in preparing and staining smears to avoid 
such problems as poorly stained preparations and false positive or 
false negative reports. The following suggestions may be helpful in 
avoiding some of these problems.
1. Avoid insufficient destaining with acid-alcohol.
a. Most mycobacteria are strongly acid fast and are not
easily decolorized.
b. Smears that are too thick are difficult to destain, and
when counterstained, may obscure acid-fast bacilli.
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2. Use contrasting counterstain.
a. -Counterstain should not be so intense that it “hides”
mycobacteria.
b. Color-blind individuals may find fluorochrome-stained
smears easier to examine.
3. Beware of false-positive smears. Common sources of acid-
fast bacilli which can contribute to this problem are:
a. Tap water and infrequently cleaned distilled water reser­
voirs. Check these sources from time to time to see if 
acid-fast bacilli can be detected.
b. Ice-making machines; ice from these machines is often 
used to facilitate passage of gastric tubes and may cause 
false-positive smears or cultures.
C. Transfer of material from slide to slide in bulk-staining 
tanks. To avoid this, stain slides individually.
d. Transfer of “positive” flakes from thick slides to other 
slides via immersion oil. Do not make thick smears; 
carefully heat-fix smears; wipe oil immersion lens be­
tween slides; allow oil to free-fall from applicator onto 
the smear instead of touching applicator to the slide.
For a more detailed look at acid-fast microscopy, see Laboratory 
Manual for Acid- Fast Microscopy (19).
1. Staining Procedures
Acid-fast staining procedures are of two general types: those 
em ploy ing  basic  fuchsin dyes and those u tiliz ing  
fluorochrome dyes. Both types are described below.
BASIC FUCHSIN ACID-FAST STAINS
a. Ziehl-Neelsen (ZN) Acid-Fast Stain (5,10,19,22). THIS 
IS A HOT STAIN.
(1) MATERIALS
Basic fuchsin 
Ethanol, 95%
Phenol crystals
Hydrochloric acid, concentrated 
Methylene blue chloride 
Water, distilled
k .
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(2) PREPARATION
(a) Fuchsin: Dissolve 0.3 g basic fuchsin in 10 ml 
95% ethanol.
(b) Phenol: Weigh 5.0 g phenol crystals; melt with 
gentle heat; add 100 ml water.
(c) Mix solution (a) with 90 ml solution (b); this is 
now called carbol fuchsin.
(d) Acid alcohol: Carefully add 3 ml concentrated 
hydrochloric acid to 97 ml 95% ethanol and 
gently mix.
(e) Methylene blue: Dissolve 0.3 g methylene blue 
chloride in 100 ml distilled water.
(3) PROCEDURE
(a) Prepare smear by spreading material over an 
area 1 x 2 cm on the slide and allow to air dry.
(b) Fix smear on an electric slide warmer at 65” to 
75°C for at least 2 hours, or use a Bunsen 
burner flame as for other bacteriological 
smears. DO NOT OVERHEAT.
(c) Cover the heat-fixed smear with a small (2 x 3 
cm) rectangular piece of filter paper. This holds 
the stain on the slide and minimizes the deposi­
tion of dye crystals onto the slide.
(d) Apply enough carbol fuchsin to the preparation 
to cover the paper strip.
(e) Heat the slide to steaming with a Bunsen burner 
flame or an electric staining rack as follows:
(i) With a Bunsen burner flame, gently heat the 
bottom of the slide until the stain begins to 
steam. Let stand for 5 minutes without addi­
tional heat. Do not boil or allow to dry; add 
more stain if necessary, but do not reheat.
(ii) With an electric staining rack, place slides 
on the rack, turn switch onto “high,” and 
flood slides with staining solution. When 
stain begins to steam, let it steam 5 minutes. 
If necessary, add more stain to prevent slide 
from drying.
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(f) Remove filter paper strips with forceps and 
place in discard container. Wash slides with 
water.
(g) Flood smear with acid alcohol and destain for 2 
minutes.
(h) Wash smear with water and drain.
(i) Flood smear with methylene blue and counter­
stain for 1 to 2 minutes.
(j) Rinse with water, drain, and air dry. DO NOT 
BLOT.
(k) Examine smear under oil immersion (see 3., pp. 
71-75 and 84-85).
b. Kinyoun Acid-Fast Stain (10,13,15,19,22). THIS IS A 
COLD STAIN.
(1) MATERIALS
Basic fuchsin
Ethanol, 95%
Phenol crystals
Hydrochloric acid, concentrated
Methylene blue
Water, distilled
(2) PREPARATION
(a) Basic fuchsin: Dissolve 4 g basic fuchsin in 20 
ml 95% ethanol.
(b) Phenol: Dissolve 8 g phenol crystals in 100 ml 
distilled water (if necessary, heat gently to get 
into solution).
(c) Mix solutions (a) and (b). This solution is called 
carbol fuchsin.
(d) Acid alcohol: Carefully add 3 ml concentrated 
hydrochloric acid to 97 ml of 95% ethanol, and 
gently mix.
(e) Methylene blue: Dissolve 0.3 g methylene blue 
chloride in 100 ml distilled water.
(3) PROCEDURE
(a) Prepare smear, by spreading material over 1 - x 
2-cm area of slide and allow to air dry.
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(b) Fix smear on an electric slide warmer at 65” to 
75°C for at least 2 hours or use a Bunsen burner 
flame as for other bacteriological smears. DO 
NOT OVERHEAT.
(c) Cover the heat-fixed smear with a small (2 x 3 
cm) rectangular piece of filter paper. This holds 
the stain on the slide and filters the stain. This is 
important because the increased dye concentra­
tion may leave artifacts on the smear which may 
be confused with acid-fast bacilli.
(d) Apply enough Kinyoun carbol fuchsin to the 
preparation to cover the paper strip. Allow to 
stain for 5 minutes. DO NOt  HeAt .
(e) Remove paper with forceps and place into dis­
card container. Rinse slide with water and 
drain.
(f) Flood the smear with acid alcohol and destain 
for 2 minutes.
(g) Rinse smear with water and drain.
(h) Flood smear with methylene blue and counter­
stain for 1 to 2 minutes.
(i) Rinse, drain, and air dry. DO NOT BLOT.
(j) Examine smear under oil immersion (see 3., pp.
71-75 and 84-85).
FLUOROCHROME ACID-FAST STAINS
These stains employ dyes that fluoresce when excited by ultraviolet or 
blue light. Just as the basic fuchsin stains, fluorochrome dyes stain 
acid-fast organisms, and the bacilli are not destained by acid alcohol. 
This is true acid-fast staining and should not be confused with 
fluorescent antibody microscopy. More acid-fast smears are found 
positive by the fluorochrome method than by the Z-N method (4,6), 
and some microscopists hold that fluorescence microscopy is 
superior to light microscopy (16,23) for observing acid-fast stained 
preparations. Fluorochrome-stained smears may lose their fluores­
cence with time, therefore they should be observed within 24 hours of 
staining. The smears should not be stained unless they can be ob­
served within this time (19). If stained smears must be kept overnight 
before being examined, they should be stored at 5°C to minimize the 
loss of fluorescence.
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a. Auramine 0 Fluorescence Acid-Fast Stain (4,15,19,22).
(1) MATERIALS
Auramine 0
Phenol crystals
Hydrochloric acid, concentrated
Ethanol, 70%
Potassium permanganate
Water, distilled
(2) PREPARATION
(a) Auramine 0: Dissolve 0.1 g auramine 0 in 10 
ml 95% ethanol.
(b) Dissolve 3 g phenol crystals in 87 ml distilled 
water.
(c) Mix solutions (a) and (b).
(d) Acid alcohol: Carefully add 0.5 ml concen­
trated hydrochloric acid to 100 ml 70% 
ethanol.
(e) Potassium  permanganate: D issolve 0.5 g 
potassium permanganate (KM n04) in 100 ml 
distilled water.
(3) PROCEDURE
(a) Prepare smear by spreading material over 1 - x 
2-cm area of slide and allow to air dry.
(b) Fix smear on an electric slide warmer at 65” to 
75°C for at least 2 hours, or use a Bunsen 
burner flame, as for other bacteriological 
smears. DO NOT OVERHEAT.
(c) Flood smear with auramine 0 solution and 
allow to stain for 15 minutes, making certain 
that the staining solution remains on the smear. 
Do not apply heat to smear. Do not use filter 
paper strips.
(d) Rinse smear with water and drain.*
(e) Flood smear with acid alcohol and destain for 2 
minutes.
(f) Rinse smear and drain.
*If rinse water contains an appreciable amount of chlorine. it may interfere 
with fluorescence. In this case use deionized or distilled water to rinse.
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(g) Flood smear with potassium permanganate and 
allow to stand for 2 minutes. Do not allow 
potassium permanganate to act over 3 or 4 min­
utes or it may quench the fluorescence of acid- 
fast bacilli.
(h) Rinse, drain, and air dry,
(i) Examine smear as soon as possible after staining 
(see 3., pp. 76-85).
b. Auramine O-Rhodamine B Fluorescence A cid-Fast
Ethanol, 70% 
Hydrochloric acid, con­
centrated
Potassium permanganate 
Water, distilled
(a) Auramine 0-Rhodamine B-Phenol: Dissolve 
1.5 g auramine 0, 0.75 g rhodamine B in a so­
lution of 75 ml glycerol, 10 ml of melted phenol 
crystals, and 50 ml distilled water. Mix well. 
This staining solution may be clarified by 
filtering through glass wool.
(b) Acid alcohol: Carefully add 0.5 ml concentrated 
hydrochloric acid to 100 ml 70% ethanol.
(c) Potassium permanganate: Dissolve 0.5 g potas­
sium permanganate (K MnO4)inl00 ml distilled 
water.
(3) PROCEDURE
(a) Prepare smear by spreading material over I- x 
2-cm area of slide and allow to dry.
(b) Fix smear on an electric slide warmer at 65” to 
75” C for at least 2 hours, or use a Bunsen burner 
flame as for other bacteriological smears. DO 
NOT OVERHEAT.
Stain (15,18,19,21).
(1) MATERIALS
Auramine 0
Rhodamine B
Phenol crystals 
Glycerol
(2) PREPARATION
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(c) Flood smear with auramine O-rhodamine B- 
phenol solution and allow to stain for 15 
minutes, making certain that the staining solu­
tion remains on the smear. Do not apply heat to 
smear. Do not use filter paper strips.
(d) Rinse smear with water and drain.*
(e) Flood smear with acid alcohol and destain for 2 
minutes.
(f) Rinse smear and drain.
(g) Floodsmear with potassium permanganate and 
allow to act for 2 minutes. Do not allow the po­
tassium permanganate to act over 3-4 minutes 
or it will quench the acid-fast fluorescence.
(h) Rinse, drain, and air dry.
(i) Examine smear as soon as possible after staining 
(see 3., pp. 76-85).
c. Auramine 0-Acridine Orange Fluorescence Acid-Fast 
Stain (20).
(1) MATERIALS
Auramine 0
Acridine orange 
Phenol crystals
Sodium phosphate, 
anhyd. dibasic
Ethanol, 95%
Ethanol, 70%
H ydrochloric acid, con­
centrated 
Water, distilled
(2) PREPARATION
(a) Auramine 0. Dissolve 0.1 g auramine 0 in 10 
ml 95% ethanol.
(b) Dissolve 3 g phenol crystals in 87 ml distilled 
water.
(c) Mix solutions (a) and (b).
(d) Acid alcohol: Carefully add 0.5 ml concentrated 
hydrochloric acid to 100 ml 70% ethanol.
L
*lf rinse w ater contains an a pprec iab le  am ount of chlorine, it mas interfere 
with fluorescence. In this case usedcioni/ed or distilled w ater to rinse smear.
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(e) Acridine orange: Dissolve 0.01 g anhydrous 
dibasic sodium phosphate (Na2 HP0 4 ) in 100 
ml distilled water, then add and dissolve 0.01 g 
acridine orange.
(3) PROCEDURE
(a) Prepare smear by spreading material over 1- x 
2-cm area of slide and allow to air dry.
(b) Fix smear on an electric slide warmer at 65” to 
75°C for at least 2 hours, or use a Bunsen 
burner flame as for other bacteriological 
smears. DO NOT OVERHEAT.
(c) Flood smear with auramine 0 solution and 
allow to stain for 15 minutes. Do not apply heat 
to smear. Do not use filter paper strip.
(d) Rinse smear with water and drain.*
(e) Flood smear with acid alcohol and destain for 2 
minutes.
(f) Rinse smear and drain.
(g) Flood smear with acridine orange and counter­
stain for 2 minutes.
(h) Rinse, drain, and air dry.
(i) Examine smears as soon as possible after stain­
ing (see 3.,pp. 76-85).
2. Sodium Hypochlorite (Clorox) Method for Smear Without 
Culture (7, 9, 17, 19).
This method is useful when a smear examination alone is re­
quired and when no biological safety cabinet is available to 
protect personnel from infection when processing specimens 
by conventional procedures. Because clorox (or other ap­
propriate hypochlorite solutions) will kill most of the organ­
isms in the specimen, the specimen, after being treated with 
clorox may be handled safely without a safety cabinet. Clorox 
is bactericidal for mycobacteria and may cause the bacilli to 
disintegrate if it is allowed to act longer than 15 minutes, 
therefore, smears should be prepared, stained, and examined 
promptly.
*11 rinse water contains an appreciable amount of chlorine, it may interfere 
with fluorescence. In this case use dcionired or distilled water to rinse smear.
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Ea. Materials
(1) Clorox or other commercial household bleach con­
taining 5% to 6% sodium hypochlorite (NaOCl).
(2) Screw cap plastic centrifuge tubes, preferably 50 ml.
(3) Centrifuge and head to provide 2,000 to 3,000 x g.
b. Procedure
(1) Mix equal volumes of sputum and clorox in a 
screwcap centrifuge tube.
(2) Tighten cap and shake the tube to liquefy the speci­
men. A test-tube mixer may be used.
(3 ) Let the mixture stand for 15 minutes at room tem­
perature.
(4) Add distilled water to the 50 ml mark on the tube.
(5 ) Centrifuge the tube(s) at 2,000 to 3,000 x g for 15 
minutes.
(6) Decant the supernatant fluid and retain the sedi­
ment.
(7 ) Suspend the sediment in several drops of water and 
prepare the smear by spreading a drop of the resus­
pended material over an area 1- x 2-cm. Allow to 
air dry.
(8) Fix the smear by passing the slide through the blue 
cone of a Bunsen burner flame about three times.
(9 ) Perform acid-fast stain as described in the preced­
ing sections.
3. Examination of Smears
Learn to use the microscope properly, because improper 
handling or operating may cause costly damage. Much of the 
following information regarding light microscopy and 
fluorescence microscopy has been adapted with permission 
from earlier work of Smithwick (19) and Koch (14). For a 
more detailed study of fluorescence microscopy techniques 
see Jones et al. (12).
W.
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LIGHT MICROSCOPY
Figure 19 is a schematic of a microscope; study it to familiar­
ize yourself with the names of the basic parts of this instru­
ment.
a. General Instructions
(1) Always read the instruction manual for your 
microscope before attempting to operate it.
(2) When the microscope is not in use, protect it from
dust by a covering or case.
(3) Always carry a microscope with both hands, one
firmly grasping the arm and the other supporting the 
base.
-Oculars
Neutral Density 
Filter Control
Figure 19. Schematic of a microscope.
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(4 ) Microscope lenses may be scratched by dirt or grit; 
therefore, clean the lenses only with lens tissue. 
Never use soap, alcohols, xylene, or other solvents. 
If lens tissue does not clean the lenses, consult the 
microscope manufacturer for cleaning recommen­
dations.
(5) The oil immersion objective lenses should be 
cleaned after each day’s work. Only nondrying, low 
viscosity, synthetic immersion oils should be used 
(they are easier to remove).
(6) Some microscopes have a single eyepiece (monocu­
lar); others have two eyepieces (binocular). Most 
microscopists recommend keeping both eyes open 
while looking into a monocular microscope with 
one eye. This prevents fatigue from holding the 
other eye closed. Although it may be difficult to 
learn to do this, the effort is worthwhile.
b. Methods of Microscopy
(1) Microscopes may be used in many ways. Some of
these methods will be mentioned to familiarize you 
with them. A text should be consulted for detailed 
descriptions.
(2) In incident light-microscopy the object is lighted 
from above (epiillumination), and the surface of the 
object is the most prominent feature.
(3) In transmitted light microscopy the light passes 
through the object; variations in color due to stain­
ing and differences in refraction and transparency 
show the form, structure, and other properties of the 
object.
(a) Bright-field microscopy is the most common 
form of transmitted light microscopy. The light 
passes directly through the object and is altered 
only by the object and any dyes used to color 
this object.
(b) In dark-field microscopy the light is transmitted 
through the object at an angle from the sides 
rather than from directly below. The refraction 
and reflection of the light by the object shows its 
structure in shades of light and dark against a 
black background.
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c. Procedure for Using a Microscope
(1) Be sure the light source is working properly.
(2) Be sure the lenses, mirrors, and other light-conduct­
ing surfaces are clean.
(3) Check for broken or damaged parts.
(4) Adjust the light, mirror, condenser, and diaphragm 
so that a strong beam of light is directed toward the 
objective lens.
(5) Turn the coarse adjustment knob to move the objec­
tive lens away from the stage.
(6) Rotate the nosepiece so that a low power objective 
lens (5X or 10X) is directly over the condenser.
(7) Place the slide on the stage so that the object to be 
viewed is under an objective lens.
(8) Look from the side of the stage so that you can see 
the space between the slide and the objective lens. 
Slowly turn the coarse adjustment knob to bring the 
objective lens very near, but not near enough to 
touch the slide, or until the knob stops turning.
(9) Adjust the light so that it is bright, but not uncom­
fortably bright, when you look into the eyepiece. 
This may be done by changing the intensity of the 
lamp, changing mirror surfaces, using dark filters, 
adjusting the diaphragm, or adjusting the con­
denser. Usually, adjusting the diaphragm is suffi­
cient.
(10) While looking into the eyepiece, slowly turn the 
coarse adjustment to separate the objective lens and 
the stage. The object should come into focus within 
several turns. If not, go back to step 8.
(11) Turn the fine adjustment knob until the object is 
seen most clearly.
(12) While looking from the side, turn the nosepiece to 
select a higher power lens. Be sure the lens does not 
touch the slide. The field of view should be almost 
in focus and can be brought into focus by turning 
the fine adjustment knob. The intensity of the light 
may also need to be adjusted.
(13) To use the oil immersion lens, turn the nosepiece so 
that no lens is over the object. Let a drop of oil fall 
on the slide, but do not touch the slide with the
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dropper. Now, turn the nosepiece so that the oil im­
mersion lens comes in contact with the oil. Turn the 
fine adjustment knob to focus.
(14) Move the slide slowly and systematically across the 
stage to observe the object.
(15) Scan the slide as directed for your work or as 
needed.
(16) Report only what you see and not what you think 
you are supposed to see.
(17) When you have finished with the slide, raise the ob­
jective lens, remove the slide, and clean the oil from 
the lens.
(18) When you have finished with the microscope, clean 
the oil off the lens, place the low power objective 
lens as if it were to be used, turn off the light source, 
and cover the microscope or place it in its cabinet.
d. Reading Fuchsin Stained Smears
Carbol fuchsin stained acid-fast bacilli appear as red 
stained organisms; with the methylene blue counterstain, 
nonacid-fast organisms and the background are stained 
blue (Fig.20).
F igure  20 . S h o rt , lo n g , and c lu m p s  o f re d , fu c h s in -p h e n o l s ta ined  b a c il li  w ith  a 
m e th y le n e  b lu e  s ta ine d  b a c k g ro u n d .
FLUORESCENCE MICROSCOPY
The lens system of a fluorescence microscope is the same as, or 
similar to, that of a standard microscope and, after some adjustments, 
usually may be used for transmitted light microscopy. Any one of 
several lighting systems can be used. All of these lighting systems re­
quire one of the standard electrical power supplies with little or no 
fluctuation in voltage:
(1) The high intensity tungsten filament lamp can be used for most 
fluorescence acid-fast techniques, but not for the fluorescent an­
tibody technique. This is the least expensive and the easiest 
system to maintain.
(2) The halogen lamp system can be used for most fluorescence 
microscopy methods, including the fluorescent antibody.
(3) The high pressure mercury vapor lamp system has been the most 
widely used, but it is costly and requires advanced technical skill 
to operate.
(4) Some xenon lamps and carbon arcs have been used, but they have 
not been popular.
The lamp must have its maximum output in that part of the light 
spectrum that includes both the desired waveband and the light in­
tensity that will excite the stain to its maximum fluorescence. The 
position of the lamp can be adjusted within its housing to focus the 
light source on the stained object. The lamp housing usually contains 
a reflector and/or a collecting lens to aid in concentrating the light 
on the object.
Many lamps produce enough heat to damage the glass filters 
transmitting the light; therefore, a heat absorption filter is placed be­
tween the lamp and the wavelength selection filters to protect them.
An exciter filter is chosen to absorb the unwanted red, yellow, 
and green light and to transmit the waveband of light that excites the 
stain to fluoresce. These exciter filters may be made of colored glass 
(usually dark blue), or they may be interference type of light filters; 
they are placed between the heat absorption filter and the stained ob­
ject. In some microscopes the exciting light is transmitted down 
through the body tube and the objective lens to excite the 
fluorochrome stain in the object (epiillumination). This allows the 
microscopist to scan objects that would not transmit light well, such 
as rocks, minerals, or thick specimens. This type of illumination may 
also be used for fluorescence microscopy of smears and tissue sec­
tions.
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A mirror is usually used to direct the light into the condenser; the 
mirror must have a front surface of aluminum or silver if it is to 
reflect ultraviolet light.
The condenser must be designed to provide maximum illumina­
tion of the object directly under the objective lens. It may be an oil 
immersion, dark-field condenser. Some techniques require only a 
bright-field, dry condenser that focuses the light source on the object 
(critical illumination).
Between the objective lens and the eye place a filter which ab­
sorbs the light passed by the exciter filter, but allows the light emitted 
by the fluorescing bacilli to pass. This is the barrier filter. It is usually 
made of colored glass or colored gelatin that has been laminated be­
tween two pieces of plain glass: these filters usually appear yellow or 
orange. The exciter and barrier filters must be properly matched to 
block out all light from the lamp and still allow the light from the 
fluorescing stains to reach the eye.
a. Illuminating Methods in Fluorescence Microscopy
(1) TRANSMITTED LIGHT FLUORESCENCE
Figure 21. Schematic representation of transmitted light fluorescence system.
Fluorescence excitation by means of transmitted light is 
the classical method used in fluorescence microscopy to­
day. Either dark-field or bright-field condensers may be 
used. With dark-field condensers no excitation light 
reaches the objective, thus insuring a dark background 
for the specimen. With bright-field condensers, however, 
excitation light does reach the objective, giving a bright 
background which reduces the contrast between the 
background and the bacilli being sought.
(2) I N C I D E N T  L I G H T  F L U O R E S C E N C E  
(EPIILLUMINATION)
fcp
—  exciting light 
— -  fluorescent light
eyepiece
I
suppression filte r 
bu ilt-in
supression filte r
dichroic beam 
splitting m irror
objective
specimen
Figure 22. Schematic representation of incident-light fluorescence system.
In fluorescence excitation with incident light (epiillumin- 
ation), the light is radiated from above the specimen. This 
insures a strong light intensity, because no light is lost 
through scattering or absorption in the specimen, a con­
dition possible in transmitted light excitation.
(3) BLUE LIGHT FLUORESCENCE
ESSENTIAL PARTS OF THE MICROSCOPIC 
SYSTEM (See Fig. 23)
(a) Light source.
The conventional light source for the excitation 
of fluorescent stains has been the ultraviolet 
light produced by high-pressure mercury vapor 
bulbs. This is still an excellent source of exciting 
light, but a cheaper and simpler source is a low- 
voltage 6V, 15W lamp of high luminous density 
in a special mount in the base of a microscope. 
This housing concentrates the light so that 
sufficient blue rays are collected to excite the 
auramine O stain.
(b) Microscope.
A binocular microscope with bright-field sub­
stage condenser is employed. It is cheaper and 
easier to operate than most other fluorescence 
equipment, and can also be used to examine 
smears stained with Ziehl-Neelsen, Gram, etc.
(c) Lens system.
(1) It contains a bright-field substage condenser 
which does not require the use of oil.
(2) Planachromat objectives provide a wide, flat 
field of vision and do not require immersion 
oil for high magnification.
(3) Compensating 10X oculars.
(d) Filters.
(1) Exciter filter: 3-mm BG12. The transmis­
sion peak is around 404 nm. This is in the 
visible blue light-ray zone, hence the term 
“blue-light excitation system.”
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(2) Barrier filters. These filters will pass the 
yellow rays emitted by auramine O after it 
has been excited by blue light.
(i) Zeiss 50 (or GG 14) transmits rays 
above 500 nm. The dark green back­
ground reveals debris and makes it 
possible to focus easily on a negataive 
smear. Some workers prefer to use 
this barrier filter exclusively.
(ii) Zeiss 53 transmits rays above 530 nm. 
The background is dark brown, pro­
viding the greatest brilliance and 
contrast. The background debris may 
be obliterated, which makes focus­
sing difficult on a negative smear.
(iii) OG-1, a yellow gelatin filter, some­
times used; it transmits above 500 nm.
Figure 23. Schematic representation of blue light brightfield microscopy for acid- 
fast organisms stained with auramine O.
(a) Examine with fluorescence microscopy equip­
ment outfitted with BG-12 exciter filter and an 
O G -1 barrier filter.
(b) With this system auramine O stained organisms 
emit a bright yellow fluorescence and auramine 
O-rhodamine B stained organisms emit a 
yellow-orange fluorescence (Fig.24,25).
(c) With the potassium permanganate counterstain, 
the nonspecific fluorescing debris is usually a 
pale yellow; the acid-fast organisms, bright 
yellow (Fig.24,25); the background, almost 
black.
(d) With the acridine orange counterstain, the 
background is stained red to orange, which 
sharply contrasts with the bright yellow acid- 
fast organisms (Fig.26).
(e) Smears may be scanned rapidly with a 10X to 
25X objective. Occasionally, the 45X or 63X 
objective may have to be used to ascertain actual 
bacterial morphology.
(f) If culture work is not done, or until the 
microscopist has demonstrated competence, all 
positive smears should be confirmed with the 
Ziehl-Neelsen stain.
Reading Fluorochrome Stained Smears
(1 )  W i th  H ig h  D ry  O b je c t iv e s
F igure  2 4 . Y e llo w  flu o re s c in g , a u ra m in e  O -p h e no f s ta ine d  b a c il li .  The 
b a c k g ro u n d  flu o re sce n ce  is q u e n ch ed  w ith  p o ta ss iu m  perm angana te .
(g) After the fluorochrome smear has been ex­
amined, it may be overstained with Z-N without 
removing the auramine stain. After the smear 
has been overstained with Z-N, however, it is no 
longer satisfactory for examination by fluores­
cence microscopy.
Figure 25. Yellow-orange fluorescing, auramine O-rhodamine 
B-phenol stained bacilli. The background fluorescence is 
quenched with potassium permanganate.
Figure 26. A yellow fluorescing, auramine O-phenol stained 
bacillus with an orange fluorescing, acridine orange stained 
background.
Most acid-fast fluorescence microscopy is per­
formed with low power and high power dry objec­
tives, but some laboratories have old FA equipment 
outfitted with oil immersion objectives and 
microscopists use them from time to time. The 
method follows.
(a) When fluorescence microscopy equipment has 
been properly aligned and appropriate filters 
(BG-12 and OG-1) are in position, examine 
stained slides as follows.
(b) Clean objective and condenser lenses carefully 
with lens paper.
(c) Lower condenser slightly and place one or two 
drops of low fluorescence immersion oil 
(Cargille’s type A) on condenser lens.
(d) Place slide to be examined in mechanical stage 
and move so that desired area is over condenser 
lens. Place immersion oil on cover slip.
(e) Raise condenser slowly until oil contacts slide 
over an area about 1/2 inch (ca. 12 mm) in 
diameter. Avoid making bubbles in the oil.
(f) Examine field with low power (10X) objective 
and bring into focus.
(g) Adjust level of condenser (up or down) until 
light in the microscopic field is concentrated in 
a small circle.
(h) Adjust position of circle of light to center of 
field, using adjusting screws on right and left 
front area of condenser base.
(i) When field is in proper focus under low power, 
and only then, examine with oil-immersion ob­
jective.
(j) Most microscopes are approximately parfocal, 
but may require slight adjustment on changing 
from low power to oil immersion objective lens.
(k) The dark field condenser may also have to be 
adjusted slightly (up, down, or centered) for the 
oil immersion objective lens.
(l) When field is in sharp focus under oil immer-
(2) With Oil Immersion Objectives
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sion, establish the best possible lighting condi­
tion by slightly adjusting the collecting lens and 
iris diaphragms (if present) in lamp housing 
assembly and/or oil immersion objective.
(m) If culture work is not done or until the 
microscopist feels confident, all positive smears 
should be confirmed with the Ziehl-Neelsen 
stain.
(n) After the fluorochrome smear has been ex­
amined, it may be overstained with Z-N without 
removing the auramine stain. After the smear 
has been overstained with Z-N, however, it is no 
longer satisfactory for examination by fluores­
cence microscopy. Remove residual oil with 
xylene.
Smear Examination
Careful smear examination is an essential part of today’s tuber­
culosis control program. The microscopist’s training should empha­
size the importance the clinician attaches to results of smear ex­
amination in deciding to discharge a patient to outpatient treatment 
or to gainful employment (3,8,11).
To obtain excellence in microscopic examination, one should 
have a good microscope and a comfortable work area. Methods of 
reading smears vary from laboratory to laboratory. At CDC, no time 
limit has been set for examining a smear. Instead, a system has been 
adopted which insures that a representative area of the smear is ex­
amined. To insure that an area is covered only once, the smear 
should be searched in an orderly manner by making a series of 3 
horizontal or 9 vertical parallel sweeps of the slide (see Fig.27). All 
parts of the smear should be sampled. Each field should be searched 
thoroughly, with a rapid change to the next field. These procedures 
should be followed regardless of how much time it takes. In this man­
ner, the microscopist should see 60 to 100 fields in one sweep, or as 
many as 300 fields if he finds it necessary to examine the entire 
smear. If the smear is moderately or heavily positive, then fewer 
fields may be examined, and a report of positive may be made even 
though the entire smear has not been examined.
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Figure 27. Recommended methods for examining acid-fast stained smears.
Acid-fast bacilli in specimens are usually in the form of rods, but 
they also may appear coccoid (round-like) or filamentous (long, 
slender, and even branching). They are frequently bent and may con­
tain heavily stained areas called beads, or alternating stained and 
clear areas that make them appear to be banded. See Figures 28 and 
29. From pure cultures, individual rods of M. tuberculosis may be ag­
gregated side by side and end to end to form “cords” (Fig. 30). This 
is often the case in smears made from the turbid fluid at the bottom of 
Lowenstein-Jensen slants on which M. tuberculosis is growing.
As smears of pure cultures show, not all of the mycobacteria in a 
given smear are necessarily acid fast. Some species of the genera 
Nocardia and Corynebacterium and even some bacterial and fungal 
spores may be acid fast (2). In fluorescence acid-fast microscopy 
debris may fluoresce and thus be mistaken for acid-fast bacilli. The 
microscopist should learn to distinguish acid-fast bacilli from these 
other sometimes confusing organisms and artifacts by examining 
smears frequently and thus learning to recognize the morphology of 
acid-fast organisms.
Figure 28. Branching filaments with beading and small coccoid forms. 
From Smithwick (19).
N
Figure 29. Alternating clear and pink-stained parts of the bacilli that show the 
characteristic of banding. Note the dark-stained parts called beads.
Figure 30. Strands of bacilli in cords. From Smithwick (19).
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4. Reporting of Smears
a. Make sure reports state the staining method used and the 
number of acid-fast bacilli seen on the smear.
b. Observe only enough fields to get an average number of 
acid-fast organisms.
c. Count a clump of bacilli that are touching as one. Give 
separate counts to separate organisms. A clump of bacilli 
is considered a single colony forming unit; this is impor­
tant to know when determining dilutions of sediment for 
direct drug susceptibility tests.
d. Note any large numbers of clumps on the report, thus in­
dicating that the actual number of acid-fast organisms is 
larger than that actually reported.
e. REPORT ONLY THE NUMBER OF ACID-FAST 
BACILLI SEEN; DO NOT TRY TO “SPECIATE” 
WITH MICROSCOPY ALONE.
f. Counts of less than 3 per 300 fields by fuchsin stains (or 
10 per 300 fields by fluorochrome stains) are not con­
sidered positive. A report of “doubtful” may be sent or, if 
the specimen is still available, a second smear may be 
prepared, stained, and examined. In either case, request 
another specimen.
g. Several systems are used for reporting the results of acid- 
fast microscopy. Two such systems are given here.
(1) Both Smithwick (19) and David (10) recommend 
the reporting scheme tabulated below (Table 3).
Table 3. Suggested method for reporting the number of acid-fast 
bacilli observed in smears when scanning at 100X  to 1 ,0 0 0 X *
N um ber of AFB found: Report: A lternate:
0 Negative for AFB _
1 - 2 / 300 fields Number seen* * ±
1 - 9 / 1 0 0  fields Number /100 fields 1 +
1 - 9 / 1 0  fields Number / 10 fields 2+
1 - 9 / field Number / field 3+
>9 / fie ld *" >9 / field 4+
‘ Magnifications less than 800X should be clearly stated on the report or 
counts should be adjusted as follows: near 650X, divide count by 2; near 450X, 
divide count by 4; near 250X, divide count by 10. Example: observed average 
of 8 AFB per 10 fields at 450X, adjusted to 2 AFB per 10 fields at 800X to 
1000X.
"A n y  number of AFB that is less than 3 per 300 fields at 800X to 1000X is not 
considered positive, but it does indicate that another specimen should be pro­
cessed if available.
* "  >  = greater than.
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(2) The American Lung Association recommends the 
following method: (1,22).
N um ber of B acilli Report
0 No acid-fast bacilli found.
1-2 in entire smear Report number found and 
request repeat specimen.
3-9 in entire smear Rare or +
10 or more in entire smear Few or + +
1 or more per field Numerous or + + +
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E. CULTURE AND PRELIMINARY OBSERVATION OF 
MYCOBACTERIA ON LOWENSTEIN-JENSEN AND  
MIDDLEBROOK 7H-10 MEDIUM.
M. tuberculosis is the most common species of Mycobacterium found 
in clinical specimens from patients suspected of having tuberculosis. 
Other mycobacteria are also found in these specimens, and some may 
even be associated with disease. Technical personnel in the level II
(4) laboratory must therefore be able to identify M. tuberculosis, and 
they must understand that some of these other acid-fast bacilli may be 
potential pathogens and should be sent to a level III laboratory for 
precise characterization.
Even though acid-fast microscopy is a valuable aid in today’s tuber­
culosis control programs, it does not provide specific identification 
of mycobacteria. The organism must be grown on culture medium to 
permit a definitive diagnosis of M. tuberculosis.
Many formulations of media have been proposed for the cultivation 
of mycobacteria. Most are variations of egg-potato base or serum- 
agar base formulations. An ideal medium should (i) support rapid 
and luxuriant growth from minimal inocula, (ii) permit preliminary 
separation of mycobacteria based upon pigment production and co­
lonial morphology, (iii) inhibit the growth of contaminants, (iv) per­
mit the performance of drug susceptibility tests, (v) be easy to pre­
pare, and (vi) be economical. Unfortunately, no single medium meets 
all of these criteria, but many of them have been used with varying 
degrees of success.
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Two of the more widely used egg-base formulations are the American 
Trudeau Society (ATS) medium (7) and Lowenstein-Jensen (L-J) 
medium (3). Of the agar base formulations, the most popular are 
Middlebrook 7H-10 medium (5) and 7H -11 medium (1). A general 
purpose broth medium that can be used for routine diagnostic work 
(e.g., dilutions, growth studies, and indirect drug susceptibility tests) 
is Middlebrook 7H-9 broth (5) medium or Dubos- Middlebrook 
tween-albumin broth (2) medium. Both the agar and broth media are 
available commercially as powdered bases (with enrichments). The 
Lowenstein-Jensen medium is available commercially as ready pre­
pared tubed slants and butts. Also available is a commercial 
powdered base which must be enriched with fresh eggs. A totally self- 
contained egg base medium (using powdered eggs) has been 
marketed but has not yet been fully evaluated. The various commer­
cial media work well, but each lot should be checked with a strain of 
M. tuberculosis having known growth characteristics.
Several factors may contribute to the difficulties the microbiologist 
encounters when trying to culture mycobacteria from digested, de­
contaminated clinical specimens. Some of these factors are (i) varia­
tions in the growth requirements of different strains of mycobacteria, 
(ii) uneven distribution of mycobacteria in clinical specimens, (iii) 
harmful effects of the digestant-decontaminant solution on mycobac­
teria, and (iv) toxicity of some specimen component for the 
mycobacteria. Because of these factors, digested, decontaminated 
specimens should be inoculated, both undiluted and after a tenfold 
dilution (to dilute possible toxic materials in the specimen), onto 
multiple units of at least two different kinds of basal medium. If 
space and money permit, at least four units of an egg base medium 
and one biplate of an agar base medium should be used, as described 
in III.B.l.c, p. 46. All cultures should be incubated as outlined in 
III.C, p. 58.
1. Examination of Cultures
When reading cultures, use some type of magnification to 
better visualize the colonies; a hand lens or dissecting 
microscope is suitable. With the aid of magnification, the 
microbiologist can observe young colonies at an early stage 
of growth, can report detailed morphology of mature col­
onies, and can more easily detect transparent colony forms.
Cultures should be examined 5 to 7 days after primary in­
oculation, and at least weekly thereafter for 6 to 8 weeks be­
fore they are discarded as negative. If facilities permit, 
prolonged incubation may be advisable in selected cases. If 
cultures become contaminated (obvious overgrowth, or, in
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the case of LJ medium, when slants become deep blue or pale 
yellow) this should be reported immediately and another 
specimen should be requested from that patient.
2. Reporting Observations
a. Growth rate. This is defined as the number of days of in­
cubation required for colonies to become visible without 
the aid of magnification. Rapid growers usually mature 
within 7 days. Slow growers require more than 7 days. 
Because the true “speed of growth” of a culture may be 
grossly exaggerated on primary isolation from clinical 
material, the true growth rate should be determined only 
on fresh subcultures.
b. Amounts of growth. Record as follows:
No colonies = Negative 200-500 colonies = 3+
<50 colonies = Actual Count (almost confluent)
50-100 colonies = 1+ Over 500 colonies = 4+
100-200 colonies = 2+ (confluent)
c. Pigment production. The mycobacteria may be divided 
into three groups on the basis of pigment production. 
Pigment formation is best observed in cultures which 
have isolated colonies. Yellow, orange, or red colonies 
are considered pigmented or chromogenic (CH). Pale 
yellow, pink or tan colonies are recorded as such. White, 
cream, or buff colonies are considered nonpigmented or 
nonchromogenic (NC). To demonstrate pigment produc­
tion, cultures should be grown initially in the dark, and 
later the young, actively growing colonies may be ex­
posed to light. The three groups are identified as:
(1) Photochromogens, cultures whose colonies are non­
pigmented when grown in the dark, but become 
pigmented after they are exposed to light for 1 or 
more hours and reincubated overnight (Fig. 31).
(2) Scotochromogens. Cultures whose colonies produce 
pigment when grown either in the dark or the light 
(Fig. 32). Cultures grown in continuous or prolonged 
exposure to light may reveal more intense pigment 
than companion cultures protected from light.
(3) Nonphotochromogens. Cultures whose colonies are 
nonpigmented or possess only pale shades of pig­
ment, and whose color is unaffected by exposure to 
light (Fig. 33).
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a. S m o o th  c o lo n ie s  g ro w n  in  d a rk  o n  
LJ m e d iu m .
b. R ough  c o lo n ie s  g ro w n  o n  LJ m e d iu m ; 
som e c o lo n ie s  sh ie ld e d  f ro m  lig h t.
c . S m o o th  c o lo n ie s  g ro w n  o n  7 H -1 0  agar. d . S m o o th  {som e ro ug h ) c o lo n ie s  g ro w n  
on  LJ m e d iu m .
Figure 31. Colonies of several species of photochromogenic mycobacteria.
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na. S m o o th  c o lo n ie s  o n  7 H -1 0  agar b. R ough  co lo n ie s  on  7 H -1 0  agar
e. S m o o th  co lo n ie s  o n  LJ  m e d iu m f.  S m o o th  co lo n ie s  o n  LJ m e d iu m
F ig u re  32 . C o lo n ie s  o f  several species o f  s c o to c h ro m o g e n ic  m y c o b a c te r ia .
L
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Figure 33. Colonies of several species of nonphotochromgenic mycobacteria.
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3. Colony Morphology
On culture media inoculated with bacterial suspensions 
diluted to yield isolated colonies, individual colony types 
may be observed, and described, and they may prove to be 
helpful in identifying the cultured organism. Some of the 
descriptive terms for mycobacterial colonies on culture 
media are listed below. Other symbols for recording colony 
characteristics can be found in Vestal’s manual (6).
a. Surface:
Smooth (Sm)
Rough (R or Rg)
Cording
b. Elevation and Colony Form:
Flat Umbonate (raised center)
Convex Rosette (lobate)
Pyramidal Doughnut
c. Edge:
Entire
Irregular
Flat and Spreading
d. Opacity:
Transparent Opaque 
Translucent
e. Pigment (in dark):
Nonpigmented (buff)
Pigmented
“Greening”: Some cultures absorb the malachite green 
dye from LJ slants during incubation, or when they are 
stored in the refrigerator.
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IV . SPECIFIC IDENTIFICATION OF 
M y c o b a c t e r iu m  tu b e r c u lo s is
The procedures presented here are those used at the Centers for Dis­
ease Control (CDC). They are not the only methods available, but 
they have proved to be reliable at CDC and in other public health 
laboratories for the identification of M. tuberculosis.
After being isolated in pure culture, mycobacteria may be grouped 
roughly by (1) the time and temperature of incubation needed to ob­
tain macroscopic growth—that is, mature colonies on culture media, 
and (2) the presence or absence of pigment. If the cultures are ex­
amined weekly, and their purity has been confirmed by smear ex­
amination, most of these observations may be made on primary isola­
tion.
M. tuberculosis is the species most commonly isolated from suspected 
pulmonary tuberculosis. The appearance of slow-growing, rough col­
onies on culture media and the detection of niacin in culture extracts 
is a presumptive identification of this species, but the mycobac- 
teriologist must still perform additional tests to arrive at a definitive 
identification.
Each culture isolate should be transferred to a liquid medium and 
then subcultured to solid medium to determine rate of growth and 
pigment production and to perform the niacin, nitrate reduction, 
and 68°C catalase tests.
Microscopically, individual cells of M. tuberculosis are rod shaped, 2 
to 5 jam or more long, and 0.4 to 0.6 £im wide. After dividing, the 
multiplying cells tend to form tightly packed cords that appear to pile 
up at the center, giving the colonies a characteristic rough, corded 
appearance. The colonies are nonpigmented, grow best between 35° 
and 37°C, and usually require 2 weeks or more to form macroscopic 
colonies. Although the features are characteristic and suggestive of 
M. tuberculosis, they are not unique to that species. By adding to these 
features the niacin, nitrate reduction, and 68°C catalase tests, the 
Level II laboratory should be able to identify M. tuberculosis with a 
high degree of reliability. Recommended methods for performing 
these tests are outlined below.
A. SPEED OF GROWTH
On primary isolation, even rapidly growing mycobacteria may take 3 
weeks or more to appear on the culture medium (8); consequently, 
the rate of growth should always be determined by using as inoculum
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a fresh, liquid subculture diluted sufficiently to yield isolated col­
onies on whatever solid medium (usually egg-base) is inoculated.
The liquid medium most commonly used is enriched Middlebrook 
7H-9 broth (made from commercial ingredients). Once the purity of 
the unknown culture growing on primary isolation medium has been 
determined by smear examination, several colonies are aseptically 
picked and inoculated into 5 ml of 7H-9 broth contained in 20-x 
150-mm screwcapped test tubes (or 3 ml of 7H-9 in 16-x 125-mm 
tubes). Cultures are incubated at 35° to 37°C for 5 to 7 days; shaking 
the cultures daily by hand will increase the amount of growth at the 
end of the incubation period (be certain the screwcap is securely 
tightened before shaking the culture).
At the end of the incubation period, the bacterial suspension is 
diluted to the “high dilution” (see chart below), on the basis of the 
extent of turbidity of the broth culture, and 0.1 ml of this dilution is 
inoculated onto each of several tubes of egg medium. As a safeguard 
against overdilution, several tubes of media should also be inoculated 
with the next lower or “medium dilution.” The recommended dilu­
tions are given in the chart. The suspension should be diluted as 
described earlier in I.F.6., p. 27.
Broth
Consistency
Dilutions to be made
Low Medium High
Very turbid 10~4 10“ 5 1 0 '6
Moderately turbid 10-2 or1CT3 10-3  or 10-4 10~4 or 10-5
Slightly turbid undil. or 10“ 1 10 -1 or 10~2 10~2 or 10~3
Inoculated media are incubated at 35° to 37°C (lower or higher tem­
peratures may be used if other species are expected). Examine tubes 
after 5 to 7 days of incubation and weekly thereafter.
M tuberculosis is grouped with the slow-growing mycobacteria 
because it takes more than 7 days of incubation for mature colonies 
to be visible to the unaided eye. Tubercle bacilli also exhibit a 
restricted growth temperature range, growing best between 35° and 
39°C; growth of diluted inocula (described above) will not be seen in 
tubes incubated at 22° to 25°C or at 42°C or above.
B. COLONY MORPHOLOGY
Colonies of M. tuberculosis on most egg media are rough, dry, friable, 
and nonpigmented. They are usually heaped up in the center and 
have a thin, almost transparent, trailing edge. Occasionally, the col­
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Figure 34. Colonies of M. tuberculosis on egg medium.
onies are flat, rough, and spreading, with only a slight central eleva­
tion. Combinations of colony forms between these extremes may be 
seen. See Figure 34 for examples.
On 7H-10 or 7H -11 agar based media, M  tuberculosis grows as flat, 
rough, spreading, nonpigmented colonies, with only slight elevations 
in the center. When viewed through a dissecting microscope, by 
transmitted light, the colonies appear dark, rough, and ropey or cor­
ded (because of the close alignment of multiplying bacilli in side-by­
side and end-to-end arrangement). See Figure 35 for examples.
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Figure 35. Colonies of M. tuberculosis on 7H-10 agar medium.
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The microbiologist should also know what M. tuberculosis does not 
look like on these two types of media. Although colonies of tubercle 
bacilli may, on rare occasions, absorb the dye (especially from egg 
medium) and appear green, they do not appear bright yellow and 
orange as do some other mycobacteria. Colonies of M. tuberculosis 
are always rough, never smooth and hemispherical (if a tube of 
medium has an excessive amount of water in it, this may flow over the 
colonies and make them “appear” smooth, but if the caps are 
loosened and the moisture dries up, the colonies again look rough). 
Examples of some of these non-M tuberculosis colonies are shown in 
Figures 31-33.
C. NIACIN TESTS (6)
This is one of the most reliable in vitro tests for the identification of 
M tuberculosis. The fact that a few species other than M. tuberculosis 
occasionally produce positive results in the niacin test emphasizes the 
importance of performing supportive tests to confirm the niacin test 
reaction.
Most consistent results in the niacin test are obtained from cultures 
grown on egg medium; therefore, except in unusual circumstances, 
niacin tests should be performed only on cultures grown on egg-base 
medium. Cultures grown on 7H-10 or 7H -11 agar media may give 
negative results unless the media are supplemented with 0.1% 
potassium aspartate (4) or unless the niacin extraction is carried out 
at elevated temperature, and usually for a prolonged time (10).
Cultures should be pure (check them with a fuchsin acid-fast stain), 
have a least 50 or more colonies on the medium, and be 3 to 4 weeks 
old (if tests are still negative on 4-week-old cultures and cultures 
have been handled aseptically, reincubate until they are 6 weeks old 
and retest; otherwise use a fresh subculture). Because the bacteria ex­
crete niacin into the growth medium, a slant with confluent growth 
may give a negative niacin test result because the extracting fluid can­
not contact the culture medium. In such cases, use a transfer spade or 
the tip of a pipette to scrape away or puncture the growth, thus expos­
ing the surface of the medium. Additional precautions and com­
ments about false positive or false negative niacin test reactions can 
be found elsewhere (8).
The niacin test may be done either with chemical reagents prepared 
in the laboratory or with commercially available paper strips for 
detecting the niacin. Several investigators (2,3,5,14) have obtained 
comparable results with both procedures. They are described below.
1. N iacin  Test W ith Chem ical Reagents (12)
a. Materials
4% aniline
10% cyanogen bromide 
Sterile distilled water or 0.85% saline 
Sterile screwcap test tubes, 16 x 125 mm 
95% ethanol
b. Preparations
4% aniline solution
To 96.0 ml of 95% ethanol, add 4.0 ml of colorless 
aniline. Store in a brown bottle in the refrigerator. If 
solution turns yellow, discard.
10% cyanogen brom ide*
Dissolve 5.0 g cyanogen bromide in 50 ml distilled 
water. Store in a tightly capped brown bottle in the 
refrigerator. If a precipitate forms upon cooling, warm to 
room temperature to dissolve. Cyanogen bromide is 
volatile. Weak solutions give false negative results, so pre­
pare the reagent in small amounts.
0.85%  saline
Dissolve 0.85 g sodium chloride in 100 ml distilled 
water. Sterilize by autoclaving.
c. Procedures
(1) To the culture slant on egg base medium, add 1.0 ml 
of sterile distilled water or saline.
(2) Place the tube so that the fluid covers the entire sur­
face of the medium. Allow the extraction to proceed 
for 15 minutes. Longer extraction times may be 
used under some circumstances (e.g., cultures with 
few colonies or cultures known to be weak niacin 
producers).
(3) Remove 0.5 ml of the fluid extract and transfer to a 
clean 16-x 125-mm screwcap tube.
(4) Add 0.5 ml of the aniline solution.
‘ Cyanogen bromide is a severe lacrimator, is very toxic, and. in acid solutions, it 
forms hydrocyanic acid. The compound should, therefore, be handled only in a well- 
ventilated safety cabinet. The test tubes used in performing the tests should be dis­
carded into a disinfectant solution made alkaline by the addition of sodium 
hydroxide.
(5) Add 0.5 ml of the cyanogen bromide solution.
(6) Observe for the formation of a yellow color, which 
should develop immediately.
d. Results
Positive = yellow color.
Negative = no color change.
See Figure 36.
e. Controls
Reagent controls on extract from uninoculated medium 
(negative).
Negative control on extract from known culture of M. 
avium complex. Positive control on extract of a known 
culture of M. tuberculosis.
2. Paper Strip Procedure (5,14).
A paper strip method for detecting niacin obviates the need 
to prepare and store unstable chemicals used to demonstrate 
niacin. Originally described by Kilburn and Kubica (5), 
these paper strips are now available from several commercial 
suppliers (Difco, General Diagnostics).
Comparative studies conducted by several researchers 
(2,3,14, and the authors’ personal experience) indicate that 
these paper strips are as sensitive for detecting niacin produc­
tion by M. tuberculosis as the chemical method described 
above.
NIACIN 1
1 2  3 4 1
i H pi H
Figure 36. Niacin test with chemical reagents. Tubes 1 and 2 negative; 
tubes 3 and 4 positive.
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a. Materials
Reagent-impregnated paper strips
Sterile sealable test tubes (screwcap, cork or rubber stop­
per): 12 x 75 mm for Difco strips; 13 x 100 mm for 
General Diagnostics strips.
b. Procedure
(1) Into 0.6 ml of the culture extract, obtained as
described under C.l.c., p. 102, insert the strip with 
identification end up (some strips have an arrow 
indicating which end of the strip to insert first). 
Immediately seal the tube.
(2) Allow the test system to react at room temperature 
for 15 to 20 minutes; agitate occasionally. Do not 
tilt the tube.
(3) Observe the color of the liquid in the bottom of the 
tube against a white background.
c. Results
positive = development of yellow color in extract 
negative = no color development in extract.
Any color development on the strip itself should be dis­
regarded.
d. Controls
Same as indicated for the chemical procedure.
See Figure 37 for examples.
NIACIN
Figure 37. Niacin test by the paper strip procedure.
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NOTE: Neutralize the strips with 10% sodium hydroxide 
before discarding, or discard them into alkaline disinfectant.
D. NITRATE REDUCTION TESTS
The ability of mycobacteria to reduce nitrates (N 03) to nitrite (N 02) 
provides a differential tool that aids in species identification. The test 
can be performed by using chemical reagents, or reagent- impreg­
nated paper strips or it can be combined with a test for niacin detec­
tion. M. tuberculosis is one of the strongest reducers of nitrate among 
the mycobacteria, a trait that makes the paper strip test especially 
valuable for this species. Other mycobacteria may give results in the 
paper strip test which conflict with those obtained by the classical 
procedure with chemical reagents. If reliable results are to be ex­
pected for the classical and strip tests, a heavy suspension of the 
organisms must be used. A light suspension may yield a questionable 
reaction. The combined test, performed directly on egg-base slants, 
often gives more intense reactions and more reliable results (personal 
experience at CDC). Each of the three tests is described here.
1. Nitrate Reduction Test With Chemical Reagents (13).
a. Materials
Screwcap test tubes, 16 x 125 mm
Sterile pipettes, capillary or 1.0 ml, and 5.0 ml
Inoculating spade or applicator sticks
Water bath at 37°C or constant temperature block heater
NaNOj, KH2P 0 4, Na2H P 04.12H 20 ,
HC1, Sulfan ilam ide, N -naphthy le thy lened iam ine
dihydrochloride
Distilled water, zinc powder
b. Preparation
(1) Substrate. 0.01 M sodium nitrate in 0.022 M 
phosphate buffer, pH 7.0
Dissolve the following chemicals in order in 100 ml 
distilled water:
N aN 03-----------------------0.085g
KH2P 0 4--------------------- 0 .1 17g
Na2H P 0 4.12H20-------- 0.4 8 5g
Sterilize by autoclaving.
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(2) Reagent #1 . Carefully add 50.0 ml concentrated 
HC1 to 50.0ml distilled water (NEVER ADD 
WATER TO ACID).
(3) Reagent # 2 . Dissolve 0.2g sulfanilamide in 100.0 
ml distilled water.
(4) Reagent #3. Dissolve 0.1 g N-naphthylethylenedia- 
mine dihydrochloride in 100.0 ml distilled water. 
Store the substrate and reagents in the dark under 
refrigeration. If a precipitate forms or the reagents 
change color, discard and prepare afresh.
c. Procedure
(1) Use a 3 to 4 week old culture from Lowenstein- 
Jensen or some other egg base medium.
(2) Add 0.2 ml sterile distilled water to a sterile 16-x 
125-mm screwcap test tube.
(3) Using a sterile spade or applicator stick, emulsify 2 
spadesful of growth into the water.
(4) Add 2.0 ml of the N aN 03 substrate solution. Shake 
by hand and incubate in upright position in 37°C 
water bath for 2 hours. If water bath is not available, 
a pan of water may be placed in a 37°C incubator, 
and test cultures placed in this pan for incubation. 
Heat transfer in the water “medium” is more rapid 
and insures better enzymic activity.
(5) Remove from the temperature bath.
(6) Add one drop of reagent #  1.
(7) Add two drops of reagent #2 .
(8) Add two drops of reagent #3 .
d. Results
Positive = Red color development, which may range 
from pale pink (± ) to deep red (5 + ) by comparison with 
the color standards described in the appendix. M. tuber­
culosis generally gives a 3+ to 5+ color reaction.
Negative = No color development. If no color develops, 
the test is either negative or the reduction has proceeded 
beyond nitrite. To confirm, add a small amount of 
powdered zinc to the mixture. The zinc catalytically 
reduces nitrate to nitrite, and therefore a true negative
test becomes red when zinc is added. If there is no color 
change when zinc dust is added to an apparently negative 
reaction tube, the test may have been positive with reduc­
tion having gone beyond nitrite. In such cases, repeat the 
test. See Figure 38 for examples.
Controls
Positive = M. tuberculosis, which is usually a 3+ to 5 + . 
Negative = Reagents without organisms.
.NITRATE REDNri * 1 2 3 4
rj 1 «
Figure 38. Nitrate reduction test with chemical reagents. 
Tubes 1 and 2 negative; tubes 3 and 4 positive.
2. Combined Niacin/Nitrate Test (7).
a. Materials
Same as in D .l.a., p. 105.
b. Preparation
Same as in D .l.b., p. 105.
c. Procedure
(1) Use a 3-to 4-week old culture from Lowenstein- 
Jensen or some other egg base medium.
(2) Add 2 ml of the nitrate substrate to each slant.
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(3) Place the tube so that the fluid covers the slants and 
let stand for 15 minutes*.
(4) If necessary, remove 0.6 ml of the nitrate solution 
and place in a clean tube for the niacin test (use cor­
rect tube size, depending upon niacin test method 
employed).
(5) With the tip of a pipette, dislodge several colonies 
into the remaining solution.
(6) Incubate at 37°C for 2 hours.
(7) Remove tubes from the water bath and acidify the 
solution with one drop of reagent # 1 . Be certain 
that this and the other two reagents are added 
directly to the fluid and not allowed to run down 
the surface of the egg slant.
(8) Add two drops of reagent # 2
(9) Add two drops of reagent # 3
(10) To all negative tubes, add a small quantity of zinc 
dust.
d. Results
(1) Make observations as described in the standard 
nitrate test (D.I., p. 105).
(2) The niacin test may be performed and read by any 
of the methods described earlier.
See Figure 39 for examples of the reaction.
3. Nitrite Test Strips for Detection of Nitrate Reduction
(1,11).
a. Materials
Reagent-impregnated test strips (Difco, General Diag­
nostics)
*An alternative method used at CDC is to add 2 ml of the buffered nitrate substrate 
to the test culture and to place the tube upright in a 37°C water bath for 2 hours 
(NOTE: if the substrate solution is not in direct contact with some of the colonies on 
the slant when the tube is upright, dislodge some growth into the substrate with the 
pipette tip.) After the 2 hour incubation, remove 0.5 to 0.6 ml of the substrate 
solution to a clean tube for the niacin test (using any desired procedure), and add 
reagents for the nitrate reduction test as described above. In contrast to the usual 
niacin test procedure (C .l.c ., p. 102), the prolonged time for extraction of niacin 
and the higher tem perature o f 37° C used here often makes positive niacin test 
reactions more definitive.
Sterile screwcap test tubes, 13 x 100 mm
Sterile spade or applicator sticks
Forceps
Water bath, 37°C or constant-temperature block heater.
Sterile saline, 0.85%
b. Procedure
(1) Use a 3 to 4 week old culture from Lowenstein- 
Jensen or some other egg base medium.
(2) Add 1.0 ml sterile saline to a sterile screwcap 13-x 
100-mm test tube.
(3) Using a sterile spade or applicator stick, remove two 
spadesful of growth from the culture and add to the 
saline; break up the culture with the spade or stick.
(4) Using flamed forceps, carefully insert a nitrite test 
strip so the bottom of the strip is inserted first. Hold 
the tube in a vertical position and do not let the strip 
contact any fluid on the sides of the tube. Cap 
tightly and incubate at 37°C for 2 hours.
(5) Shake tube gently at end of first and second hour of 
incubation. Do not tilt the tube at this point.
(6) After 2 hours of incubation, carefully tilt the tube 
back and forth six times to wet the entire strip.
(7) Slant tube at room temperature to cover the strip 
with the liquid. Let it remain in this position for 10 
minutes.
Figure 39. Nitrate reduction test by the combined method.
d. Results
Positive = Top portion of strip changing to light blue or 
dark blue (Difco); central portion of strip changing to 
pink (General Diagnostics).
Negative = No color change.
See Figure 40 for examples.
The test strips are sensitive to excessive heat, light, and 
moisture. Store between 2° to 8°C in the original con­
tainer, tightly capped. Any discoloration on the strips in­
dicates that the reagent has deteriorated and the strips 
should be discarded.
e. CAUTION: see page 112.
NITRATE RED
PAPER STRIPS
n  § - *  OIFCO PATHOTEC
Figure 40. Nitrate reduction test by the paperstrip procedure.
E. CATALASE TEST AT pH 7 /68T  (9)
Except for some isoniazid-resistant mutants of M. tuberculosis, most 
mycobacteria possess catalase enzymes which break down hydrogen 
peroxide to water and oxygen. When suspended in pH 7 buffer and 
heated to 68°C for 20 minutes, several species (most notably M. 
tuberculosis) lose this enyzmatic activity (9). This “hot catalase” test, 
then, is a valuable adjunct to the other in vitro tests described for 
specifically identifying M. tuberculosis. It may be especially helpful 
with strains of tubercle bacilli that give negative or only weakly posi­
tive results in niacin tests.
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c1. Materials
Pipettes, 1.0 ml
Sterile screwcap test tubes, 16 x 125 mm
Water bath or constant temperature block heater, 68°C
Inoculating spade or loop
30% hydrogen peroxide (Superoxol). Store in refrigerator 
10% Tween 80
0.067 M Phosphate buffer, pH 7
2. Preparation
a. 10% Tween 80. Mix 10.0 ml Tween 80 with 90.0 ml dis­
tilled water. Autoclave for 10 minutes at 121°C. Store in 
the refrigerator. Immediately before performing the test, 
mix equal parts of the Superoxol and the Tween 80 solu­
tion (0.5 to 1.0 ml will be needed for each test).
b. 0.067 M phosphate buffer, pH 7.0 (see III.B. 1 .b. (2) (a), 
P- 45).
Mix 61.1 ml of disodium phosphate with 38.9 ml of 
monopotassium phosphate. Check pH on meter or with 
pH test paper.
3. Procedure
a. Use a culture from solid media.
b. With a sterile pipette, dispense 0.5 ml of the pH 7 
phosphate buffer into a sterile 16-x 125-mm screwcap 
test tube.
c. With a sterile spade or applicator stick, emulsify one 
spadeful of growth from the culture into the buffer.
d. Place the tubes at 68°C for 20 minutes (the time and tem­
perature are critical).
e. Remove from heat and cool to room temperature.
f. Add 0.5 ml of the Tween-peroxide mixture.
4. Results
Observe for the formation of bubbles at the surface of the li­
quid. Hold the tubes for 20 minutes before reporting as nega­
tive.
Positive = Bubble formation
Negative = No bubble formation
See Figure 41 for examples.
L
in
Figure 41. The pH7/68°C catalase test.
Tubes 1 and 2 positive; tubes 3 and 4 negative.
Controls
Positive = M  fortuitum
Negative = M. tuberculosis or M. gastri
WARNING - 30% hydrogen peroxide is a strong OXI­
DANT. Handle with care; rubber gloves are recommended.
Using the three in vitro tests described (niacin, nitrate reduc­
tion, and pH 7/68°C catalase tests), CDC personnel have 
demonstrated a high degree of reliability for the tests in the 
specific identification of M. tuberculosis. Of more than 200 
strains of M. tuberculosis examined as unknowns, 96% were 
observed to yield the correct reactions in these three tests, i.e., 
positive results in niacin and nitrate reduction tests and nega­
tive results in pH 7/68°C catalase tests. Of more than l ,000 
other unknown mycobacteria studied, less than l in l ,000 
reacted in in vitro tests like M. tuberculosis.
The paper strip method for detecting niacin production has 
been approved by most who have used it, and it appears 
especially valuable for laboratories that have trouble main­
taining fresh chemical reagents. The nitrite test strip is less 
reliable for some species of mycobacteria that are weak 
reducers of nitrate. Most strong nitrate reducers, notably M. 
tuberculosis, give generally acceptable reactions in the paper 
strip test for nitrate reduction, and at this time we recom­
mend the strip test for this species of Mycobacterium only.
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CAUTION: If control cultures of M. tuberculosis fail to give 
consistently good results in any laboratory, the paper strip 
test for nitrate reduction should be abandoned.
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V. DRUG SUSCEPTIBILITY TESTS
cV. DRUG SUSCEPTIBILITY TESTS
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Drug susceptibility tests for tubercle bacilli are among the most 
difficult procedures to standardize. Several standard methods have 
been proposed (1) and are in use throughout the world. The method 
most widely used in the United States, and the one to be discussed 
later, is designed to determine the proportion of bacilli in the test 
population which is resistant to the drug(s) being tested.
Because most cases of newly diagnosed tuberculosis in previously 
untreated patients in the United States are caused by drug susceptible 
tubercle bacilli (i.e., primary drug resistant cases are not common), 
most clinicians prescribe antituberculosis chemotherapy without the 
benefit of drug susceptibility tests. In those areas where primary resis­
tance is recognized as a problem, however, susceptibility tests should 
be done before therapy is started. Unless there is a clinical reason to 
suspect the emergence of resistant bacilli (as outlined immediately 
below), susceptibility tests need only be run on the first set of positive 
specimens, preferably before initiation of treatment. For certain pa­
tients susceptibility tests should be required. These groups include (1) 
patients who suffer relapses, (2) patients whose sputa become culture 
positive after having been negative, (3) patients whose sputa remain 
positive after 3 to 6 months of aggressive chemotherapy, (4) patients 
whose secretions show a definite and persistent increase in detectable 
acid-fast bacilli after the numbers of such bacilli previously had been 
declining, and (5) patients suspected of being infected with drug 
resistant bacilli.
Proficiency in performance of susceptibility tests for tubercle 
bacilli demands an understanding of (1) the origin of drug resis­
tance, (2) the effect of medium components on the minimal inhibito­
ry concentrations (MIC) of the drugs tested, (3) the stability of the 
drugs both during storage and in a medium, (4) the type of suscep­
tibility test performed, (5) the criteria of resistance, and (6) the read­
ing and reporting of test results. These points are thoroughly dis­
cussed in several publications (1-4,8).
The submerged disc method of susceptibility testing described 
here and recommended (9,10) for use in Level II laboratories was 
first described in 1966 (11). The procedure has been critically evalu­
ated (5-7) and has been shown to obviate many of the problems 
associated with susceptibility testing, such as drug instability, im­
precision in weighing and diluting drugs, mislabeling of media, and 
the difficulty of preparing quality media.
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A. PREPARATION OF MEDIUM
1. Enriched Middlebrook 7H-10 agar medium, made accord­
ing to directions from commercially available powdered base 
and oleic acid-albumin-dextrose-catalase (OADC) enrich­
ment, is recommended for susceptibility testing of tubercle 
bacilli. Prepare only the volume needed to test those cultures 
immediately at hand.
2. Directions for preparing most commonly needed volumes of 
medium are summarized in Table 4.
Table 4. Preparation of enriched Middlebrook 7H -10 agar from commercially 
available ingredients,* 1-5.
Final
volume
needed
(ml)
Wt. Of 7H-10 
powdered 
basal medium 
needed (in g)
Vol. o f 
water
(ml)
Reagent
grade
glycerol
(ml)
Add
OADC
enrich­
ment
(ml)
Total number 
of quadrants 
(not plates) 
to  be 
prepared
50 0.95 45 0.25 Swirl to 
suspend.
5 9-10
100 1.9 90 0.5 Autoclave 
at 121 °C
10 18-20
200 3.8 180 1.0 for 10 to 
15 mins.
20 38-40
500 9.5 450 2.5 Cool to 
50°-52°C
50 98-100
1000 19.0 900 5.0 100 198-200
* 1. When calculating number of quadrants or plates needed, do not forget that duplicate sets 
of plates are needed for each culture because two different inocula are used in the test.
2. Do not forget to include the drug-free control quadrants in your calculated volume of 
medium needed.
3. NOTE: Experience has shown that preboiling the basal m edium  before au toclav­
ing results in a m edium  of inferior quality. Avoid this by sw irling the pow dered  
base into suspension just before autoclaving.
4. Do not allow sterile medium base, with or without oleic acid-albumin-dextrose-catalase 
(OADC) enrichment added, to stand in 50° to 52°C water bath too long. Temper medium 
to 50°C, add OADC, and pour medium into plates within 1 hour.
5. Protect prepared medium from exposure to daylight coming through laboratory windows.
3. The paper drug-containing discs currently available are 
listed in Table 5. Not all antituberculosis drugs are available 
in disc form; if special requests are made for tests of suscep­
tibility to drugs not listed in Table 5, the laboratory must 
either prepare its own medium or refer the request to a 
reference laboratory where such tests are done (e.g., state 
health department, or even CDC, provided the request is 
routed through the State laboratory).
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T a b le  5 . D ru g -c o n ta in in g  discs fo r  s u s c e p tib ility  tests.
DRUG
** M c g  of Drug  
in Disc
Final m cg/m l 
Drug in M edium
Isoniazid 1 0.2
5 1.0
Streptomycin 10 2.0
50 10.0
Rifampin 5 1.0
25 5.0
Ethambutol 25 5.0
50 10.0
p-Aminosalicylic Acid 10 2.0
50 10.0
Ethionamide 25 5.0
Kanamycin 30 6.0
*Do not forget to include drug-free control quadrants in your susceptibility test.
Remember: Duplicate sets of drug plates are needed for each test culture because two 
different inocula must be used.
* * Discs are coded to identify both the drug and its concentration.
4. Appropriate drug discs are dispensed aseptically into the 
center of individual quadrants of sterile plastic dishes. This 
may be done while the basal medium is being sterilized in the 
autoclave or tempered at 50°C before the OADC enrichment 
is added.
5. Exactly 5.0 ml of sterile, tempered (50°C), complete 7H-10 
medium is pipetted over the disc. Remember the disc must re­
main submerged and not be allowed to float to the top. Let 
the medium solidify. See Figure 42 for example of drug 
susceptibility test media made by using commercially avail­
able drug-impregnated discs.
6. Incubate the plates overnight at room temperature to permit 
the drug to diffuse uniformly. Discs containing ethambutol 
lose activity rapidly when allowed to diffuse overnight; after 
medium has solidified over ethambutol discs, the plates 
should be placed at 5°C to permit diffusion of drug.
Control
PAS INH
RA
F igure  4 2 . D ru g  s u s c e p t ib i li ty  te s t m e d iu m  m ade w ith  d ru g -im p re g n a te d  discs.
7. Storage of Drug Medium
Since 7H-10 agar medium in plates dehydrates more readily 
when stored than does egg medium in tubes, the 7H-10 drug 
medium should be used within 1 month of preparation. This 
recommendation is for drug medium prepared “from 
scratch” with powdered drug. Because of the very low final 
concentrations of most antituberculosis drugs incorporated 
into media, coupled with the difficulty of weighing and dilut­
ing small amounts of drugs or their solutions, most investiga­
tors elect to make more-than-needed quantities of drug 
medium and to store it for future use.
The proper use of drug-impregnated discs insures both a sta­
ble and precisely measured quantity of drug. The exact num­
ber of drug plates needed for a given day can be prepared 
without the worries of quantitation and stability, therefore, 
long-term storage is no longer a problem. This means that a 
drug medium can be prepared on the day before it is needed 
and problems of storage, dehydration, or loss of drug activity 
can be avoided. This alone should greatly improve the quality 
of drug susceptibility test results.
B. TYPE OF SUSCEPTIBILITY TEST
Either the direct or the indirect drug susceptibility test may be used.
The inoculum for the direct test is a digested, decontaminated
sputum (or other specimen) in which acid-fast bacilli may be
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demonstrated in stained smear. The inoculum size is adjusted on the 
basis of numbers of bacilli counted in the smear, and the tested 
bacilli are representative of the bacterial population in the lesion(s) 
of the host.
The inoculum for the indirect test is a subculture of the organism. 
Such a test would be needed when (i) smears are negative but cultures 
positive, (ii) growth on the control medium of a direct test is inade­
quate (less than 50 colonies), and (iii) a reference culture is submit­
ted for testing. The inoculum for the indirect test is adjusted tur- 
bidimetrically.
Details for performing each test are given below.
1. Direct Test
a. Stain and examine smears of concentrated clinical speci­
mens, and, after first observing an acid-fast organism, 
record the average number of bacilli observed in the next 
20 fields. Count clumps as only one organism, because 
they will give rise to only one colony on the medium.
b. Select dilutions of sputum concentrate to be used as in-
ocula on the basis of Ziehl-Neelsen smear results as 
follows:_________________________________
M icroscopy Inoculate
Less than 1 AFB/field Undiluted and 10~2
1-10 AFB/field 10“ 1 and 10-3
More than 10 AFB/field 10~2 and 10-4
c. Make dilutions as described in I.F.6., p. 27.
d. Use a capillary pipette to inoculate three drops onto each 
quadrant of the drug and control media. Inoculate one 
set of plates with the highest dilution and the duplicate 
plates with the lower dilution.
If the patient has been under treatment, one plate should 
also be inoculated with undiluted inoculum, regardless of 
smear results. Bacilli from such patients may be stained, 
but because of drug action, they may be nonviable.
e. Include a set of control plates inoculated with a drug- 
suseptible strain of M. tuberculosis (the H37Rv strain is 
commonly used). This serves as a quality control check 
on the presence of drug in the discs.
f. Place plates, medium side down, in individual 
polyethylene bags and seal.
g. Incubate at 35° to 37°C in an atmosphere of 10% C 0 2.
h. Read and report results of drug tests at 3 weeks. If 
cultures are fully matured, and only i f  they show drug 
resistance, they may be reported in less than 3 weeks. 
Even though colonies may be fully matured on control 
media in less than 3 weeks, “drug susceptible” reports 
should not be tendered until the third week, because 
resistant colonies often grow more slowly than suscepti­
ble ones and may not come up until the third week.
i. On drug medium colonies appearing after 3 weeks do not 
necessarily represent resistant bacilli. Some drugs are 
only bacteriostatic and may be inactivated on prolonged 
incubation to substatic levels, thereby permitting still 
fully susceptible colonies to grow after 3 weeks. Such 
colonies are usually smaller than those on the control 
quadrant.
j. Drug plates containing the control quadrants should not 
be discarded as negative until the end of the fifth or sixth 
week. This is not to permit a reading of the drug suscep­
tibility test, but rather to use the control quadrant as 
another “tube” of isolation medium, because it has been 
inoculated with the digested-decontaminated specimen.
k. Examine all grossly “negative” quadrants with the aid of 
a dissecting microscope (30x to 60x); drug resistant or 
very slowly growing mycobacteria may be invisible to the 
naked eye.
l. Record the colony characteristics on the control 
medium. Report results obtained with both dilutions of 
inoculum and calculate the percent resistance. A conve­
nient way to record growth is as follows:
Confluent (500 or more colonies) 4+
Almost confluent (200-500 colonies) 3 +
100-200 colonies 2+
50-100 colonies 1 +
Less than 50 colonies Actual count
m. For a test to be valid, the control must show good growth 
(at least 50 to 100 colonies), but not so much as to simul­
ate drug resistance due to growth of spontaneously occur­
ring drug-resistant mutants (i.e., only confluent growth 
on control). In a properly performed drug susceptibility 
test one of the control media should have countable col­
onies so that the percentage of resistant organisms can be
calculated. The only time a control quadrant with con­
fluent growth is acceptable as a valid test is when the 
culture exhibits total susceptibility to each drug tested.
2. Indirect Test
To prepare inoculum from growth on solid medium:
a. Scrape several spadesful (2 to 5 mg) of growth from drug- 
free medium. Try to pick a portion from each colony.
b. Transfer to a sterile 16-x 125-mm screwcap tube con­
taining 6 to 8 glass or plastic beads* *and 3 ml of Tween- 
albumin liquid medium.
c. Homogenize on a test tube mixer for 5 to 10 minutes.
d. Allow larger particles to settle. Withdraw supernatant 
suspension and adjust density to that of a MacFarland 
No. 1 * * with sterile distilled water or saline.
e. Dilute to 10-2 and 10-4 (see I.F.6., p. 27 for dilution) in 
sterile distilled water or saline.
f. Proceed as for Direct Test for inoculation, incubation, 
and reading (see V.B.l.d-i. and k.-m., pp. 119-120).
To prepare inoculum with Tween-albumin liquid culture:
a. Transfer a portion of each colony from drug-free 
medium into a Tween-albumin liquid medium, such as 
Middlebrook 7H-9.
b. Incubate at 35°C for 7 days or until turbidity matches 
that of MacFarland No. 1 standard.
c. Dilute to 10 - 3 and 10~5 in sterile water or saline.
d. Inoculate the two dilutions, incubate, and read as 
described for the Direct Test (V.B.l .d.-m., pp. 119-120).
*Glass beads, 1-2 mm diameter, or high-heat polystyrene plastic beads, such as 
Styron (R) 700, 27 clear, No. 7, from Dow Chemical Co.
**Prepare MacFarland No. 1 standard by adding 0.1 ml o f 1% BaClj to 9.9 ml o f  1%  
H2S 0 4 .
C. Reporting Test Results
1. The report should contain:
The type of test, Direct or Indirect.
The amount of growth on the control medium.
The amount of growth on each drug medium.
The concentration of each drug in the medium.
A rough calculation of the percentage of bacilli resistant 
to the drug.
2. This formula may be used to calculate percent:
Number of colonies on the drug
— “------------------------------------ X 1 0 0 =  % resistant
Number of colonies on the control
Example a.
Drug
Growth on
% ResistantUndilute 10-2
Control 4+ 150C
1 NH 0.2 jug 1 + 9C 6
SM 2.0 M9 0 0 0
EMB 5.0 jug 0 0 0
9 colonies 
150 colonies
X 100 -  6%
In this example 6% of the organisms were resistant to 0.2 /xg/ml 
INH.
Example b.
Drug Growth on
KM 10-3
■ /o Resistant
Control 4+ 60C
1 NH 0.2 jug 120C 0 2
SM 2.0 jug 0 0 0
RIF 1.0 jug 0 0 0
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The 10-1 control inoculum gave 4 + , or colonies too numerous 
to count. The hundredfold dilution (10~3) gave 60 countable 
colonies. Therefore, the 4+  = 60 x 100 or 6000 colonies. 
Knowing this figure, the proportion of resistant bacilli may be 
calculated as 2% to 0.2 jug/ml 1NH.
120
------- X 100 = 2%
6000
For other examples, see Figures 43 to 45 on pages 124-126.
If more than 1% of the test population is resistant to the drug 
under test, this suggests that resistance to that drug has devel­
oped or is in an advanced stage of development.
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CON PAS 2.0
The organisms inoculated onto these plates were susceptible to 0.2 mcg/ml INH (isoniazid), 
2.0 mcg/ml SM (streptomycin)/ and 2.0 mcg/ml PAS (para-amino-salicylic acid).
D  g V ^ ^ T I i n A
□  n s M \
LJ Spinal ( H ] p a S V i e s
L J  Pleural C IJkm Q ]^e TH □  _______
1 1 Culture If repeat, date last 
|— | specimen subm itted
(ZiD  Cod*) Q  F irst 
1 1 Repeat
Mo. Day Year
Laboratory Raport DRUG SUSCEPTIBILITY TESTS IN 7H-10 AGAR 
AflOIRECT CD INDIRECT
IDENTIFICATION
[ 0 ^  tuberculosis  
1 '"I M. bovis 
1 1 M. kansasii 
1 1 M. m arinum  
1 - 1 M. scrofulaceum  
1 1 M. szulgai 
□  M. gordonae  
1 1 M. flavescans 
1 1 M. avium  com plex  
fin trace llu la re)
1 I M. xenop i 
1 1 M. terrae com plex  
1 1 M. triv ia le  
1__ J M. gastri
1 1 M. fo r tu itu m  com plex  
1 1 R apid G rower 
1__ 1 O the r M ycobacterium
EXAMINEp MICROSCOPICALLY
BY: L C Z IE H L - N E E L S E N
O flu o r o c h ro m en
Drug
(Jlg/m l)
G ro w th *  at O ils. Percent
of
Pop./ o ' ' / O ' *
ACH^FAST BACILLI:
I t^ F o u n d  [ 1 Not Found
D s a r *
0 F * w
[HI Num erous 
FUNGI OR YEAST:
1 1 Fo und  1 iN o t Found 
1 1 Sp lit G iven to  M ycology Lab .
C O N T R O L  0 .0 H-t X t 100
IN H  0 .2 o O o
IN H  1.0
SM  2.0 o 0 o
SM 10.0
PA S  2 .0 O o 0
PA S 10.0
FINAL REPORT MAY 
REQUIRE 8 WEEKS
KM  5 .0
VM  5 .0
SPECIMEN UNSATISFACTORY 
FOR TESTING BECAUSE:
1 1 In su ffic ien t Am ount 
1 1 Leaked in Transit 
f t  Not m ycobacterium  
1 _ J Contaminated
n
T H A  5 .0
C S  20.0
E T H  5.0
*4  ♦ = > 5 0 0 , 3 + *  200  — 5 0 0 , T E N T A T IV E  
2 + = 1 0 0 - 2 0 0 ,1  ♦ = 5 0 - 1 0 0  ID E N T IF IC A T IO N : 
< 5 0  recorded & followed by 
" c " ,  as 10C = 10 colonies
Oat* Received and Laborato ry  Specim en Number
Month Day Y ea r Fo rm  N o . Specim en Number
Date Reported 
1st 2nd
Form
3rd Contro l 
Number
SAMPLE LABORATO RY REPORT FORM
Figure 43. Drug susceptibility test. From Vestal (10).
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CON. PAS 2.0
INH 0.2 SM 2.0
The inoculum (10_1) on the right shows 4-f growth on the controls and INH quadrants, 23 
colonies on SM, and 2 on PAS. A 100-fold dilution (10 **) of the inoculum on a second drug plate 
shows 59 colonies on the control, 54 on INH, and none on SM and PAS. Hence, 54/59 gives 92% 
resistance to INH. To determine percent resistant to SM and PAS, multiply 59 X  100 =  5900 
colony units inoculated on to each quadrant of the 10 1 plate.
23/5900 x 100 =  0.4% R to SM.
2/5900 x 100 =  0.03% R to PAS.
u .  Repeat
Laboratory Raport DRUG SUSCEPTIBILITY TESTS IN 7H-10 AGAR
E j d ir e c t  □ in d ir e c tEXAMINE* MICROSCOPICALLY
BY: [ 0 Z I E H L - N E E L S E N  
F L U O R O C H R O M E
n
Drug
(/W/ml)
G ro w th * at D ils . Percent
of
Pop.
ACID FAST BACILLI:
1 1 Found  | 1 Not Found 
□ f a r e  
D 0 F e w  
LJ Num erous 
FUNGI OR YEAST:
1 1 Fo und  1 1 N et Found 
1 1 S p lit G iven to  M ycology Lab .
C O N T R O L  0 .0 -5T O 100
INH  0 .2 4 t
INH  1.0
SM 2 .0 2 3 C o O
SM 10.0
PA S  2 .0 i-C, e O.CZ
P A S  10.0
FINAL REPORT MAY 
REQUIRE 8 WEEKS
KM  5.0
VM  5.0
SPECIMEN UNSATISFACTORY 
FOR TESTING BECAUSE:
1 1 In su ffic ien t Am ount
1_J Leaked In Transit
1 1 Not m ycobacterium  
1 1 Contaminated
n ___  .
T H A  5.0
CS 20.0
E T H  5 .0
*4 + = > 500 , 3 + *  200  — 500 , T E N T A T IV E  
2 *  100 — 2 00 ,1  + = 50 —100 ID E N T IF IC A T IO N : 
< 5 0  recorded & fo llow ed by 
" c " ,  as 10C s  10 colonies
I I M. tuberculosis 
I I M. bovis  
E V  kansasii
□  M. m arinum
i I M. scrofulaceum  
I I M. szulgai 
I 1 M. gordonae  
I 1 M. flavescens
□  M. avium  com plex
iin trece llu la re )
I 1 M. xenop i
□  M. terrae com plex
□  M. triv ia le
□  M. gastri
[Z D  M. fo r tu itu m  com plex  
L -  J R apid G row er 
I___I O ther M ycobacterium
Date Received and Laborato ry  Specim en Number Form
Month Day Y ear Fo rm  N o . Specim en Number 1st 2nd 3rd Contro lNumber
SAMPLE LABORATO RY REPORT FORM
Figure 44. Drug susceptibility test. See Vestal (10).
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CON PAS 2.0
INN 0.2 SM 2.0 -
The inoculum on the plate at the right (TO-1) is too heavy to determine actual colony counts.
In the hundredfold dilution of inoculum (10~3) on the plate to the left we count 41 colonies on
the control and 17 on the PAS quadrant. Hence, the apparent resistance to PAS observed in ___
the heavily inoculated plate is a true one, and approximately 41% of the population was 
resistant to PAS (17/41 X  100 =  41%).
W ^^dffure \  i< N S \ ..
X^^'ipaelman sufitK^Cd
! 1 First 
□  Repeat
Mo. Day Year(Zip Code)
Laboratory Raport DRUG SUSCEPTIBILITY TESTS IN 7H-10 AGAR 
Q S d ir e c t  □  INDIRECT
IDENTIFICATION
1 1 Af. tuberculosis  
1 1 A f bovis  
1 1 A f kansasii 
1 I Af. m arinum
scrofulaceum  
1 1 Af. szulgai 
1 1 Af. gordonae  
1 1 A f flavescens 
1 1 Af. avium  com plex  
(in trace llu lare)
1 ! A f  xenop i 
1 1 Af. terras com plex  
1 1 Af. triv ia le  
1 1 Af. gastri
1 1 Af. fo r tu itu m  com plex  
1 1 R apid G row er 
1 1 O the r M ycobacte rium
EXAMINED MICROSCOPICALLY
BY: [0ZIEHL-NEELSEN  
Q flu o r o c h ro m en
ACID FAST BACILLI:
1 I^Found 1 1 Not Found 
□  R|pa
Q0Few 
L-J Numerous 
FUNGI OR YEAST:
1 1 Found 1 1 Not Found 
1 1 Split Qivan to Mycology Lab.
Drug
(/Jg/ml)
Growth* at Oils. Percentof
Pop.10-' to-3
CONTROL 0.0 - V / O - 100
INH 0.2 o o o
INH 1.0
SM 2.0 o O o
SM 10.0
PAS 2.0 S t J jC s #■/
PAS 10.0
FINAL REPORT MAY 
REQUIRE 8 WEEKS
KM 5.0
VM 5.0
SPECIMEN UNSATISFACTORY 
FOR TESTING BECAUSE:
1 1 Insufficient Amount 
1 1 Leaked in Transit 
1 I Not mycobacterium 
U  Contaminated
n
THA 5.0
CS 20.0
ETH 5.0
*4 ♦ - > 500, 3 + - 200 — 50 
2 + ■ 100 — 200,1 ♦ * 50 —10 
<50 recorded & followed by 
as IOC * 10 colonies
5, TENTATIVE 
0 IDENTIFICATION:
Date Received and Laboratory Specimen NumberMonth Day Vear Form No. Specimen Number Date Reported Form 1st 2nd 3rd Control Number
SAMPLE LABORATO RY REPORT FORM
Figure 45. Drug susceptibility test. From Vestal (10).
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cVI. QUALITY CONTROL PROCEDURES FOR THE 
LEVEL II  MY COBACTERIOLOGY LABORATORY
l-
L.
W.
A. INTRODUCTION
These recommendations are intended to strengthen the quality con­
trol procedures in microbiology laboratories qualified to handle 
mycobacterial cultures. They have been used with success in 
laboratories at the Center for Disease Control (CDC). Although the 
recommendations are not intended for small laboratories that pro­
vide only limited services, they (or some appropriate modifications) 
will insure the reliability of test results even in the smaller clinical 
laboratories.
For a quality control program to be of value, it must be workable and 
practical; otherwise, it will not serve the intended purpose. Quality 
control is the responsibility of all laboratory personnel; however, if a 
laboratory is able to assign at least one person to quality control, this 
individual should be well qualified in microbiology.
When applicable, quality control procedures must meet the require­
ments of the Clinical Laboratories Improvement Act of 1967.
The keys to the development of a workable quality control program 
are (1) adequately trained, interested, and committed personnel; and
(2) common sense use of practical procedures.
B. GENERAL RECOMMENDATIONS
1. All quality control records should be retained in files or note 
books for at least 2 years.
2. Procedural manual(s) should be available for every routine 
procedure performed in the laboratory. The microbiologist 
in charge should date and initial all changes in techniques.
3. All containers of media, stains, and reagents should show the 
date received and the date first opened. Each material should 
be periodically rechecked, and if it is found to be unsatisfac­
tory, it should be removed immediately from the laboratory. 
Purchases should be limited to 6 months’ supplies.
4. Laboratory procedures used routinely should be those that 
have been published in reputable microbiological books, 
manuals, or journals. Procedures that have not been 
described in publications may be used, provided the necess­
ary experimental control studies have been performed in a 
competent manner and a description of the procedure is ex­
pected to be published.
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5. Laboratories should maintain the number and variety of 
cultures needed to check the quality of tests performed.
C. LABORATORY A RRA N G EM EN T AND PERSONNEL
1. Supplies, equipment, and work area should be arranged to 
facilitate an efficient work flow. Work areas should be kept 
free of dust. Benches should be swabbed at least once a day 
with an acceptable disinfectant.
2. Personnel employed in the tuberculosis laboratory should be 
tuberculin tested and X-rayed, as suggested in I.,B., pp. 6-7.
D. LABORATORY EQUIPM ENT
Each item of equipment should meet the manufacturer’s claims and 
specifications in the user’s own laboratory. The user should consis­
tently monitor equipment to assure the constant accuracy and preci­
sion necessary for quality laboratory performance.
Table 6 indicates the monitoring necessary for equipment found in 
the mycobacteriology laboratory.
E. GLASSWARE
1. Chipped or etched glassware should be discarded. Glassware 
should be free of detergents.
2. Sterilized glassware should be checked for sterility.
3. Sterile glassware should not be stored more than 3 weeks 
before being used.
4. Paper should not be used to cap glassware before it is 
sterilized; oil-free aluminum foil is recommended.
F. M EDIA, REAGENTS, AND BIOCHEMICAL TESTS
Table 7 indicates the minimum number of tests for the quality con­
trol of media, reagents, and biochemical tests. These control tests 
should be performed each time fresh media or reagents are made, and 
each time tests are run, except as otherwise noted.
“Sterile system” tests as negative controls are tests made with 
uninoculated medium or substrate at the same time and in the same 
manner, including periods of incubation, as the regular tests.
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T ab le  6 . M o n ito r in g  o f  E q u ip m e n t
ITEM
Autoclave
Biological
Safety
Cabinet (BSC)
Centrifuge
Incubator, 35°C 
C02
Microscope
M O N ITO R  PRO C ED U R E
a. Recording thermometer advisable.
Temperature recorded each run; record held in files.
b. Cultural device (spore strips, spore suspension) used monthly. More 
frequently, if there is evidence of contamination.
c. One hour established as routine time for decontamination of waste 
materials.
a. Airflow checks:
1. Anemometer used to measure rate of airflow across front open­
ing; should be 75 linear feet/minute for Class I BSC.
2. Gauge installed in exhaust duct beyond bacterial filter and 
marked with limits reached when airflow across front opening is 
75 linear feet/minute.
3. Smoke sticks used to determine pattern of air currents. Used 
periodically, especially when new equipment is placed in the 
BSC work space, or any change is made in the room ventilation 
pattern.
b. Filters:
Replaced when gauge in exhaust duct indicates that airflow across 
front opening has dropped below 75 linear feet/minute. CAUTION: 
Entire BSC must be decontaminated before filters are removed.
c. Germicidal ultraviolet (UV) lights:
UV light meter used to measure light intensity after initial burn of 100 
hours. Test every 6 months. Replace lamp when reading drops to 
70% of the initial reading. CAUTION: Clean UV lamps every 2 weeks 
with alcohol-soaked cotton. Do not purchase UV lamps far in ad­
vance of need.
a. Use tachometer.
Use appropriate rpm on an 8-place horizontal head or 12-place 
horizontal or angular head centrifuge to attain centrifugal force of 
2,000 to 3,000 x g for sedimentation of mycobacteria. CAUTION: A 
16-place horizontal head usually cannot achieve this centrifugal 
force.
b. Check brushes and bearings every 6 months.
a. Recording thermometer advisable. If not available, record daily 
reading, preferably a m. Test temperature at several sites w ith­
in incubator; thermometer should be placed in water.
b. Control light by covering glass-front incubator door and restricting
use of any lights inside the incubator. '
Check C02 content daily with C02 indicator, such as Fyrite.
Always clean oil immersion objective after examining a positive acid-fast 
smear. Clean microscope after each use. Keep microscope under dust 
cover when not in use.
T a b le  6 . (C o n tin u e d )
ITEM M O N ITO R  PRO C ED U R E
pH meter a. Compensate for temperature with each run.
b. Date buffer solutions and discard when unsatisfactory.
c. Standardize with pH 4.0 and 7.0 buffers before each test or series of 
tests.
Water baths Check temperature before and during use. 
Clean monthly.
Refrigerator 
2° to 8°C
Check temperature daily. Walk-in should have recording 
thermometer. Connect walk-in to alarm system. Clean monthly. Defrost 
or check refrigerator and freezer compartment every 3 months.
Freezers 
0° to - 70°C
Check daily. Connect to alarm system. Clean every 
6 months.
Table 7. Quality control procedures for media, reagents, and biochemical tests
ITEM
C O N TR O LS
Positive N egative
Catalase test, pH7-68°C M. fo rtu itu m  M. gastri
CAUTION: Use of pH meter and sterile system
and thermometer is critical.
Culture purity Acid-fast stain and/or inoculation of plated media for isolated col­
onies at each transfer or subculture.
Digestion-decontamination Control by record of rate of culture contamination. Expected
Distilled water
average is 3% to 5%. If less than 1 %, the decontamination may 
be too harsh. If greater than 5% to 7%, the decontamination is too 
weak or the digestion is incomplete.
Test for presence of acid-fast bacilli by strenuous sedimentation 
of about 300-ml sample, stain with acid-fast or fluorochrome 
stain, or use the C and ida method to facilitate sedimentation of 
acid-fast bacilli (see Ref. 1).
Light exposure test M. kansasii Negative built into 
Test exposure site and test with unexposed 
lamp. Repeat test when part of culture, 
any change is made.
Media for drug
susceptibility
testing
M. tubercu los is , known Drug-free medium 
susceptible strain. inoculated with 
Test each batch. test culture.
1 3 0
T a b le  7 . (C o n tin u e d )
ITE M
CO NTRO LS
Positive Negative
Media for isolation Sample of each batch, incubated at least 48 hours for sterility. 
Check pH, color, consistency.
Test ability to support growth in 2-3 weeks of small inoculum of 
freshly isolated drug-susceptible M. tubercu los is , or use H37Ra 
strain of M. tubercu los is .
Niacin test, standard 
or strip test.
M. tubercu los is Sterile system; 
M. sm egm atis
Nitrate reduction, standard 
or strip test.
M. kansasii (not 
for strip)
M. tubercu los is , or sterile 
system with powdered zinc
Sterile system 
without zinc
Stains M. tubercu los is , 
mature but not old
CAUTION: Use CLEAN, NEW 
slides. Use AFB-free water.
Additional tests may be included in the quality control program. For 
instance, drug-resistant strains with known MIC’s may be included 
in the controls for drug susceptibility tests. Personnel in each 
laboratory must decide how many tests they will make. Whatever tests 
are elected as controls should be made consistently, and the results 
depended upon for control of the actual diagnostic procedures.
See Ellis (2) for more detailed information on quality control pro­
cedures.
G. PROCEDURE FOR TH E STORAGE OF MYCOBAC­
TER IA L STOCK CULTURES (3)
1. Place 2 ml of tap water in a 2-dram, flat-bottom, screwcap 
vial.
2. Cap the vials loosely and autoclave at 121 °C for 15 minutes.
3. Prepare suspensions of the cultures by emulsifying five or six 
colonies in the 2 ml of water. Alternatively, the cultures may 
be grown in 7H-9 broth and bottled in 1 to 2 ml amounts in 
the above vials or in vaccine-stoppered vials (4,5).
4. Tightly cap the vials and store them in an upright position in 
a freezer at a temperature ranging from -16° to -70°C. Some 
species (especially M. tuberculosis) lose viability on prolonged 
storage (1 year or more) at -20°C, but all species retain vir­
tually 100% viability when stored at -70°C.
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NOTE: The contents of vials can be thawed and refrozen several 
times.
H. SOME SOURCES OF M YCO BACTERIAL STOCK 
CULTURES
1. American Type Culture Collection (ATCC).
12301 Parklawn Dr.
Rockville, Maryland 20852
2. The Curator
Mycobacterial Culture Collection 
National Jewish Hospital and Research Center 
3800 East Colfax Avenue 
Denver, Colorado 80206
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VII. RECORDS AND REPORTS
If laboratory findings are to be useful, they must be communi­
cated to the proper authorities. Clinicians use the findings in the 
diagnosis and management of disease; public health authorities use 
the findings for statistical and epidemiologic purposes.
Laboratory procedures for mycobacteriology are notoriously 
time- consuming, often taking weeks or even months to complete. 
For this reason, interim reports should be issued. They may be sent 
out after (1) acid-fast smears have been examined, (2) growth has 
been observed on the culture medium and the species has been ten­
tatively identified or results of a direct drug susceptibility test are 
known, and finally, (3) the species has been precisely identified on 
the basis of detailed in vitro tests and/or indirect drug susceptibility 
tests have been completed.
Obviously, all of the technical details of each laboratory test can­
not be recorded on the reports, but they should be precisely outlined 
in the laboratory procedural manual, and the results must be a part of 
the daily laboratory records. The validity of these results also must be 
insured by including appropriate quality controls with each batch of 
media or each test run.
The interim reports may be provided to the clinician by mailing 
copies of the original report form as new information becomes avail­
able, or by using precarboned, sectioned, perforated forms. In the 
latter case, the appropriate section of the form may be completed, 
dated, detached, and mailed. The final report will have all of the data 
previously reported, so earlier interim reports can be destroyed and 
only the final report retained in the patient’s file.
Thus, smear reports should be completed and returned to the 
clinician within a few days of receipt of specimen; contaminated 
cultures may be noted within the first 7-10 days and repeat speci­
mens requested; preliminary (tentative) identification and/or direct 
drug susceptibility test results should be available within 3-4 weeks; 
all test results may not be available for 6 to 9 weeks.
A sample report form is shown on the next page.
S am p le  R e p o rt  F o rm
LABORATORY NAME & ADDRESS FORM NAME &  NUMBER
Patient Name Age Sex Race
Social Security Number
Please Return Report To Physician’s Code To be Filled in by Physician
Date Specimen Collected
SPECIMEN: 
Sputum 
G  Natural 
O  induced
□  Gastric
D  Urine 
Q  Other 
(Specify)______
□  Culture
Patient on Therapy? OVes O ^o  
Service Requested:
G M.x G Culture G Drugs
G INH G PAS G ______
□  SM G ETA G ______a EM8 G  KM a ___a r if  a - □ -
.  If repeat, date Mo. Day Year 
of last specimen
INTERIM REPORT #1
EXAMINED MICROSCOPICALLY 
By G Ziehl-Neelsen 
Q  FluorochromeG _________
ACIO FAST BACILLI:
G Found G Not found 
G  1-2 per 300 fields 
G  1-9/100 fields G 1-9/10 fields 
G 1-9/field G >9/fie ld
Fungi or Yeast 
G Found G Not found 
G Split sent to  Mycology 
Other bacteria 
G Found G Not found 
G Split to Gen'I. Bact'y.
SPECIMEN UNSATISFACTORY 
FOR TESTING BECAUSE:
G  Insufficient Amount
□  Leaked in transit
□  ________
G  Contaminated (Send Another)
INTERIM REPORT #2
DRUG SUSCEPTIBILITY TESTS IN 7H-10 AGAR 
□  Direct G Indirect
R EP O R T  #3 |
G FIN AL REPORT G Tentative Report
pg/ml
RIF
RIF
EMB
PAS
ETA
KM
Percent of 
Pop'ln.
G  Isolate specifically identified as 
M ycob ac te riu m  tube rcu los is
G  Culture sent to  Reference Laboratory 
Final report may take 4*6 weeks.
Tentative identification or rough grouping suggests 
Q  M. tube rcu los is
G Photochromogen G Scotochromogen 
G Nonphotochromogen G Rapid Grower
4+ = >500, 3+ = 200-500, 2+ = 100-200, 1+ = 50 colonies, 
<50 recorded, followed by "c " , as 10c *  10 colonies.
If >1% of tested population exhibits resistance to 
given drug, this suggests emergence of drug resistance.
Date reports mailed.
1st___________  2 n d .
Date specimen rec'd.
_ 3rd .
Lab. specimen No.
(For Training Use Only)
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VIII. APPENDIX
APPENDIX
PREPARATION AND STORAGE OF MEDIA 
1. Preparation of Media
Perhaps more important than the kind of medium selected 
for the culture of mycobacteria is the care employed in its 
preparation. All glassware and equipment should be 
thoroughly cleaned and sterile (when so indicated). To insure 
reproducibility of media, all reagents must be freshly pre­
pared from chemicals of certified purity and freshly distilled 
water. Media formulations and directions for preparation 
should be precisely followed. The media preparation room 
should be clean, free of dust, and preferably in an isolated 
area where traffic flow is minimal; wet mopping of floors, 
swabbing counters with disinfectant, dust-free filters in air 
intakes, and ultraviolet (UV)-irradiation of upper air (when 
room is not in use) all serve to minimize air contaminants. 
Strict aseptic technique should be used when adding heat- 
labile enrichments or drugs to media. Sterilizing capabilities 
of filters (Seitz, sintered glass, or membrane) and autoclaves 
must be monitored periodically to insure that they are func­
tioning properly. Excessive light and heat must be avoided in 
the preparation of the various types of Middlebrook media 
(7H-9, 7H-10, 7H-11), to minimize chances of toxic for­
maldehyde forming (5). Adding 0.1% L-aspartic acid 
(potassium salt) (3) to the basal 7H-10 medium greatly 
enhances niacin production by M. tuberculosis growing on 
this clear agar medium, but aspartate also interferes with the 
action of certain drugs that might be used for susceptibility 
tests, so the microbiologist must be aware of this disadvantage
(3).
a. Modified Lowenstein-Jensen Egg Medium (2).
Fresh eggs, not more than 1 week old, are cleaned by 
scrubbing with a hand brush in a soap solution for 30 
minutes. Rinse thoroughly in running water, then soak 
eggs in 70% alcohol for 15 minutes. With well-scrubbed 
hands, break the eggs into a sterile flask and homogenize 
by hand shaking. Filter eggs through four layers of sterile 
gauze into a sterile, graduated cylinder.
(1) For salt solution combine:
Monopotassium phosphate
(anhydrous).................................................... 2.4g
Magnesium sulfate. 7H 20 ...............................0.24g
Magnesium citrate..............................................0.6g
Asparagine.......................................................... 3.6g
Glycerol (reagent grade)................................12.0ml
Distilled water..............................................600.0ml
(2) Add potato flour...................................................30.0g
(3) Autoclave at 121° C for 30 minutes 
Cool to room temperature
(4) Add malachite green (2% aqueous solution
freshly prepared)................................................20.0ml
(5) Add homogenized whole eggs................... 1000.0ml
(6) Mix and pour into a sterile aspirator bottle or fun­
nel with a bell attachment (test tube filling device) 
and dispense.
(7) Place approximately 6 to 8 ml medium into each 
20 x 150-mm sterile screwcap test tube.
(8) Slant tubes and coagulate by inspissation at 85°C 
for 50 minutes
(9) Incubate at 37°C for 48 hours as a sterility check.
(10) Medium may be stored in the refrigerator for sev­
eral months if caps are tightly closed to prevent 
evaporation.
b. Preparation of 7H-10 Agar from Commerical Base (4).
Note: Experience has shown that boiling the basal 
medium before autoclaving produces a medium of in­
ferior quality. This result may be avoided by preparing 
the medium in 200 ml amounts and autoclaving for 10 
minutes.
To prepare 200 ml complete medium, follow these direc­
tions precisely:
(1) Suspend 3.6 g of Middlebrook 7H-10 basal 
medium in 180 ml of freshly distilled water and 
add 1.0 ml of reagent grade glycerol.
(2) Swirl base into suspension and sterilize in the 
autoclave for 10 minutes at 121 °C.
(3) Remove medium from autoclave as soon as the 
pressure will allow and place in a water bath at 
50° to 56°C.
(4) As soon as cooled to 50° to 56°C, add 20 ml of 
OADC enrichment.
(5) For drug media, cool to 50° to 52°C and then 
add the required amount of drug.
(6) Dispense within 1 hour after autoclaving.
(7) Allow to solidify at room temperature without 
exposure to daylight (fluorescent light is all 
right).
NOTE: When the autoclaved medium is allowed to stand for 
more than 1 hour in the water bath, a precipitate 
begins to form. Experience has shown that this 
practice should be avoided. Pour as soon as possible. 
Always check the medium when taking it out of the 
autoclave. It should be clear and transparent. If a 
precipitate is present, it may be due to (a) steriliza­
tion temperature within the autoclave being reached 
too rapidly to dissolve the base in 10 minutes, (b) 
poor quality basal medium, and /or (c) dirty glass­
ware.
CAUTION: Never autoclave 7H-10 medium base and store 
it in the refrigeratoar for future use. The heat 
required to re-melt it produces a medium of 
poor quality.
For best results do not prepare in lots of more than 400 ml.
c. Preparation of 7H-11 Agar from Commercial Base (1).
Seven H - ll  (7H-11) agar is a modification of Mid- 
dlebrook 7H -10 agar and was formulated by Cohn, Wag­
goner, and McClatchy (1), who demonstrated that adding 
an enzymatic digest of casein to 7H-10 medium'stimul­
ated the growth of the more fastidious strains of M. tuber­
culosis.
To prepare 200 ml complete medium:
(1) Suspend 3.78 g of 7H -11 agar basal medium in 
180 ml distilled water containing 1 ml glycerol.
(2) Autoclave for 15 minutes at 121 °C.
(3) Cool to 50° to 52° C, add 20 ml OADC enrich­
ment.
(4) For drug media, cool to 50° to 52° C, then add 
drugs.
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(5) Dispense within 1 hour after autoclaving.
NOTE: Observe precautions described in preparation of
7H-10 medium.
d. Preparation of 7H-9 Broth from Commercial Base (4).
To prepare 900 ml complete medium:
(1) Suspend 4.7 g of the dehydrated medium in 900 
ml distilled water containing 2 ml glycerol, or 
0.5 g (ml) Tween 80. Do not use Tween 80 and 
glycerol together.
(2) Autoclave at 121° C for 15 minutes.
(3) Remove from autoclave and cool to 45°C.
(4) As soon as cooled to 45° C, aseptically add 100 
ml of ADC enrichment.
(5) Aseptically dispense 5-ml amount into 20-x 
150-mm screwcap test tubes.
2. Storage of Media
a. Always protect any media from direct light.
b. Place plates in clean plastic bags or sterile dry containers.
c. Tighten caps of screwcap tubes before storing.
d. Media kept for longer than 1 week should be kept in the 
refrigerator to prevent dehydration.
e. Media showing signs of contamination and dehydration 
should be discarded.
B. NITRATE REDUCTION STANDARDS
STOCK SOLUTIONS
1. 0.067 M disodium phosphate
2. 0.067 M monopotassium phosphate
3. 0.067 M trisodium phosphate
4. 1% phenolphthalein (1 gram in 100 ml 95% ethyl alcohol)
5. 1 % brom thymol blue (1 gram in 100 ml 95% ethyl alcohol)
5A. 0.01% brom thymol blue: prepared by mixing 1.0 ml of 
stock No.5 above in 100 ml distilled water.
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WORKING BUFFER SOLUTION
Mix:
Stock No. 1 ..................................................  35 ml
Stock No. 2 ..................................................  5 ml
Stock No. 3 ..................................................100 ml
PREPARATION OF STANDARDS
1. Line up eight clean test tubes in a rack. Use tubes the same 
size as for the test.
2. Put 2 ml of working buffer solution into seven tubes.
3. To 10 ml of working buffer solution, add 0 .1 ml of stock No. 
4 and 0.2 ml of stock No. 5A.
4. Add 2 ml of the step 3 solution to the 8th tube. This is the 5 + 
color standard.
5. To the first tube in the series of seven tubes, add 2 ml of the 
step 3 solution. Mix well and carry over 2 ml to the next tube. 
Continue to make serial dilutions, discarding 2 ml from the 
7th tube.
6. The color standard:
tube in step 4 = 5 + 
tube 1 = 4  + 
tube 2 = 3 + 
tube 4 = 2+ 
tube 5 = 1  + 
tube 7 = ±
These colors should range from pink (± ) to purplish red 
(5 + ) (see Fig. 46).
7. Autoclave tubes, seal, and store in a refrigerator.
NITRATE RED 
STANDARDS
Figure 46. Nitrate reduction standards.
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C. IN CASE OF ACCIDENT
“Laboratory Safety” doesn’t just happen. It is the end result of: (1) 
the recognition that accidents can, will, and usually do occur at the 
most unpropitious times; (2) an open, rational discussion of ways to 
minimize or prevent such accidents; and (3) the formulation of an 
effective plan to neutralize as quickly as possible the potentially 
harmful effects of those accidents which do occur.
In the Mycobacteriology Laboratory we all hope that a laboratory ac­
cident never occurs, but we must anticipate the eventuality and have 
a well-formulated plan to minimize the spread of potentially infec­
tious mycobacteria. No laboratory accident should be regarded 
lightly, yet not all will be handled in the same manner; there will be 
room for personal judgment. Personnel should be instructed and 
urged to think about and discuss the possible accidents—the things 
that could “go wrong”—associated with each laboratory procedure 
they use.
Perhaps the most feared accidents are those involving the release of 
tubercle bacilli or other mycobacteria into the laboratory air. The 
propensity of such airborne bacilli to be carried to and to infect per­
sonnel at locations distant from the site of the accident (especially in 
buildings having a recirculating air handling system) is great.
The suggestions below are made only on the presumption that your 
institution has a one pass (non-recirculating) air handling system 
which is recommended for those laboratories engaged in work with 
mycobacteria.
NOTE: IF YOU WORK IN A LABORATORY WITH A RECIR­
CULATING AIR HANDLING SYSTEM, YOUR PROBLEMS 
OF CONTAGION CONTAINMENT ARE GREATLY MAGNI­
FIED, AND IT IS NECESSARY TO INDIVIDUALIZE YOUR 
PLANS TO PROTECT PERSONNEL FROM INFECTION. THE 
LABORATORY TRAINING AND CONSULTATION DIVI­
SION, CDC, IS AVAILABLE FOR CONSULTATION IN THESE 
SITUATIONS.
1. M inor Accidents
These accidents might include such things as breakage of a 
single tube of solid medium, dropping a plastic Petri dish so 
the top falls off (breakage may or may not occur), or spillage 
of the contents of a clinical specimen. In such cases the solid 
medium or the thick, often mucoid, nature of the clinical 
specimen would suggest (at least theoretically) that a minimal 
number of bacilli would be aerosolized. Immediate action 
should be taken to cover the spill to minimize further aero-
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solization (cover the site with a large cloth or your lab coat). 
Soak the cloth with disinfectant (e.g., 3% Amphyl) to wet the 
area, thereby minimizing further aerosol formation. Exit the 
room and stay out for 2 to 4 hours to enable the air handling 
system to evacuate most of the aerosolized bacilli. When you 
re-enter, wear protective clothing (a supply should be avail­
able outside the TB room) and mask, carefully clean up the 
spill (autoclave culture tubes, plates, and cloths), and mop the 
floors and countertops with disinfectant. Note that in anti­
cipation of such accidents there should be available a supply 
of large cloths and a reservoir of disinfectant which is readily 
accessible and can be poured quickly and easily.
2. Major Accidents
A major accident cannot be categorized exclusively by the 
volume or quantity of the breakage or spill, even though this 
is one measuring parameter. More important is whether the 
material involved is a liquid and, if so, what is the concentra­
tion of mycobacteria in the suspension. Thus, one or two 
tubes, or a flask of liquid culture containing 108 per ml could 
generate a cloud of droplet nuclei capable of infecting large 
numbers of people exposed to it. Here is where “personal 
judgment” will play a big role. Appropriate action would be:
a. Evacuate the room immediately. The danger from the po­
tentially infectious aerosol is greater than any need to 
“cover the spill.”
b. Leave the BSC operating and do not re-enter the room 
for at least 4 hours. This will enable considerable dilu­
tion of the infectious droplet nuclei. Moreover, evacua­
tion of the air through the HEPA filter system of the BSC 
should reduce the likelihood of people outside the build­
ing becoming infected.
c. Decontaminate the room(s) after the 4-hour waiting 
period by using formaldehyde gas. Because of the ready 
availability of 36% to 40% formalin in most laborato­
ries, this procedure will be outlined:
(1) Seal all air intake and exhaust grills in the room. 
This may be as simple as taping large plastic garbage 
bags over the grills, or as sophisticated as having a 
flanged frame over each grill which will accept a 
metal or solid plastic sheet that can be taped in 
place to insure tightness. In similar fashion, tape 
around door frames or other openings through 
which the formaldehyde may leak.
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(2) Use an electric hot plate to boil off 1 ml of formalin 
per cu. ft. of room space. Example: a room 
10x12x10 feet would have 1200 cu. ft. of space and 
would be treated with 1200 ml of formalin.
CAUTION: DO NOT OVERDOSE THE ROOM 
WITH FORMALDEHYDE, BECAUSE EXPLO­
SIVE CONCENTRATIONS CAN BE AT­
TAINED. THE AMOUNTS LISTED HERE ARE 
WELL WITHIN THE SAFETY RANGE.
(3) Raise the relative humidity of the room to about 
70% to insure optimal effect of the formaldehyde. 
Most Chemistry or Physics handbooks have tables 
of the amount of water that can be held in a given 
volume of air at full saturation; you need only 70% 
of this amount. Calculate the quantity needed and 
boil it off on an electric hot plate. Example: In our 
1200 cu. ft. room; the amount of water needed to 
fully saturate the room at 70°F (21 °C) is 18.45 g (or 
ml) per cubic meter (or per 35.3 cu. ft.). By simple 
mathematics, 1200 cu. ft. divided by 35.3 cu. ft. in 
1 cubic meter x 18.45 g/cubic meter x 0.7 (for 
70% humidity) equals 439 g (or ml) of water. If 500 
ml of water is boiled off in the room at the same 
time (or just before) the formaldehyde is vaporized, 
the desired humidity should be attained.
(4) Allow the formaldehyde to stay in the room over­
night. Put on a gas mask* to enter the room and 
remove the covers from air intake and exhaust grills. 
Allow the room to air until no more formaldehyde 
is detectable, then mop all residue from the floors, 
walls, and counters. If a white, powdery residue is 
obvious, this may be removed with 10% ammonium 
hydroxide (use gloves).
*MSA Chin Type Gas Mask with Ultravue Facepiece available from Mine 
Safety Appliances Co., 400 Penn Center Blvd., Pittsburgh, PA 15235. Should 
be used with Chin Type Canister. Type GM R, Approximate cost with canister 
is $90.00 (1979-80).
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